activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177488	CHEMBL761878	Inhibition of PKCtheta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	66.0	CHEMBL3920	Homo sapiens	Activity	%	66.0
	177488	CHEMBL761878	Inhibition of PKCtheta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	66.0	CHEMBL3920	Homo sapiens	Activity	%	66.0
	178801	CHEMBL761878	Inhibition of PKCtheta	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	46.0	CHEMBL3920	Homo sapiens	Activity	%	46.0
	182548	CHEMBL761878	Inhibition of PKCtheta	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	71.0	CHEMBL3920	Homo sapiens	Activity	%	71.0
Not Determined	308758	CHEMBL771062	Displacement of [3H]PDBu from protein kinase C Theta-C1A domain (Not tested)	B	CCCCCCCCCCCN1c2ccccc2C[C@@H](CO)OC(=O)[C@@H]1C(C)C		CHEMBL102991		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	308759	CHEMBL771065	Displacement of [3H]PDBu from protein kinase C Theta-C1B domain	B	CCCCCCCCCCCN1c2ccccc2C[C@@H](CO)OC(=O)[C@@H]1C(C)C		CHEMBL102991	=	Ki	nM	358.0	CHEMBL3920	Homo sapiens	Ki	nM	358.0
	308772	CHEMBL771061	Binding affinity for protein kinase C Theta-C1A domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	>	Kd	nM	200.0	CHEMBL3920	Homo sapiens	Kd	nM	200.0
	308773	CHEMBL771064	Binding affinity for protein kinase C Theta-C1B domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.72	CHEMBL3920	Homo sapiens	Kd	nM	0.72
Not Determined	312757	CHEMBL771062	Displacement of [3H]PDBu from protein kinase C Theta-C1A domain (Not tested)	B	CCCCCCCCCCc1ccc2c(c1)N(C)[C@@H](C(C)C)C(=O)O[C@H](CO)C2		CHEMBL102858		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	312758	CHEMBL771065	Displacement of [3H]PDBu from protein kinase C Theta-C1B domain	B	CCCCCCCCCCc1ccc2c(c1)N(C)[C@@H](C(C)C)C(=O)O[C@H](CO)C2		CHEMBL102858	=	Ki	nM	62.0	CHEMBL3920	Homo sapiens	Ki	nM	62.0
Not Determined	330331	CHEMBL771063	Displacement of [3H]PDBu from protein kinase C Theta-C1A domain (Not tested)	B	CCCCCCCCCCc1cccc2c1C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL103091		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	330332	CHEMBL771065	Displacement of [3H]PDBu from protein kinase C Theta-C1B domain	B	CCCCCCCCCCc1cccc2c1C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL103091	=	Ki	nM	167.0	CHEMBL3920	Homo sapiens	Ki	nM	167.0
Not Determined	330345	CHEMBL771062	Displacement of [3H]PDBu from protein kinase C Theta-C1A domain (Not tested)	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	330346	CHEMBL771065	Displacement of [3H]PDBu from protein kinase C Theta-C1B domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	=	Ki	nM	1100.0	CHEMBL3920	Homo sapiens	Ki	nM	1100.0
Not Determined	489542	CHEMBL772581	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C theta C1a domain (Not tested)	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	489543	CHEMBL771059	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C theta C1b domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	=	Ki	nM	1097.0	CHEMBL3920	Homo sapiens	Ki	nM	1097.0
Not Determined	506216	CHEMBL772581	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C theta C1a domain (Not tested)	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	506217	CHEMBL771059	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C theta C1b domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	8.7	CHEMBL3920	Homo sapiens	Ki	nM	8.7
Not Determined	507445	CHEMBL772581	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C theta C1a domain (Not tested)	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	507446	CHEMBL771059	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C theta C1b domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205	=	Ki	nM	13.2	CHEMBL3920	Homo sapiens	Ki	nM	13.2
	616553	CHEMBL772577	Inhibition of Protein kinase C theta at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	82.0	CHEMBL3920	Homo sapiens	Control	%	82.0
	616592	CHEMBL772578	Inhibition of Protein kinase C theta at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	58.0	CHEMBL3920	Homo sapiens	Control	%	58.0
	764594	CHEMBL772580	Binding affinity for Protein kinase C theta C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	>	Kd	nM	200.0	CHEMBL3920	Homo sapiens	Kd	nM	200.0
	764595	CHEMBL771057	Binding affinity for Protein kinase C theta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.72	CHEMBL3920	Homo sapiens	Kd	nM	0.72
Not Determined	769092	CHEMBL771056	Displacement of [3H]- PDBu from Protein kinase C theta C1a domain (Not tested)	B	CC(C)[C@H]1/C(S)=N/[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL63262		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	769093	CHEMBL771060	Displacement of [3H]- PDBu from Protein kinase C theta C1b domain	B	CC(C)[C@H]1/C(S)=N/[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL63262	=	Ki	nM	61.6	CHEMBL3920	Homo sapiens	Ki	nM	61.6
Not Determined	770050	CHEMBL771056	Displacement of [3H]- PDBu from Protein kinase C theta C1a domain (Not tested)	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266		Ki	nM		CHEMBL3920	Homo sapiens	Ki	nM	
	770051	CHEMBL771060	Displacement of [3H]- PDBu from Protein kinase C theta C1b domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	8.7	CHEMBL3920	Homo sapiens	Ki	nM	8.7
	866926	CHEMBL771058	Displacement of 3[H]PDBu from Protein kinase C theta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@H]3C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL265998	=	Ki	nM	0.73	CHEMBL3920	Homo sapiens	Ki	nM	0.73
	902319	CHEMBL771058	Displacement of 3[H]PDBu from Protein kinase C theta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	1.54	CHEMBL3920	Homo sapiens	Ki	nM	1.54
	910416	CHEMBL772576	Inhibition of Protein kinase C theta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340935	=	IC50	nM	835.0	CHEMBL3920	Homo sapiens	IC50	uM	0.835
	915723	CHEMBL772576	Inhibition of Protein kinase C theta	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	915764	CHEMBL772575	Inhibition of Protein kinase C theta at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	71.0	CHEMBL3920	Homo sapiens	Activity	%	71.0
	918243	CHEMBL772576	Inhibition of Protein kinase C theta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2ccccc21		CHEMBL340259	=	IC50	nM	65.0	CHEMBL3920	Homo sapiens	IC50	uM	0.065
	931184	CHEMBL772576	Inhibition of Protein kinase C theta	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	931225	CHEMBL772579	Inhibition of Protein kinase C theta at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	88.0	CHEMBL3920	Homo sapiens	Activity	%	88.0
	1189634	CHEMBL772803	Displacement of [3H]PDBu from protein kinase C theta-C1B domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL46252	=	Ki	nM	6.6	CHEMBL3920	Homo sapiens	Ki	nM	6.6
	1192010	CHEMBL772803	Displacement of [3H]PDBu from protein kinase C theta-C1B domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL46053	=	Ki	nM	147.5	CHEMBL3920	Homo sapiens	Ki	nM	147.5
	1197032	CHEMBL772803	Displacement of [3H]PDBu from protein kinase C theta-C1B domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)CCO[C@H](C(C)(C)C)C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O3		CHEMBL45053	=	Ki	nM	24.1	CHEMBL3920	Homo sapiens	Ki	nM	24.1
	1214213	CHEMBL772802	Displacement of [3H]PDBu from protein kinase C theta-C1B domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	3.4	CHEMBL3920	Homo sapiens	Kd	nM	3.4
	1483088	CHEMBL835540	Percentage inhibition of Protein kinase C theta at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Activity	%	78.0	CHEMBL3920	Homo sapiens	Activity	%	78.0
	1483100	CHEMBL835540	Percentage inhibition of Protein kinase C theta at 50 uM	B	CCCCCNC1=C(c2cn(C)c3ccccc23)C(=O)N(C)C1=O		CHEMBL365337	=	Activity	%	100.0	CHEMBL3920	Homo sapiens	Activity	%	100.0
Not Determined	1711424	CHEMBL869665	Displacement of [3H]phorbol 12,13-dibutyrate from PKC theta-C1A	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866		Ki			CHEMBL3920	Homo sapiens	Ki		
	1711425	CHEMBL869666	Displacement of [3H]phorbol 12,13-dibutyrate from PKC theta-C1B	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ki	nM	290.0	CHEMBL3920	Homo sapiens	Ki	nM	290.0
	1734108	CHEMBL862827	Residual activity at human PKCtheta at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	102.0	CHEMBL3920	Homo sapiens	Activity	%	102.0
	1748673	CHEMBL870364	Inhibition of PKCtheta	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	uM	5.0
	1790055	CHEMBL855316	Percentage activity of human PKC theta in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	113.0	CHEMBL3920	Homo sapiens	Activity	%	113.0
	1898419	CHEMBL887689	Inhibition of PKCtheta	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL3920	Homo sapiens	Activity	uM	10.0
	1923434	CHEMBL896208	Inhibition of PKCtheta	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	>	IC50	nM	50000.0	CHEMBL3920	Homo sapiens	IC50	uM	50.0
	2012734	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(Nc3cc(Cl)cc(Cl)c3)ncc2[N+](=O)[O-])CC1		CHEMBL394069	=	IC50	nM	680.0	CHEMBL3920	Homo sapiens	IC50	uM	0.68
	2012735	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCCCCCCCNc1nc(NCc2ccccc2Cl)ncc1[N+](=O)[O-]		CHEMBL246367	=	IC50	nM	110.0	CHEMBL3920	Homo sapiens	IC50	uM	0.11
	2012736	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCCCCCNc1nc(NCc2ccccc2Cl)ncc1[N+](=O)[O-]		CHEMBL246366	=	IC50	nM	450.0	CHEMBL3920	Homo sapiens	IC50	uM	0.45
	2012737	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCCCNc1nc(NCc2ccccc2Cl)ncc1[N+](=O)[O-]		CHEMBL391958	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	2012738	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	O=[N+]([O-])c1cnc(NCc2ccccc2Cl)nc1NCC1CCNCC1		CHEMBL246161	=	IC50	nM	90.0	CHEMBL3920	Homo sapiens	IC50	uM	0.09
	2012739	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCc1cccc(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])c1		CHEMBL391754	=	IC50	nM	200.0	CHEMBL3920	Homo sapiens	IC50	uM	0.2
	2012740	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])C1		CHEMBL246365	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	uM	0.003
	2012741	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	CC(=O)NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL428405	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	2012742	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	CN(C)CC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246160	=	IC50	nM	54.0	CHEMBL3920	Homo sapiens	IC50	uM	0.054
	2012743	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCc1ccc(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])cc1		CHEMBL391753	=	IC50	nM	160.0	CHEMBL3920	Homo sapiens	IC50	uM	0.16
	2012744	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NC[C@H]1CC[C@H](CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL395691	=	IC50	nM	29.0	CHEMBL3920	Homo sapiens	IC50	uM	0.029
	2012745	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NC[C@H]1CC[C@@H](CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246159	=	IC50	nM	18.0	CHEMBL3920	Homo sapiens	IC50	uM	0.018
	2012746	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	O=[N+]([O-])c1cnc(NCc2ccccc2Cl)nc1NCC1CCCCC1		CHEMBL427874	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	2012747	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCCc3ccc(F)cc3)ncc2[N+](=O)[O-])CC1		CHEMBL247377	=	IC50	nM	77.0	CHEMBL3920	Homo sapiens	IC50	uM	0.077
	2012748	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCCc3cccc(F)c3)ncc2[N+](=O)[O-])CC1		CHEMBL391610	=	IC50	nM	54.0	CHEMBL3920	Homo sapiens	IC50	uM	0.054
	2012749	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCCc3ccccc3F)ncc2[N+](=O)[O-])CC1		CHEMBL247177	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	uM	0.13
	2012750	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	Cc1ccccc1CCNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL247176	=	IC50	nM	180.0	CHEMBL3920	Homo sapiens	IC50	uM	0.18
	2012751	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCCCCc3ccccc3)ncc2[N+](=O)[O-])CC1		CHEMBL391609	=	IC50	nM	90.0	CHEMBL3920	Homo sapiens	IC50	uM	0.09
	2012752	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCCCc3ccccc3)ncc2[N+](=O)[O-])CC1		CHEMBL397397	=	IC50	nM	270.0	CHEMBL3920	Homo sapiens	IC50	uM	0.27
	2012753	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCCc3ccccc3)ncc2[N+](=O)[O-])CC1		CHEMBL247573	=	IC50	nM	94.0	CHEMBL3920	Homo sapiens	IC50	uM	0.094
	2012754	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NC3Cc4ccccc4C3)ncc2[N+](=O)[O-])CC1		CHEMBL247572	=	IC50	nM	31.0	CHEMBL3920	Homo sapiens	IC50	uM	0.031
	2012755	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(N[C@@H]3CCc4ccccc43)ncc2[N+](=O)[O-])CC1		CHEMBL246550	=	IC50	nM	460.0	CHEMBL3920	Homo sapiens	IC50	uM	0.46
	2012756	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(N[C@H]3CCc4ccccc43)ncc2[N+](=O)[O-])CC1		CHEMBL246532	=	IC50	nM	4400.0	CHEMBL3920	Homo sapiens	IC50	uM	4.4
	2012757	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	C[C@@H](Nc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1)c1ccccc1		CHEMBL392261	=	IC50	nM	5700.0	CHEMBL3920	Homo sapiens	IC50	uM	5.7
	2012758	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	C[C@H](Nc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1)c1ccccc1		CHEMBL246326	=	IC50	nM	3700.0	CHEMBL3920	Homo sapiens	IC50	uM	3.7
	2012759	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	CC(C)(Nc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1)c1ccccc1		CHEMBL246325	=	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	2012760	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NC(=O)c3ccccc3Br)ncc2[N+](=O)[O-])CC1		CHEMBL246121	=	IC50	nM	2200.0	CHEMBL3920	Homo sapiens	IC50	uM	2.2
	2012761	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	COc1cc(CNc2ncc([N+](=O)[O-])c(NCC3CCC(CN)CC3)n2)cc(OC)c1		CHEMBL394114	=	IC50	nM	1500.0	CHEMBL3920	Homo sapiens	IC50	uM	1.5
	2012762	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cc(Cl)cc(Cl)c3)ncc2[N+](=O)[O-])CC1		CHEMBL394113	=	IC50	nM	400.0	CHEMBL3920	Homo sapiens	IC50	uM	0.4
	2012763	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	Cc1ccc(C)c(CNc2ncc([N+](=O)[O-])c(NCC3CCC(CN)CC3)n2)c1		CHEMBL245914	=	IC50	nM	910.0	CHEMBL3920	Homo sapiens	IC50	uM	0.91
	2012764	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	Cc1cccc(CNc2ncc([N+](=O)[O-])c(NCC3CCC(CN)CC3)n2)c1C		CHEMBL245912	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	uM	0.013
	2012765	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	Cc1c(Cl)cccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL246387	=	IC50	nM	46.0	CHEMBL3920	Homo sapiens	IC50	uM	0.046
	2012766	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cc(Cl)ccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246386	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	uM	0.007
	2012767	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccc(Cl)cc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246184	=	IC50	nM	27.0	CHEMBL3920	Homo sapiens	IC50	uM	0.027
	2012768	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cccc(Cl)c3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246183	=	IC50	nM	8.0	CHEMBL3920	Homo sapiens	IC50	uM	0.008
	2012769	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3c(F)cccc3F)ncc2[N+](=O)[O-])CC1		CHEMBL246182	=	IC50	nM	42.0	CHEMBL3920	Homo sapiens	IC50	uM	0.042
	2012770	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cc(F)ccc3F)ncc2[N+](=O)[O-])CC1		CHEMBL396370	=	IC50	nM	35.0	CHEMBL3920	Homo sapiens	IC50	uM	0.035
	2012771	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccc(F)cc3F)ncc2[N+](=O)[O-])CC1		CHEMBL245982	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	uM	0.1
	2012772	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cccc(F)c3F)ncc2[N+](=O)[O-])CC1		CHEMBL245783	=	IC50	nM	22.0	CHEMBL3920	Homo sapiens	IC50	uM	0.022
	2012773	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3[N+](=O)[O-])ncc2[N+](=O)[O-])CC1		CHEMBL396929	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	uM	0.011
	2012774	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3-c3ccccc3)ncc2[N+](=O)[O-])CC1		CHEMBL246177	=	IC50	nM	39.0	CHEMBL3920	Homo sapiens	IC50	uM	0.039
	2012775	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3Br)ncc2[N+](=O)[O-])CC1		CHEMBL246175	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	uM	0.005
	2012776	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	uM	0.005
	2012777	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3SC(F)(F)F)ncc2[N+](=O)[O-])CC1		CHEMBL246174	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	uM	0.006
	2012778	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3C(F)F)ncc2[N+](=O)[O-])CC1		CHEMBL245977	=	IC50	nM	15.0	CHEMBL3920	Homo sapiens	IC50	uM	0.015
	2012779	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3OC(F)(F)F)ncc2[N+](=O)[O-])CC1		CHEMBL248183	=	IC50	nM	18.0	CHEMBL3920	Homo sapiens	IC50	uM	0.018
	2012780	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3C(F)(F)F)ncc2[N+](=O)[O-])CC1		CHEMBL247979	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	uM	0.012
	2012781	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	Cc1cccc(CNc2ncc([N+](=O)[O-])c(NCC3CCC(CN)CC3)n2)c1		CHEMBL438669	=	IC50	nM	39.0	CHEMBL3920	Homo sapiens	IC50	uM	0.039
	2012782	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	Cc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL428751	=	IC50	nM	34.0	CHEMBL3920	Homo sapiens	IC50	uM	0.034
	2012783	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	COc1ccc(CNc2ncc([N+](=O)[O-])c(NCC3CCC(CN)CC3)n2)cc1		CHEMBL245960	=	IC50	nM	12000.0	CHEMBL3920	Homo sapiens	IC50	uM	12.0
	2012784	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	COc1cccc(CNc2ncc([N+](=O)[O-])c(NCC3CCC(CN)CC3)n2)c1		CHEMBL395160	=	IC50	nM	210.0	CHEMBL3920	Homo sapiens	IC50	uM	0.21
	2012785	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	COc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL395690	=	IC50	nM	17.0	CHEMBL3920	Homo sapiens	IC50	uM	0.017
	2012786	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccc(F)cc3)ncc2[N+](=O)[O-])CC1		CHEMBL245958	=	IC50	nM	210.0	CHEMBL3920	Homo sapiens	IC50	uM	0.21
	2012787	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cccc(F)c3)ncc2[N+](=O)[O-])CC1		CHEMBL245757	=	IC50	nM	83.0	CHEMBL3920	Homo sapiens	IC50	uM	0.083
	2012788	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3F)ncc2[N+](=O)[O-])CC1		CHEMBL395689	=	IC50	nM	48.0	CHEMBL3920	Homo sapiens	IC50	uM	0.048
	2012789	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccc(Cl)cc3)ncc2[N+](=O)[O-])CC1		CHEMBL246972	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	uM	0.17
	2012790	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3cccc(Cl)c3)ncc2[N+](=O)[O-])CC1		CHEMBL437941	=	IC50	nM	85.0	CHEMBL3920	Homo sapiens	IC50	uM	0.085
	2012791	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	IC50	nM	46.0	CHEMBL3920	Homo sapiens	IC50	uM	0.046
	2012792	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(NCc3ccccc3)ncc2[N+](=O)[O-])CC1		CHEMBL247571	=	IC50	nM	500.0	CHEMBL3920	Homo sapiens	IC50	uM	0.5
	2012793	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(Nc3cccc(Cl)c3)ncc2C(F)(F)F)CC1		CHEMBL247376	=	IC50	nM	640.0	CHEMBL3920	Homo sapiens	IC50	uM	0.64
	2012794	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(Nc3cccc(Cl)c3)ncc2[N+](=O)[O-])CC1		CHEMBL396924	=	IC50	nM	60.0	CHEMBL3920	Homo sapiens	IC50	uM	0.06
	2012795	CHEMBL902302	Inhibition of PKCtheta by FP assay	B	NCC1CCC(CNc2nc(Nc3cc(Cl)cc(Cl)c3)ncc2C(F)(F)F)CC1		CHEMBL247375	=	IC50	nM	4200.0	CHEMBL3920	Homo sapiens	IC50	uM	4.2
	2012828	CHEMBL902303	Inhibition of PKCtheta in presence of 50 uM ATP	B	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	IC50	nM	290.0	CHEMBL3920	Homo sapiens	IC50	uM	0.29
	2012829	CHEMBL902304	Inhibition of PKCtheta in presence of 100 uM ATP	B	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	IC50	nM	630.0	CHEMBL3920	Homo sapiens	IC50	uM	0.63
	2025185	CHEMBL887012	Inhibition of human PKCtheta at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	27.0	CHEMBL3920	Homo sapiens	Inhibition	%	27.0
	2025447	CHEMBL887012	Inhibition of human PKCtheta at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	21.0	CHEMBL3920	Homo sapiens	Inhibition	%	21.0
	2025448	CHEMBL887012	Inhibition of human PKCtheta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	33.0	CHEMBL3920	Homo sapiens	Inhibition	%	33.0
	2025449	CHEMBL887012	Inhibition of human PKCtheta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	29.0	CHEMBL3920	Homo sapiens	Inhibition	%	29.0
	2025517	CHEMBL885894	Inhibition of human PKCtheta	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	IC50	nM	98.0	CHEMBL3920	Homo sapiens	IC50	nM	98.0
	2050278	CHEMBL925574	Inhibition of PKC theta at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	0.0	CHEMBL3920	Homo sapiens	Inhibition	%	0.0
	2064414	CHEMBL927266	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	8.7	CHEMBL3920	Homo sapiens	Ki	nM	8.7
	2064424	CHEMBL927266	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ki	nM	290.0	CHEMBL3920	Homo sapiens	Ki	nM	290.0
	2064434	CHEMBL927266	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C2		CHEMBL399981	=	Ki	nM	1.4	CHEMBL3920	Homo sapiens	Ki	nM	1.4
	2064444	CHEMBL927266	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ki	nM	12.0	CHEMBL3920	Homo sapiens	Ki	nM	12.0
	2068376	CHEMBL944943	Inhibition of PKC theta	B	Oc1cc(O)c(-c2noc3ccc(NCCN4CCOCC4)cc23)cc1Cl		CHEMBL404630	>	IC50	nM	20000.0	CHEMBL3920	Homo sapiens	IC50	uM	20.0
	2085343	CHEMBL929994	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3nc(C(F)(F)F)c4ccc(c2c43)N1C		CHEMBL261387	=	Ki	nM	51.1	CHEMBL3920	Homo sapiens	Ki	nM	51.1
	2085354	CHEMBL929994	Displacement of [3H]PDBu from PKCtheta C1B domain	B	Cc1nn2cc3c4c(ccc1c42)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C3		CHEMBL441897	=	Ki	nM	149.0	CHEMBL3920	Homo sapiens	Ki	nM	149.0
	2085355	CHEMBL929994	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3ncc4ccc(c2c43)N1C		CHEMBL271403	=	Ki	nM	18.6	CHEMBL3920	Homo sapiens	Ki	nM	18.6
	2085367	CHEMBL929994	Displacement of [3H]PDBu from PKCtheta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	8.7	CHEMBL3920	Homo sapiens	Ki	nM	8.7
	2144712	CHEMBL934582	Inhibition of PKCtheta	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	>	IC50	nM	11000.0	CHEMBL3920	Homo sapiens	IC50	nM	11000.0
	2144716	CHEMBL935467	Inhibition of PKCtheta at 10 uM	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	=	Inhibition	%	8.0	CHEMBL3920	Homo sapiens	Inhibition	%	8.0
	2147361	CHEMBL922146	Activity of human PKCtheta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	112.0	CHEMBL3920	Homo sapiens	Activity	%	112.0
	2168078	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Nc1ccc2[nH]ccc2c1		CHEMBL409155	=	IC50	nM	460.0	CHEMBL3920	Homo sapiens	IC50	nM	460.0
	2168079	CHEMBL927978	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL402818	=	IC50	nM	7.5	CHEMBL3920	Homo sapiens	IC50	nM	7.5
	2168080	CHEMBL927978	Inhibition of PKCtheta	B	CN(C)Cc1ccccc1-c1cc2c(Nc3ccc4[nH]ccc4c3)c(C#N)cnc2s1		CHEMBL253755	=	IC50	nM	570.0	CHEMBL3920	Homo sapiens	IC50	nM	570.0
	2168081	CHEMBL927978	Inhibition of PKCtheta	B	CN1CCN(Cc2ccccc2-c2cc3c(Nc4ccc5[nH]ccc5c4)c(C#N)cnc3s2)CC1		CHEMBL256318	=	IC50	nM	730.0	CHEMBL3920	Homo sapiens	IC50	nM	730.0
	2168082	CHEMBL927978	Inhibition of PKCtheta	B	CN(C)Cc1cccc(-c2cc3c(Nc4ccc5[nH]ccc5c4)c(C#N)cnc3s2)c1		CHEMBL256317	=	IC50	nM	75.0	CHEMBL3920	Homo sapiens	IC50	nM	75.0
	2168083	CHEMBL927978	Inhibition of PKCtheta	B	CN1CCN(Cc2cccc(-c3cc4c(Nc5ccc6[nH]ccc6c5)c(C#N)cnc4s3)c2)CC1		CHEMBL256533	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	2168084	CHEMBL927978	Inhibition of PKCtheta	B	CN(C)Cc1ccc(-c2cc3c(Nc4ccc5[nH]ccc5c4)c(C#N)cnc3s2)cc1		CHEMBL257818	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	nM	130.0
	2168085	CHEMBL927978	Inhibition of PKCtheta	B	CN1CCN(Cc2ccc(-c3cc4c(Nc5ccc6[nH]ccc6c5)c(C#N)cnc4s3)cc2)CC1		CHEMBL401611	=	IC50	nM	200.0	CHEMBL3920	Homo sapiens	IC50	nM	200.0
	2168086	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccc(CN4CCOCC4)cc3)cc2c1Nc1ccc2[nH]ccc2c1		CHEMBL257819	=	IC50	nM	450.0	CHEMBL3920	Homo sapiens	IC50	nM	450.0
	2168087	CHEMBL927978	Inhibition of PKCtheta	B	CCc1c(Nc2c(C#N)cnc3sc(-c4ccccc4)cc23)ccc2[nH]ccc12		CHEMBL256739	=	IC50	nM	830.0	CHEMBL3920	Homo sapiens	IC50	nM	830.0
	2168088	CHEMBL927978	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4ccccc4)cc23)ccc2[nH]ccc12		CHEMBL256535	=	IC50	nM	52.0	CHEMBL3920	Homo sapiens	IC50	nM	52.0
	2168089	CHEMBL927978	Inhibition of PKCtheta	B	Cc1c[nH]c2ccc(Nc3c(C#N)cnc4sc(-c5ccccc5)cc34)cc12		CHEMBL256740	=	IC50	nM	1300.0	CHEMBL3920	Homo sapiens	IC50	nM	1300.0
	2168090	CHEMBL927978	Inhibition of PKCtheta	B	Cc1cc2cc(Nc3c(C#N)cnc4sc(-c5ccccc5)cc34)ccc2[nH]1		CHEMBL403187	=	IC50	nM	1800.0	CHEMBL3920	Homo sapiens	IC50	nM	1800.0
	2168091	CHEMBL927978	Inhibition of PKCtheta	B	Cn1ccc2cc(Nc3c(C#N)cnc4sc(-c5ccccc5)cc34)ccc21		CHEMBL401702	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	2168092	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1NC(=O)c1ccc2[nH]ccc2c1		CHEMBL257194	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	2168093	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1NCc1ccc2[nH]ccc2c1		CHEMBL401703	=	IC50	nM	3700.0	CHEMBL3920	Homo sapiens	IC50	nM	3700.0
	2168094	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Oc1ccc2[nH]ccc2c1		CHEMBL258383	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	2168095	CHEMBL927978	Inhibition of PKCtheta	B	CN(c1ccc2[nH]ccc2c1)c1c(C#N)cnc2sc(-c3ccccc3)cc12		CHEMBL258382	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	2168096	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Nc1cccc2cc[nH]c12		CHEMBL255238	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	2168097	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Nc1ccc2cc[nH]c2c1		CHEMBL439413	>	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	2168098	CHEMBL927978	Inhibition of PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Nc1cccc2[nH]ccc12		CHEMBL409274	=	IC50	nM	230.0	CHEMBL3920	Homo sapiens	IC50	nM	230.0
	2168119	CHEMBL927978	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL402818	=	Ki	nM	9.0	CHEMBL3920	Homo sapiens	Ki	nM	9.0
	2168121	CHEMBL927989	Inhibition of PKCtheta in wild type T-cell assessed as blockade of anti CD3-stimulated IL2 production	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL402818	=	IC50	nM	230.0	CHEMBL3920	Homo sapiens	IC50	nM	230.0
	2182442	CHEMBL941328	Inhibition of PKCtheta at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	36.0	CHEMBL3920	Homo sapiens	INH	%	36.0
	2251066	CHEMBL1011941	Inhibition of PKCtheta at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	97.0	CHEMBL3920	Homo sapiens	INH	%	97.0
	2362651	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Br)c2)cc1OC		CHEMBL448406	=	IC50	nM	4600.0	CHEMBL3920	Homo sapiens	IC50	uM	4.6
	2362652	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3cc[nH]c3c2)cc1OC		CHEMBL492252	=	IC50	nM	2000.0	CHEMBL3920	Homo sapiens	IC50	uM	2.0
	2362653	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	=	IC50	nM	70.0	CHEMBL3920	Homo sapiens	IC50	uM	0.07
	2362654	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(Nc2c(C#N)cncc2-c2ccc(OC)c(OC)c2)cc1OC		CHEMBL521814	=	IC50	nM	2200.0	CHEMBL3920	Homo sapiens	IC50	uM	2.2
	2362655	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc(Cl)c(Cl)c2)cc1OC		CHEMBL492688	=	IC50	nM	2400.0	CHEMBL3920	Homo sapiens	IC50	uM	2.4
	2362656	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cc(Cl)ccc2Cl)cc1OC		CHEMBL495139	=	IC50	nM	470.0	CHEMBL3920	Homo sapiens	IC50	uM	0.47
	2362657	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc(C)cc2C)cc1OC		CHEMBL495138	=	IC50	nM	160.0	CHEMBL3920	Homo sapiens	IC50	uM	0.16
	2362658	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc(Cl)cc2Cl)cc1OC		CHEMBL522199	=	IC50	nM	80.0	CHEMBL3920	Homo sapiens	IC50	uM	0.08
	2362659	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc(Oc3ccccc3)cc2)cc1OC		CHEMBL493716	=	IC50	nM	8400.0	CHEMBL3920	Homo sapiens	IC50	uM	8.4
	2362660	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(Nc2c(C#N)cncc2-c2ccc(OC)c(OC)c2)cc1		CHEMBL522677	=	IC50	nM	400.0	CHEMBL3920	Homo sapiens	IC50	uM	0.4
	2362661	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc(C)cc2)cc1OC		CHEMBL523688	=	IC50	nM	900.0	CHEMBL3920	Homo sapiens	IC50	uM	0.9
	2362662	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc(Cl)cc2)cc1OC		CHEMBL494314	=	IC50	nM	2800.0	CHEMBL3920	Homo sapiens	IC50	uM	2.8
	2362663	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(OCc3ccccc3)c2)cc1OC		CHEMBL494313	>	IC50	nM	30000.0	CHEMBL3920	Homo sapiens	IC50	uM	30.0
	2362664	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Oc3ccccc3)c2)cc1OC		CHEMBL493918	>	IC50	nM	30000.0	CHEMBL3920	Homo sapiens	IC50	uM	30.0
	2362665	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(F)c2)cc1OC		CHEMBL495128	=	IC50	nM	1400.0	CHEMBL3920	Homo sapiens	IC50	uM	1.4
	2362666	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Cl)c2)cc1OC		CHEMBL523718	=	IC50	nM	3900.0	CHEMBL3920	Homo sapiens	IC50	uM	3.9
	2362667	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccccc2)cc1OC		CHEMBL494927	=	IC50	nM	1600.0	CHEMBL3920	Homo sapiens	IC50	uM	1.6
	2362668	CHEMBL1034873	Inhibition of PKCtheta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3c(c2)CCC3)cc1OC		CHEMBL492450	=	IC50	nM	2200.0	CHEMBL3920	Homo sapiens	IC50	uM	2.2
	2362675	CHEMBL1034870	Inhibition of recombinant PKCtheta kinase domain by Lineweaver-Burke plot	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	=	Ki	nM	79.0	CHEMBL3920	Homo sapiens	Ki	uM	0.079
	2362697	CHEMBL1035665	Displacement of FITC-BIM-1 fluorescent probe from PKCtheta by fluorescence polarization competition displacement method	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	=	IC50	nM	150.0	CHEMBL3920	Homo sapiens	IC50	uM	0.15
	2362701	CHEMBL1034870	Inhibition of recombinant PKCtheta kinase domain by Lineweaver-Burke plot	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Br)c2)cc1OC		CHEMBL448406	=	Ki	nM	4900.0	CHEMBL3920	Homo sapiens	Ki	uM	4.9
	2362702	CHEMBL1035665	Displacement of FITC-BIM-1 fluorescent probe from PKCtheta by fluorescence polarization competition displacement method	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Br)c2)cc1OC		CHEMBL448406	=	IC50	nM	150.0	CHEMBL3920	Homo sapiens	IC50	nM	150.0
Active	2362703	CHEMBL1034871	Binding affinity to PKCtheta assessed as saturation transfer difference at 80 uM by NMR	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Br)c2)cc1OC		CHEMBL448406		Activity			CHEMBL3920	Homo sapiens	Activity		
Not Active	2362704	CHEMBL1034872	Binding affinity to PKCtheta assessed as saturation transfer difference at 80 uM by NMR in presence of BIM-1	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc(Br)c2)cc1OC		CHEMBL448406		Activity			CHEMBL3920	Homo sapiens	Activity		
	2367320	CHEMBL1028106	Inhibition of human PKCtheta	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	uM	0.002
	2401975	CHEMBL1011860	Inhibition of PKCtheta	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1		CHEMBL504547	=	IC50	nM	25900.0	CHEMBL3920	Homo sapiens	IC50	uM	25.9
	2419148	CHEMBL1019636	Inhibition of PRKCQ at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	22.0	CHEMBL3920	Homo sapiens	INH	%	22.0
	2467258	CHEMBL991661	Inhibition of PKCtheta in presence of 6 uM ATP	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	IC50	nM	27400.0	CHEMBL3920	Homo sapiens	IC50	uM	27.4
	2470321	CHEMBL992498	Inhibition of PRKCQ at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3920	Homo sapiens	INH	%	10.0
	2489339	CHEMBL991248	Inhibition of human full length PKCtheta	B	COc1c(CN(C)C)cccc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL480223	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	2489340	CHEMBL991248	Inhibition of human full length PKCtheta	B	COc1ccc(CN(C)C)c(-c2cc3c(Nc4ccc5[nH]ccc5c4C)c(C#N)cnc3s2)c1		CHEMBL479835	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
	2489341	CHEMBL991248	Inhibition of human full length PKCtheta	B	Cc1ccc(CN(C)C)cc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL480222	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	2489342	CHEMBL991248	Inhibition of human full length PKCtheta	B	CCOc1ccc(CN(C)C)cc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL479470	=	IC50	nM	9.2	CHEMBL3920	Homo sapiens	IC50	nM	9.2
	2489343	CHEMBL991248	Inhibition of human full length PKCtheta	B	COc1ccc(CN(C)C)cc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL516913	=	IC50	nM	8.7	CHEMBL3920	Homo sapiens	IC50	nM	8.7
	2489344	CHEMBL991248	Inhibition of human full length PKCtheta	B	COc1ccccc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL480839	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	nM	23.0
	2489345	CHEMBL991248	Inhibition of human full length PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cncc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL518942	=	IC50	nM	84.0	CHEMBL3920	Homo sapiens	IC50	nM	84.0
	2489346	CHEMBL991248	Inhibition of human full length PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4csc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL480838	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
	2489347	CHEMBL991248	Inhibition of human full length PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4ccccc4CN(C)C)cc23)ccc2[nH]ccc12		CHEMBL480641	=	IC50	nM	93.0	CHEMBL3920	Homo sapiens	IC50	nM	93.0
	2489348	CHEMBL991248	Inhibition of human full length PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4ccc(CN(C)C)cc4)cc23)ccc2[nH]ccc12		CHEMBL471795	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	2489349	CHEMBL991248	Inhibition of human full length PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL402818	=	IC50	nM	7.5	CHEMBL3920	Homo sapiens	IC50	nM	7.5
	2489350	CHEMBL991248	Inhibition of human full length PKCtheta	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Nc1ccc2[nH]ccc2c1		CHEMBL409155	=	IC50	nM	52.0	CHEMBL3920	Homo sapiens	IC50	nM	52.0
	2528959	CHEMBL985894	Inhibition of PKCtheta	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	>	IC50	nM	30000.0	CHEMBL3920	Homo sapiens	IC50	uM	30.0
	2559669	CHEMBL986466	Inhibition of PKCtheta	B	N#Cc1cnc2sc(/C=C/C(=O)N3CCCC3)cc2c1Nc1ccc2[nH]ccc2c1		CHEMBL479058	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	nM	130.0
	2559686	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	=	IC50	nM	3.8	CHEMBL3920	Homo sapiens	IC50	nM	3.8
	2559687	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)c(C)c23)ccc2[nH]ccc12		CHEMBL479057	=	IC50	nM	3.5	CHEMBL3920	Homo sapiens	IC50	nM	3.5
	2559688	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(C(=O)N5CCCC5)c4)cc23)ccc2[nH]ccc12		CHEMBL476746	=	IC50	nM	58.0	CHEMBL3920	Homo sapiens	IC50	nM	58.0
	2559689	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(CCC(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL476134	=	IC50	nM	250.0	CHEMBL3920	Homo sapiens	IC50	nM	250.0
	2559690	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)NN4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL515456	=	IC50	nM	370.0	CHEMBL3920	Homo sapiens	IC50	nM	370.0
	2559691	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)NN(C)C)cc23)ccc2[nH]ccc12		CHEMBL515166	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	2559692	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N(C)CCN(C)C)cc23)ccc2[nH]ccc12		CHEMBL477173	=	IC50	nM	150.0	CHEMBL3920	Homo sapiens	IC50	nM	150.0
	2559693	CHEMBL986466	Inhibition of PKCtheta	B	COCCNC(=O)/C=C/c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL476127	=	IC50	nM	48.0	CHEMBL3920	Homo sapiens	IC50	nM	48.0
	2559694	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/CN4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL517677	=	IC50	nM	22.0	CHEMBL3920	Homo sapiens	IC50	nM	22.0
	2559695	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)Nc4ccccc4)cc23)ccc2[nH]ccc12		CHEMBL475919	=	IC50	nM	110.0	CHEMBL3920	Homo sapiens	IC50	nM	110.0
	2559696	CHEMBL986466	Inhibition of PKCtheta	B	CCNC(=O)/C=C/c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL514041	=	IC50	nM	15.0	CHEMBL3920	Homo sapiens	IC50	nM	15.0
	2559698	CHEMBL986466	Inhibition of PKCtheta	B	CCN(CC)C(=O)/C=C/c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL475918	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	nM	2.0
	2559699	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N(C)C)cc23)ccc2[nH]ccc12		CHEMBL513913	=	IC50	nM	1.6	CHEMBL3920	Homo sapiens	IC50	nM	1.6
	2559700	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(N)=O)cc23)ccc2[nH]ccc12		CHEMBL477617	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	2559701	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCN(C)CC4)cc23)ccc2[nH]ccc12		CHEMBL477405	=	IC50	nM	43.0	CHEMBL3920	Homo sapiens	IC50	nM	43.0
	2559702	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCNCC4)cc23)ccc2[nH]ccc12		CHEMBL477404	=	IC50	nM	88.0	CHEMBL3920	Homo sapiens	IC50	nM	88.0
	2559703	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCOCC4)cc23)ccc2[nH]ccc12		CHEMBL476150	=	IC50	nM	53.0	CHEMBL3920	Homo sapiens	IC50	nM	53.0
	2559704	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCCC4)cc23)ccc2[nH]ccc12		CHEMBL476149	=	IC50	nM	48.0	CHEMBL3920	Homo sapiens	IC50	nM	48.0
	2559705	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CC[C@H](N(C)C)C4)cc23)ccc2[nH]ccc12		CHEMBL514356	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	2559706	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CC[C@@H](N(C)C)C4)cc23)ccc2[nH]ccc12		CHEMBL514533	=	IC50	nM	180.0	CHEMBL3920	Homo sapiens	IC50	nM	180.0
	2559707	CHEMBL986466	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCC(O)C4)cc23)ccc2[nH]ccc12		CHEMBL477818	=	IC50	nM	41.0	CHEMBL3920	Homo sapiens	IC50	nM	41.0
	2567274	CHEMBL975461	Inhibition of human PKCtheta kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	95.0	CHEMBL3920	Homo sapiens	Activity	%	95.0
	2596900	CHEMBL1017913	Inhibition of PRKCQ assessed as enzyme activity relative to control	B	C[C@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL457871	=	Activity	%	27.0	CHEMBL3920	Homo sapiens	Activity	%	27.0
	2613496	CHEMBL1031538	Inhibition of PKCtheta	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	=	IC50	nM	3500.0	CHEMBL3920	Homo sapiens	IC50	uM	3.5
	2624267	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	=	IC50	nM	70.0	CHEMBL3920	Homo sapiens	IC50	nM	70.0
	2624268	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc3[nH]ccc23)cc1OC		CHEMBL513485	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	2624269	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3cc[nH]c3c2)cc1OC		CHEMBL492252	=	IC50	nM	2300.0	CHEMBL3920	Homo sapiens	IC50	nM	2300.0
	2624270	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc3cc[nH]c23)cc1OC		CHEMBL511716	=	IC50	nM	740.0	CHEMBL3920	Homo sapiens	IC50	nM	740.0
	2624271	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2N(C)c2ccc3[nH]ccc3c2)cc1OC		CHEMBL494229	=	IC50	nM	270.0	CHEMBL3920	Homo sapiens	IC50	nM	270.0
	2624272	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Oc2ccc3[nH]ccc3c2)cc1OC		CHEMBL494237	=	IC50	nM	1700.0	CHEMBL3920	Homo sapiens	IC50	nM	1700.0
	2624273	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2-c2ccc3[nH]ccc3c2)cc1OC		CHEMBL494238	=	IC50	nM	1700.0	CHEMBL3920	Homo sapiens	IC50	nM	1700.0
	2624275	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	CCc1c(Nc2c(C#N)cncc2-c2ccc(OC)c(OC)c2)ccc2[nH]ccc12		CHEMBL494000	=	IC50	nM	55.0	CHEMBL3920	Homo sapiens	IC50	nM	55.0
	2624276	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cc(C)c3[nH]ccc3c2)cc1OC		CHEMBL494001	=	IC50	nM	120.0	CHEMBL3920	Homo sapiens	IC50	nM	120.0
	2624277	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2cc3cc[nH]c3cc2C)cc1OC		CHEMBL494165	=	IC50	nM	10.5	CHEMBL3920	Homo sapiens	IC50	nM	10.5
	2624278	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2OC)cc1OC		CHEMBL509448	=	IC50	nM	10.6	CHEMBL3920	Homo sapiens	IC50	nM	10.6
	2624279	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2F)cc1OC		CHEMBL466036	=	IC50	nM	5.3	CHEMBL3920	Homo sapiens	IC50	nM	5.3
	2624280	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3c(ccn3C)c2C)cc1OC		CHEMBL466037	=	IC50	nM	260.0	CHEMBL3920	Homo sapiens	IC50	nM	260.0
	2624281	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccccc2)ccc2[nH]ccc12		CHEMBL466653	=	IC50	nM	27.0	CHEMBL3920	Homo sapiens	IC50	nM	27.0
	2624282	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1		CHEMBL466654	=	IC50	nM	5.6	CHEMBL3920	Homo sapiens	IC50	nM	5.6
	2624283	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1cccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)c1		CHEMBL513827	=	IC50	nM	36.0	CHEMBL3920	Homo sapiens	IC50	nM	36.0
	2624284	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccccc1-c1cncc(C#N)c1Nc1ccc2[nH]ccc2c1C		CHEMBL512606	=	IC50	nM	82.0	CHEMBL3920	Homo sapiens	IC50	nM	82.0
	2624285	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCOCC3)cc2)ccc2[nH]ccc12		CHEMBL467068	=	IC50	nM	20.0	CHEMBL3920	Homo sapiens	IC50	nM	20.0
	2624286	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL467069	=	IC50	nM	7.4	CHEMBL3920	Homo sapiens	IC50	nM	7.4
	2624287	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCCC3)cc2)ccc2[nH]ccc12		CHEMBL494412	=	IC50	nM	4.5	CHEMBL3920	Homo sapiens	IC50	nM	4.5
	2624288	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCN(CCO)CC3)cc2)ccc2[nH]ccc12		CHEMBL522344	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	2624289	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCC(N4CCCC4)CC3)cc2)ccc2[nH]ccc12		CHEMBL493999	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	2624290	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCNCCN(C)C)cc2)ccc2[nH]ccc12		CHEMBL494166	=	IC50	nM	5.9	CHEMBL3920	Homo sapiens	IC50	nM	5.9
	2624291	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL493825	=	IC50	nM	19.0	CHEMBL3920	Homo sapiens	IC50	nM	19.0
	2624292	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	CN1CCN(CCOc2ccc(-c3cncc(C#N)c3Nc3cccc4[nH]ccc34)cc2)CC1		CHEMBL493987	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	2624293	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	CN1CCN(CCOc2ccc(-c3cncc(C#N)c3Nc3ccc4[nH]ccc4c3)cc2)CC1		CHEMBL523194	=	IC50	nM	73.0	CHEMBL3920	Homo sapiens	IC50	nM	73.0
	2624294	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	Cc1cc2[nH]ccc2cc1Nc1c(C#N)cncc1-c1ccc(OCCN2CCN(C)CC2)cc1		CHEMBL467871	=	IC50	nM	33.0	CHEMBL3920	Homo sapiens	IC50	nM	33.0
	2625357	CHEMBL1007475	Inhibition of human PKCtheta by IMAP assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1OC		CHEMBL494595	=	IC50	nM	6.3	CHEMBL3920	Homo sapiens	IC50	nM	6.3
	2636747	CHEMBL1021131	Inhibition of PKCtheta	B	COc1ccc(-c2cncc(C#N)c2Nc2cccc3[nH]ccc23)cc1OC		CHEMBL513485	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	2636748	CHEMBL1021131	Inhibition of PKCtheta	B	N#Cc1cncc(-c2cccc(OCCN3CCOCC3)c2)c1Nc1ccc2cc[nH]c2c1		CHEMBL513323	=	IC50	nM	9500.0	CHEMBL3920	Homo sapiens	IC50	nM	9500.0
	2636749	CHEMBL1021131	Inhibition of PKCtheta	B	N#Cc1cncc(-c2cccc(OCCN3CCOCC3)c2)c1Nc1ccc2[nH]ccc2c1		CHEMBL468140	=	IC50	nM	200.0	CHEMBL3920	Homo sapiens	IC50	nM	200.0
	2636750	CHEMBL1021131	Inhibition of PKCtheta	B	N#Cc1cncc(-c2cccc(OCCN3CCCC3)c2)c1Nc1ccc2[nH]ccc2c1		CHEMBL513162	=	IC50	nM	190.0	CHEMBL3920	Homo sapiens	IC50	nM	190.0
	2636751	CHEMBL1021131	Inhibition of PKCtheta	B	CN1CCN(CCOc2cccc(-c3cncc(C#N)c3Nc3cccc4[nH]ccc34)c2)CC1		CHEMBL467321	=	IC50	nM	18.0	CHEMBL3920	Homo sapiens	IC50	nM	18.0
	2636752	CHEMBL1021131	Inhibition of PKCtheta	B	N#Cc1cncc(-c2cccc(OCCN3CCOCC3)c2)c1Nc1cccc2[nH]ccc12		CHEMBL468139	=	IC50	nM	17.0	CHEMBL3920	Homo sapiens	IC50	nM	17.0
	2636753	CHEMBL1021131	Inhibition of PKCtheta	B	N#Cc1cncc(-c2cccc(OCCN3CCCCC3)c2)c1Nc1cccc2[nH]ccc12		CHEMBL468135	=	IC50	nM	60.0	CHEMBL3920	Homo sapiens	IC50	nM	60.0
	2636754	CHEMBL1021131	Inhibition of PKCtheta	B	N#Cc1cncc(-c2cccc(OCCN3CCCC3)c2)c1Nc1cccc2[nH]ccc12		CHEMBL467723	=	IC50	nM	29.0	CHEMBL3920	Homo sapiens	IC50	nM	29.0
	2636755	CHEMBL1021131	Inhibition of PKCtheta	B	COCCOc1cccc(-c2cncc(C#N)c2Nc2cccc3[nH]ccc23)c1		CHEMBL467722	=	IC50	nM	32.0	CHEMBL3920	Homo sapiens	IC50	nM	32.0
	2636756	CHEMBL1021131	Inhibition of PKCtheta	B	COCCOc1cc(-c2cncc(C#N)c2Nc2ccc3cc[nH]c3c2)ccc1OC		CHEMBL511569	=	IC50	nM	6300.0	CHEMBL3920	Homo sapiens	IC50	nM	6300.0
	2636757	CHEMBL1021131	Inhibition of PKCtheta	B	COCCOc1cc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)ccc1OC		CHEMBL467524	=	IC50	nM	320.0	CHEMBL3920	Homo sapiens	IC50	nM	320.0
	2636758	CHEMBL1021131	Inhibition of PKCtheta	B	COCCOc1cc(-c2cncc(C#N)c2Nc2cccc3[nH]ccc23)ccc1OC		CHEMBL511403	=	IC50	nM	63.0	CHEMBL3920	Homo sapiens	IC50	nM	63.0
	2639161	CHEMBL1025479	Inhibition of PKCtheta	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	=	Ki	nM	1800.0	CHEMBL3920	Homo sapiens	Ki	nM	1800.0
	2639162	CHEMBL1025479	Inhibition of PKCtheta	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	>	Ki	nM	4000.0	CHEMBL3920	Homo sapiens	Ki	nM	4000.0
	2721697	CHEMBL1054326	Inhibition of PKCtheta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	2905454	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905455	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905456	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2200.0	CHEMBL3920	Homo sapiens	Kd	nM	2200.0
	2905457	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905458	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905459	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905460	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3200.0	CHEMBL3920	Homo sapiens	Kd	nM	3200.0
	2905461	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905462	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905463	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905464	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905465	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905466	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905467	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905468	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	350.0	CHEMBL3920	Homo sapiens	Kd	nM	350.0
	2905469	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905470	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905471	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905472	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905473	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	4400.0	CHEMBL3920	Homo sapiens	Kd	nM	4400.0
	2905474	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905475	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2.5	CHEMBL3920	Homo sapiens	Kd	nM	2.5
	2905476	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905477	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905478	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905479	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	920.0	CHEMBL3920	Homo sapiens	Kd	nM	920.0
	2905480	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905481	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905482	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905483	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905484	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905485	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905486	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.5	CHEMBL3920	Homo sapiens	Kd	nM	8.5
	2905487	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	7200.0	CHEMBL3920	Homo sapiens	Kd	nM	7200.0
	2905488	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4300.0	CHEMBL3920	Homo sapiens	Kd	nM	4300.0
	2905489	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905490	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2905491	CHEMBL1051255	Binding constant for PRKCQ kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	2921196	CHEMBL1058402	Inhibition of PRKCQ assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3920	Homo sapiens	Activity	%	100.0
	2924046	CHEMBL1041533	Inhibition of N-terminal FLAG-tagged PKCtheta by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	2924047	CHEMBL1041533	Inhibition of N-terminal FLAG-tagged PKCtheta by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	2938455	CHEMBL1041410	Inhibition of PKCtheta at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	17.0	CHEMBL3920	Homo sapiens	INH	%	17.0
	2992425	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	1.0	CHEMBL3920	Homo sapiens	IC50	nM	1.0
	2992428	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	6.7	CHEMBL3920	Homo sapiens	IC50	nM	6.7
	2992429	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN(C)CCOc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc2c1		CHEMBL565632	=	IC50	nM	3.3	CHEMBL3920	Homo sapiens	IC50	nM	3.3
	2992433	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3c2)CC1		CHEMBL568580	=	IC50	nM	4.8	CHEMBL3920	Homo sapiens	IC50	nM	4.8
	2992440	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN(C)CCOc1cccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL566853	=	IC50	nM	52.0	CHEMBL3920	Homo sapiens	IC50	nM	52.0
	2992460	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN1CCN(c2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL585500	=	IC50	nM	76.0	CHEMBL3920	Homo sapiens	IC50	nM	76.0
	2992463	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN(C)CCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL566424	=	IC50	nM	255.0	CHEMBL3920	Homo sapiens	IC50	nM	255.0
	2992470	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN(C)CCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL584483	=	IC50	nM	165.0	CHEMBL3920	Homo sapiens	IC50	nM	165.0
	2992474	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCOCC2)nc2ccccc12		CHEMBL584817	=	IC50	nM	1382.0	CHEMBL3920	Homo sapiens	IC50	nM	1382.0
	2992484	CHEMBL1040091	Inhibition of PKCtheta by SPA	B	CN(C)CCCn1cc(C2=C(c3n[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL585281	>	IC50	nM	315.0	CHEMBL3920	Homo sapiens	IC50	nM	315.0
	3001895	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CNCCO)ccc3o2)ccc2[nH]ccc12		CHEMBL571785	=	IC50	nM	1.6	CHEMBL3920	Homo sapiens	IC50	nM	1.6
	3001898	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CNCCCO)ccc3o2)ccc2[nH]ccc12		CHEMBL583903	=	IC50	nM	2.3	CHEMBL3920	Homo sapiens	IC50	nM	2.3
	3001901	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CNCC(O)CO)ccc3o2)ccc2[nH]ccc12		CHEMBL585753	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
	3001904	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	CCN1CCN(Cc2ccc3oc(-c4cncc(C#N)c4Nc4ccc5[nH]ccc5c4C)cc3c2)CC1		CHEMBL570713	=	IC50	nM	0.48	CHEMBL3920	Homo sapiens	IC50	nM	0.48
	3001907	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(CCN(C)C)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL569822	=	IC50	nM	2.4	CHEMBL3920	Homo sapiens	IC50	nM	2.4
	3001910	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(S(C)(=O)=O)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL568923	=	IC50	nM	15.0	CHEMBL3920	Homo sapiens	IC50	nM	15.0
	3001913	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(c5ccccn5)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL571281	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	3001916	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCNCC4)ccc3o2)ccc2[nH]ccc12		CHEMBL583906	=	IC50	nM	5.3	CHEMBL3920	Homo sapiens	IC50	nM	5.3
	3001918	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CC[N+](C)([O-])CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL570924	=	IC50	nM	6.1	CHEMBL3920	Homo sapiens	IC50	nM	6.1
	3011552	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN(C)C)cc2)ccc2[nH]ccc12		CHEMBL585697	=	IC50	nM	8.4	CHEMBL3920	Homo sapiens	IC50	nM	8.4
	3011553	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2cccc(CN(C)C)c2)ccc2[nH]ccc12		CHEMBL567930	=	IC50	nM	6.9	CHEMBL3920	Homo sapiens	IC50	nM	6.9
	3011554	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccccc2CN(C)C)ccc2[nH]ccc12		CHEMBL566868	=	IC50	nM	200.0	CHEMBL3920	Homo sapiens	IC50	nM	200.0
	3011555	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL567299	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	nM	5.0
	3011556	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2cccc(CN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL585307	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	nM	3.0
	3011557	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCOCC3)cc2)ccc2[nH]ccc12		CHEMBL586046	=	IC50	nM	9.0	CHEMBL3920	Homo sapiens	IC50	nM	9.0
	3011558	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2cccc(CN3CCOCC3)c2)ccc2[nH]ccc12		CHEMBL567730	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	nM	23.0
	3011559	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCN(C)CC3)nc2)ccc2[nH]ccc12		CHEMBL567092	=	IC50	nM	38.0	CHEMBL3920	Homo sapiens	IC50	nM	38.0
	3011560	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2cncc(CN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL567093	=	IC50	nM	190.0	CHEMBL3920	Homo sapiens	IC50	nM	190.0
	3011561	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCN(C)CC3)s2)ccc2[nH]ccc12		CHEMBL567300	=	IC50	nM	6.1	CHEMBL3920	Homo sapiens	IC50	nM	6.1
	3011562	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	C#Cc1cccc(-c2csc(CN3CCN(C)CC3)c2)c1Cc1ccc2c(c1C)C=CC2		CHEMBL567082	=	IC50	nM	4.9	CHEMBL3920	Homo sapiens	IC50	nM	4.9
	3011563	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	C#Cc1cccc(-c2ccc(CN3CCN(C)CC3)o2)c1Cc1ccc2c(c1C)C=CC2		CHEMBL570865	=	IC50	nM	4.5	CHEMBL3920	Homo sapiens	IC50	nM	4.5
	3011564	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2coc(CN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL568547	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	3011565	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCOCC3)o2)ccc2[nH]ccc12		CHEMBL585858	=	IC50	nM	7.8	CHEMBL3920	Homo sapiens	IC50	nM	7.8
	3011566	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCSCC3)o2)ccc2[nH]ccc12		CHEMBL585323	=	IC50	nM	7.5	CHEMBL3920	Homo sapiens	IC50	nM	7.5
	3011567	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCCCC3)o2)ccc2[nH]ccc12		CHEMBL585113	=	IC50	nM	41.0	CHEMBL3920	Homo sapiens	IC50	nM	41.0
	3011568	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(CN3CCCC3)o2)ccc2[nH]ccc12		CHEMBL567094	=	IC50	nM	35.0	CHEMBL3920	Homo sapiens	IC50	nM	35.0
	3011569	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	CCN(CC)Cc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)o1		CHEMBL568142	=	IC50	nM	42.0	CHEMBL3920	Homo sapiens	IC50	nM	42.0
	3011570	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2coc(CN3CCC(N(C)C)CC3)c2)ccc2[nH]ccc12		CHEMBL567103	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
	3011571	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2coc(CN3CCN(C(C)C)CC3)c2)ccc2[nH]ccc12		CHEMBL568371	=	IC50	nM	2.4	CHEMBL3920	Homo sapiens	IC50	nM	2.4
	3011572	CHEMBL1037484	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2-c2coc(CN3CCN(C4CCCC4)CC3)c2)ccc2[nH]ccc12		CHEMBL568581	=	IC50	nM	3.5	CHEMBL3920	Homo sapiens	IC50	nM	3.5
	3017779	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2)ccc2[nH]ccc12		CHEMBL585192	=	IC50	nM	8.3	CHEMBL3920	Homo sapiens	IC50	nM	8.3
	3017780	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	N#Cc1cncc(/C=C/c2ccccc2)c1Nc1ccc2[nH]ccc2c1		CHEMBL579201	=	IC50	nM	24.0	CHEMBL3920	Homo sapiens	IC50	nM	24.0
	3017781	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	N#Cc1cncc(/C=C/c2ccccc2)c1Nc1cccc2c1CC=N2		CHEMBL576232	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	3017782	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	N#Cc1cncc(/C=C/c2ccccc2)c1Nc1ccc2cc[nH]c2c1		CHEMBL578348	=	IC50	nM	1400.0	CHEMBL3920	Homo sapiens	IC50	nM	1400.0
	3017783	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cn1ccc2cc(Nc3c(C#N)cncc3/C=C/c3ccccc3)ccc21		CHEMBL568186	=	IC50	nM	4700.0	CHEMBL3920	Homo sapiens	IC50	nM	4700.0
	3017784	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1cc2cc(Nc3c(C#N)cncc3/C=C/c3ccccc3)ccc2[nH]1		CHEMBL569203	=	IC50	nM	360.0	CHEMBL3920	Homo sapiens	IC50	nM	360.0
	3017785	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1cc2c(C)c(Nc3c(C#N)cncc3/C=C/c3ccccc3)ccc2[nH]1		CHEMBL585878	=	IC50	nM	70.0	CHEMBL3920	Homo sapiens	IC50	nM	70.0
	3017786	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2)cc(C)c2[nH]ccc12		CHEMBL566060	=	IC50	nM	34.0	CHEMBL3920	Homo sapiens	IC50	nM	34.0
	3017787	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2)ccc2c1ccn2C		CHEMBL585681	=	IC50	nM	190.0	CHEMBL3920	Homo sapiens	IC50	nM	190.0
	3017788	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	N#Cc1cncc(/C=C/c2ccccc2)c1Nc1cc2cc[nH]c2cc1Cl		CHEMBL578169	=	IC50	nM	65.0	CHEMBL3920	Homo sapiens	IC50	nM	65.0
	3017789	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2)cc(Cl)c2[nH]ccc12		CHEMBL568687	=	IC50	nM	77.0	CHEMBL3920	Homo sapiens	IC50	nM	77.0
	3017790	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	N#Cc1cncc(/C=C/c2ccccc2)c1Oc1ccc2[nH]ccc2c1		CHEMBL568973	=	IC50	nM	690.0	CHEMBL3920	Homo sapiens	IC50	nM	690.0
	3017791	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Oc2c(C#N)cncc2/C=C/c2ccccc2)ccc2[nH]ccc12		CHEMBL578984	=	IC50	nM	90.0	CHEMBL3920	Homo sapiens	IC50	nM	90.0
	3017792	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	CN(c1ccc2[nH]ccc2c1)c1c(C#N)cncc1/C=C/c1ccccc1		CHEMBL576233	=	IC50	nM	440.0	CHEMBL3920	Homo sapiens	IC50	nM	440.0
	3017793	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2CCc2ccccc2)ccc2[nH]ccc12		CHEMBL578783	=	IC50	nM	34.0	CHEMBL3920	Homo sapiens	IC50	nM	34.0
	3017794	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/C2CCCCC2)ccc2[nH]ccc12		CHEMBL566074	=	IC50	nM	26.0	CHEMBL3920	Homo sapiens	IC50	nM	26.0
	3017795	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	COc1ccccc1/C=C/c1cncc(C#N)c1Nc1ccc2[nH]ccc2c1C		CHEMBL568407	=	IC50	nM	8.2	CHEMBL3920	Homo sapiens	IC50	nM	8.2
	3017796	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	COc1cccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)c1		CHEMBL567363	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	nM	7.0
	3017797	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	COc1ccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1		CHEMBL566263	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	3017798	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2OCCN2CCN(C)CC2)ccc2[nH]ccc12		CHEMBL567952	=	IC50	nM	7.6	CHEMBL3920	Homo sapiens	IC50	nM	7.6
	3017799	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(OCCN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL567124	=	IC50	nM	4.7	CHEMBL3920	Homo sapiens	IC50	nM	4.7
	3017800	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL568457	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
	3017801	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2OCCN2CCCC2)ccc2[nH]ccc12		CHEMBL583879	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	3017802	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(OCCN3CCCC3)c2)ccc2[nH]ccc12		CHEMBL565353	=	IC50	nM	4.7	CHEMBL3920	Homo sapiens	IC50	nM	4.7
	3017803	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(OCCN3CCCC3)cc2)ccc2[nH]ccc12		CHEMBL579260	=	IC50	nM	9.1	CHEMBL3920	Homo sapiens	IC50	nM	9.1
	3019001	CHEMBL1039087	Inhibition of human PKCtheta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C\c2ccccc2)ccc2[nH]ccc12		CHEMBL568974	=	IC50	nM	79.0	CHEMBL3920	Homo sapiens	IC50	nM	79.0
	3023246	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3ccccc3o2)ccc2[nH]ccc12		CHEMBL570247	=	IC50	nM	1.7	CHEMBL3920	Homo sapiens	IC50	nM	1.7
	3023249	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3ccccc3s2)ccc2[nH]ccc12		CHEMBL578174	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	nM	23.0
	3023252	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCCCC4)ccc3o2)ccc2[nH]ccc12		CHEMBL569108	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
	3023255	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCCCC4)ccc3s2)ccc2[nH]ccc12		CHEMBL570047	=	IC50	nM	2.5	CHEMBL3920	Homo sapiens	IC50	nM	2.5
	3023258	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL571581	=	IC50	nM	0.28	CHEMBL3920	Homo sapiens	IC50	nM	0.28
	3023261	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3s2)ccc2[nH]ccc12		CHEMBL570277	=	IC50	nM	0.67	CHEMBL3920	Homo sapiens	IC50	nM	0.67
	3023264	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN(C)C)ccc3o2)ccc2[nH]ccc12		CHEMBL571784	=	IC50	nM	6.4	CHEMBL3920	Homo sapiens	IC50	nM	6.4
	3023267	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCCC4)ccc3o2)ccc2[nH]ccc12		CHEMBL569796	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
	3023270	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCOCC4)ccc3o2)ccc2[nH]ccc12		CHEMBL576278	=	IC50	nM	13.0	CHEMBL3920	Homo sapiens	IC50	nM	13.0
	3023273	CHEMBL1047183	Inhibition of human PKCtheta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CNC4CCCCC4)ccc3o2)ccc2[nH]ccc12		CHEMBL569590	=	IC50	nM	1.4	CHEMBL3920	Homo sapiens	IC50	nM	1.4
	3052453	CHEMBL1072491	Residual activity of PKCtheta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL3920	Homo sapiens	Residual activity	%	95.0
	3052705	CHEMBL1041115	Residual activity of PKCtheta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	100.0	CHEMBL3920	Homo sapiens	Residual activity	%	100.0
	3054014	CHEMBL1050345	Residual activity of PKCtheta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL3920	Homo sapiens	Residual activity	%	87.0
	3054266	CHEMBL1072491	Residual activity of PKCtheta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	100.0	CHEMBL3920	Homo sapiens	Residual activity	%	100.0
	3055553	CHEMBL1041115	Residual activity of PKCtheta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	113.0	CHEMBL3920	Homo sapiens	Residual activity	%	113.0
	3056858	CHEMBL1050345	Residual activity of PKCtheta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL3920	Homo sapiens	Residual activity	%	96.0
	3057110	CHEMBL1072491	Residual activity of PKCtheta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL3920	Homo sapiens	Residual activity	%	95.0
	3058430	CHEMBL1041115	Residual activity of PKCtheta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	111.0	CHEMBL3920	Homo sapiens	Residual activity	%	111.0
	3059714	CHEMBL1050345	Residual activity of PKCtheta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	64.0	CHEMBL3920	Homo sapiens	Residual activity	%	64.0
	3090402	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@H](O)C2)ccc2[nH]ccc12		CHEMBL592935	=	IC50	nM	120.0	CHEMBL3920	Homo sapiens	IC50	nM	120.0
	3090414	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCN(c3ccccc3)CC2)ccc2[nH]ccc12		CHEMBL605112	=	IC50	nM	68.0	CHEMBL3920	Homo sapiens	IC50	nM	68.0
	3090421	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(CO)CC2)ccc2[nH]ccc12		CHEMBL596424	=	IC50	nM	39.0	CHEMBL3920	Homo sapiens	IC50	nM	39.0
	3090422	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCCN2CCOCC2)ccc2[nH]ccc12		CHEMBL596412	=	IC50	nM	34.0	CHEMBL3920	Homo sapiens	IC50	nM	34.0
	3090426	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(c3ccccc3)CC2)ccc2[nH]ccc12		CHEMBL596206	=	IC50	nM	19.0	CHEMBL3920	Homo sapiens	IC50	nM	19.0
	3090428	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCOCC2)ccc2[nH]ccc12		CHEMBL595500	=	IC50	nM	51.0	CHEMBL3920	Homo sapiens	IC50	nM	51.0
	3090431	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCC(O)CC2)ccc2[nH]ccc12		CHEMBL604050	=	IC50	nM	140.0	CHEMBL3920	Homo sapiens	IC50	nM	140.0
	3090432	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(NS(C)(=O)=O)C(C)C2)ccc2[nH]ccc12		CHEMBL592936	=	IC50	nM	57.0	CHEMBL3920	Homo sapiens	IC50	nM	57.0
	3090433	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCN(OC(=O)C(C)(C)C)CC2)ccc2[nH]ccc12		CHEMBL577254	=	IC50	nM	51.0	CHEMBL3920	Homo sapiens	IC50	nM	51.0
	3090436	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	COC1CCN(CC/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)CC1		CHEMBL593891	=	IC50	nM	42.0	CHEMBL3920	Homo sapiens	IC50	nM	42.0
	3090437	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(NS(=O)(=O)C(C)C)CC2)ccc2[nH]ccc12		CHEMBL596173	=	IC50	nM	22.0	CHEMBL3920	Homo sapiens	IC50	nM	22.0
	3090439	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCCN2CCCCC2)ccc2[nH]ccc12		CHEMBL593388	=	IC50	nM	19.0	CHEMBL3920	Homo sapiens	IC50	nM	19.0
	3090441	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CC[C@H](O)C2)ccc2[nH]ccc12		CHEMBL595492	=	IC50	nM	24.0	CHEMBL3920	Homo sapiens	IC50	nM	24.0
	3090445	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(NS(C)(=O)=O)CC2)ccc2[nH]ccc12		CHEMBL595048	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
	3090446	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	CCS(=O)(=O)NC1CCN(CC/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)CC1		CHEMBL595752	=	IC50	nM	22.0	CHEMBL3920	Homo sapiens	IC50	nM	22.0
	3090447	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	CC(=O)NC1CCN(CC/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)CC1		CHEMBL596414	=	IC50	nM	31.0	CHEMBL3920	Homo sapiens	IC50	nM	31.0
	3090449	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCN(S(=O)(=O)c3ccccc3)CC2)ccc2[nH]ccc12		CHEMBL594784	=	IC50	nM	50.0	CHEMBL3920	Homo sapiens	IC50	nM	50.0
	3090450	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCN(C)CC2)ccc2[nH]ccc12		CHEMBL596413	=	IC50	nM	31.0	CHEMBL3920	Homo sapiens	IC50	nM	31.0
	3090452	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCNCC2)ccc2[nH]ccc12		CHEMBL593619	=	IC50	nM	10.0	CHEMBL3920	Homo sapiens	IC50	nM	10.0
	3090453	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCOCC2)ccc2[nH]ccc12		CHEMBL595732	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
	3090454	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CC(N)C2)ccc2[nH]ccc12		CHEMBL596172	=	IC50	nM	8.9	CHEMBL3920	Homo sapiens	IC50	nM	8.9
	3090455	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/CCN1CCNCC1		CHEMBL593892	=	IC50	nM	17.0	CHEMBL3920	Homo sapiens	IC50	nM	17.0
	3090457	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCCN2CCN(C)CC2)ccc2[nH]ccc12		CHEMBL603217	=	IC50	nM	6.4	CHEMBL3920	Homo sapiens	IC50	nM	6.4
	3090459	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCCCC2)ccc2[nH]ccc12		CHEMBL593387	=	IC50	nM	35.0	CHEMBL3920	Homo sapiens	IC50	nM	35.0
	3090461	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CC[C@@H](O)C2)ccc2[nH]ccc12		CHEMBL595724	=	IC50	nM	7.4	CHEMBL3920	Homo sapiens	IC50	nM	7.4
	3090463	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	CNC1CCN(CC/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)CC1		CHEMBL606146	=	IC50	nM	9.3	CHEMBL3920	Homo sapiens	IC50	nM	9.3
	3090464	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	CC(=O)N1CCN(CC/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)CC1		CHEMBL595753	=	IC50	nM	38.0	CHEMBL3920	Homo sapiens	IC50	nM	38.0
	3090465	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCCNCC2)ccc2[nH]ccc12		CHEMBL606133	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
	3090466	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCCCC2)ccc2[nH]ccc12		CHEMBL596207	=	IC50	nM	190.0	CHEMBL3920	Homo sapiens	IC50	nM	190.0
	3090468	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCNCC2)ccc2[nH]ccc12		CHEMBL603418	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
	3090469	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCCN2CCC(N)CC2)ccc2[nH]ccc12		CHEMBL605318	=	IC50	nM	5.2	CHEMBL3920	Homo sapiens	IC50	nM	5.2
	3090470	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(NS(=O)(=O)c3ccccc3)CC2)ccc2[nH]ccc12		CHEMBL605086	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	nM	23.0
	3090471	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCN(S(C)(=O)=O)CC2)ccc2[nH]ccc12		CHEMBL595734	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	3090472	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCN(C)CC2)ccc2[nH]ccc12		CHEMBL595521	=	IC50	nM	2.2	CHEMBL3920	Homo sapiens	IC50	nM	2.2
	3090474	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCCN2CCNCC2)ccc2[nH]ccc12		CHEMBL593162	=	IC50	nM	2.8	CHEMBL3920	Homo sapiens	IC50	nM	2.8
	3090475	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(CN)CC2)ccc2[nH]ccc12		CHEMBL596398	=	IC50	nM	5.7	CHEMBL3920	Homo sapiens	IC50	nM	5.7
	3090476	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCC(N)CC2)ccc2[nH]ccc12		CHEMBL593163	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
	3090477	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL595733	=	IC50	nM	3.5	CHEMBL3920	Homo sapiens	IC50	nM	3.5
	3090478	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCN(S(=O)(=O)C(C)C)CC2)ccc2[nH]ccc12		CHEMBL605534	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	3090479	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(N(C)C)CC2)ccc2[nH]ccc12		CHEMBL596397	=	IC50	nM	4.9	CHEMBL3920	Homo sapiens	IC50	nM	4.9
	3090480	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CC[C@H](N)C2)ccc2[nH]ccc12		CHEMBL606148	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
	3090482	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	1.8	CHEMBL3920	Homo sapiens	IC50	nM	1.8
	3090483	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@H](N)C2)ccc2[nH]ccc12		CHEMBL595955	=	IC50	nM	6.8	CHEMBL3920	Homo sapiens	IC50	nM	6.8
	3090484	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](O)C2)ccc2[nH]ccc12		CHEMBL606342	=	IC50	nM	71.0	CHEMBL3920	Homo sapiens	IC50	nM	71.0
	3090485	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	CCS(=O)(=O)N1CCN(CC/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)CC1		CHEMBL592934	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	3090486	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(N)C(C)C2)ccc2[nH]ccc12		CHEMBL607036	=	IC50	nM	46.0	CHEMBL3920	Homo sapiens	IC50	nM	46.0
	3090487	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCCN2CCC(O)CC2)ccc2[nH]ccc12		CHEMBL595989	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	3090488	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(O)CC2)ccc2[nH]ccc12		CHEMBL593890	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
	3090490	CHEMBL1070540	Inhibition of PKCtheta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(N)CC2)ccc2[nH]ccc12		CHEMBL593883	=	IC50	nM	0.88	CHEMBL3920	Homo sapiens	IC50	nM	0.88
	3103046	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	EC50	nM	11080.0	CHEMBL3920	Homo sapiens	EC50	uM	11.08
	3103049	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	O=C(/C=C(O)/C=C/c1ccc(O)c(O)c1)/C=C/c1ccc(O)c(O)c1		CHEMBL129964	=	EC50	nM	6570.0	CHEMBL3920	Homo sapiens	EC50	uM	6.57
	3103052	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	CCCCCCCCOc1ccc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC		CHEMBL599997	=	EC50	nM	4000.0	CHEMBL3920	Homo sapiens	EC50	uM	4.0
	3103055	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	CCCCCCCCCCCCCCCCOc1ccc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC		CHEMBL589364	=	EC50	nM	5950.0	CHEMBL3920	Homo sapiens	EC50	uM	5.95
	3103058	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	EC50	nM	3190.0	CHEMBL3920	Homo sapiens	EC50	uM	3.19
	3103061	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC		CHEMBL55267	=	EC50	nM	5240.0	CHEMBL3920	Homo sapiens	EC50	uM	5.24
	3103064	CHEMBL1072761	Binding affinity to GST-tagged PKCtheta expressed in Escherichia coli BL21(DE3) by fluorescence quenching	B	CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C\CCCCCCCC		CHEMBL590047	=	EC50	nM	8670.0	CHEMBL3920	Homo sapiens	EC50	uM	8.67
	3185567	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL1082226	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
	3185571	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1085671	=	IC50	nM	1.4	CHEMBL3920	Homo sapiens	IC50	nM	1.4
	3185575	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccccc2CN2CCN(C)CC2)ccc2[nH]ccc12		CHEMBL1084409	=	IC50	nM	9.9	CHEMBL3920	Homo sapiens	IC50	nM	9.9
	3185579	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCN(C)CC3)cn2)ccc2[nH]ccc12		CHEMBL1084410	=	IC50	nM	1.9	CHEMBL3920	Homo sapiens	IC50	nM	1.9
	3185583	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(C)CC3)n2)ccc2[nH]ccc12		CHEMBL1084411	=	IC50	nM	1.1	CHEMBL3920	Homo sapiens	IC50	nM	1.1
	3185587	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cc(CN3CCN(C)CC3)ccn2)ccc2[nH]ccc12		CHEMBL1082544	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	3185590	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCOCC3)cc2)ccc2[nH]ccc12		CHEMBL1088054	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
	3185594	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCCCC3)cc2)ccc2[nH]ccc12		CHEMBL1088055	=	IC50	nM	4.1	CHEMBL3920	Homo sapiens	IC50	nM	4.1
	3185598	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCC(N(C)C)CC3)cc2)ccc2[nH]ccc12		CHEMBL1088056	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
	3185602	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCC(O)CC3)cc2)ccc2[nH]ccc12		CHEMBL1087425	=	IC50	nM	5.5	CHEMBL3920	Homo sapiens	IC50	nM	5.5
	3185606	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCN(CCO)CC3)cc2)ccc2[nH]ccc12		CHEMBL1083522	=	IC50	nM	4.7	CHEMBL3920	Homo sapiens	IC50	nM	4.7
	3185610	CHEMBL1105142	Inhibition of PKCtheta	B	COCCNCc1ccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1		CHEMBL1086178	=	IC50	nM	5.2	CHEMBL3920	Homo sapiens	IC50	nM	5.2
	3185614	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCOCC3)c2)ccc2[nH]ccc12		CHEMBL1086419	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
	3185618	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCCCC3)c2)ccc2[nH]ccc12		CHEMBL1086420	=	IC50	nM	4.9	CHEMBL3920	Homo sapiens	IC50	nM	4.9
	3185622	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCC(N(C)C)CC3)c2)ccc2[nH]ccc12		CHEMBL1095368	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
	3185626	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCC(O)CC3)c2)ccc2[nH]ccc12		CHEMBL1095369	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
	3185630	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(CCO)CC3)c2)ccc2[nH]ccc12		CHEMBL1095682	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
	3185634	CHEMBL1105142	Inhibition of PKCtheta	B	COCCNCc1cccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)c1		CHEMBL1099371	=	IC50	nM	4.9	CHEMBL3920	Homo sapiens	IC50	nM	4.9
	3185638	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCOCC3)cn2)ccc2[nH]ccc12		CHEMBL1094375	=	IC50	nM	56.0	CHEMBL3920	Homo sapiens	IC50	nM	56.0
	3185642	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCCCC3)cn2)ccc2[nH]ccc12		CHEMBL1097695	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	3185646	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCC(N(C)C)CC3)cn2)ccc2[nH]ccc12		CHEMBL1097696	=	IC50	nM	2.8	CHEMBL3920	Homo sapiens	IC50	nM	2.8
	3185650	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCC(O)CC3)cn2)ccc2[nH]ccc12		CHEMBL1098034	=	IC50	nM	31.0	CHEMBL3920	Homo sapiens	IC50	nM	31.0
	3185654	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CN3CCN(CCO)CC3)cn2)ccc2[nH]ccc12		CHEMBL1089724	=	IC50	nM	6.2	CHEMBL3920	Homo sapiens	IC50	nM	6.2
	3185658	CHEMBL1105142	Inhibition of PKCtheta	B	COCCNCc1ccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)nc1		CHEMBL1090055	=	IC50	nM	3.2	CHEMBL3920	Homo sapiens	IC50	nM	3.2
	3185662	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCOCC3)n2)ccc2[nH]ccc12		CHEMBL1093081	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
	3185666	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCCCC3)n2)ccc2[nH]ccc12		CHEMBL1093082	=	IC50	nM	4.3	CHEMBL3920	Homo sapiens	IC50	nM	4.3
	3185670	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCC(N(C)C)CC3)n2)ccc2[nH]ccc12		CHEMBL1088737	=	IC50	nM	0.84	CHEMBL3920	Homo sapiens	IC50	nM	0.84
	3185674	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCC(O)CC3)n2)ccc2[nH]ccc12		CHEMBL1088738	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
	3185678	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(CCO)CC3)n2)ccc2[nH]ccc12		CHEMBL1091481	=	IC50	nM	0.65	CHEMBL3920	Homo sapiens	IC50	nM	0.65
	3185682	CHEMBL1105142	Inhibition of PKCtheta	B	COCCNCc1cccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)n1		CHEMBL1091482	=	IC50	nM	4.2	CHEMBL3920	Homo sapiens	IC50	nM	4.2
	3185719	CHEMBL1105142	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCNCC3)n2)ccc2[nH]ccc12		CHEMBL1082225	=	IC50	nM	0.32	CHEMBL3920	Homo sapiens	IC50	nM	0.32
	3210387	CHEMBL1109438	Inhibition of PKCtheta after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	50000.0	CHEMBL3920	Homo sapiens	IC50	uM	50.0
	3214021	CHEMBL1103216	Inhibition of PKCtheta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	8.0	CHEMBL3920	Homo sapiens	INH	%	8.0
	3219698	CHEMBL1110449	Inhibition of PKCtheta at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	91.0	CHEMBL3920	Homo sapiens	INH	%	91.0
	3219770	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(S(N)(=O)=O)cc2)ccc2[nH]ccc12		CHEMBL1080801	=	IC50	nM	5.4	CHEMBL3920	Homo sapiens	IC50	nM	5.4
	3219771	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(S(=O)(=O)N(C)C)cc2)ccc2[nH]ccc12		CHEMBL1080802	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	3219772	CHEMBL1114007	Inhibition of PKCtheta	B	CCN(CC)S(=O)(=O)c1ccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1		CHEMBL1079903	=	IC50	nM	8.7	CHEMBL3920	Homo sapiens	IC50	nM	8.7
	3219773	CHEMBL1114007	Inhibition of PKCtheta	B	CCCN(CCC)S(=O)(=O)c1ccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1		CHEMBL1079904	=	IC50	nM	350.0	CHEMBL3920	Homo sapiens	IC50	nM	350.0
	3219774	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(S(=O)(=O)N(C(C)C)C(C)C)cc2)ccc2[nH]ccc12		CHEMBL1079376	=	IC50	nM	410.0	CHEMBL3920	Homo sapiens	IC50	nM	410.0
	3219775	CHEMBL1114007	Inhibition of PKCtheta	B	CCC(C)NS(=O)(=O)Cc1ccc(/C=C/c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2C)cc1		CHEMBL1081357	=	IC50	nM	121.0	CHEMBL3920	Homo sapiens	IC50	nM	121.0
	3219776	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCCC3)c2)ccc2[nH]ccc12		CHEMBL1081358	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
	3219777	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCCCC3)c2)ccc2[nH]ccc12		CHEMBL1081359	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	nM	3.0
	3219778	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	=	IC50	nM	0.49	CHEMBL3920	Homo sapiens	IC50	nM	0.49
	3219779	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	=	IC50	nM	0.44	CHEMBL3920	Homo sapiens	IC50	nM	0.44
	3219780	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCCC2)c1		CHEMBL1080103	=	IC50	nM	2.4	CHEMBL3920	Homo sapiens	IC50	nM	2.4
	3219781	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCCCC2)c1		CHEMBL1079566	=	IC50	nM	4.8	CHEMBL3920	Homo sapiens	IC50	nM	4.8
	3219782	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1ccc(S(=O)(=O)N2CCN(C)CC2)cc1		CHEMBL1079567	=	IC50	nM	9.3	CHEMBL3920	Homo sapiens	IC50	nM	9.3
	3219783	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1ccc(S(=O)(=O)N2CCCC2)cc1		CHEMBL1079745	=	IC50	nM	21.0	CHEMBL3920	Homo sapiens	IC50	nM	21.0
	3219784	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1ccc(S(=O)(=O)N2CCCCC2)cc1		CHEMBL1080114	=	IC50	nM	68.0	CHEMBL3920	Homo sapiens	IC50	nM	68.0
	3219785	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(CS(=O)(=O)N3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL1081920	=	IC50	nM	7.9	CHEMBL3920	Homo sapiens	IC50	nM	7.9
	3219786	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CS(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1081921	=	IC50	nM	6.2	CHEMBL3920	Homo sapiens	IC50	nM	6.2
	3219787	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1ccc(CS(=O)(=O)N2CCN(C)CC2)cc1		CHEMBL1079426	=	IC50	nM	4.3	CHEMBL3920	Homo sapiens	IC50	nM	4.3
	3219788	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(CS(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1079427	=	IC50	nM	4.4	CHEMBL3920	Homo sapiens	IC50	nM	4.4
	3219789	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL467069	=	IC50	nM	7.4	CHEMBL3920	Homo sapiens	IC50	nM	7.4
	3219790	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL568457	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
	3224935	CHEMBL1101013	Inhibition of PKCtheta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3226314	CHEMBL1101013	Inhibition of PKCtheta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3227292	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(S(=O)(=O)N3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL1079435	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	nM	23.0
	3227293	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(S(=O)(=O)N3CCCC3)cc2)ccc2[nH]ccc12		CHEMBL1079611	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
	3227294	CHEMBL1114007	Inhibition of PKCtheta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2ccc(S(=O)(=O)N3CCCCC3)cc2)ccc2[nH]ccc12		CHEMBL1079612	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	3246481	CHEMBL1117092	Inhibition of PKCtheta	B	O=C(Nc1cccc(-c2ncnc3sc(-c4ccncc4)cc23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1090143	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	3332113	CHEMBL1166824	Inhibition of PRKCQ at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3333528	CHEMBL1166824	Inhibition of PRKCQ at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3334933	CHEMBL1166824	Inhibition of PRKCQ at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3336353	CHEMBL1166824	Inhibition of PRKCQ at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3341895	CHEMBL1166824	Inhibition of PRKCQ at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3343342	CHEMBL1166824	Inhibition of PRKCQ at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	3358768	CHEMBL1175234	Inhibition of PRKCQ at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	55.0	CHEMBL3920	Homo sapiens	INH	%	55.0
	3359210	CHEMBL1175234	Inhibition of PRKCQ at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	36.0	CHEMBL3920	Homo sapiens	INH	%	36.0
Not Active	3367509	CHEMBL1176375	Inhibition of PKCtheta up to 8 uM	B	Cc1cc2nc(NCCCO)n(CC(=O)c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)c2cc1C		CHEMBL374350		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	3400036	CHEMBL1217233	Inhibition of human PKCtheta at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	22.0	CHEMBL3920	Homo sapiens	INH	%	22.0
	3443499	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	1.0	CHEMBL3920	Homo sapiens	INH	%	1.0
	3443716	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	37.0	CHEMBL3920	Homo sapiens	INH	%	37.0
	3444871	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	4.0	CHEMBL3920	Homo sapiens	INH	%	4.0
	3445267	CHEMBL1244939	Binding affinity to PRKCQ	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	100.0	CHEMBL3920	Homo sapiens	Kd	nM	100.0
	3445495	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL3920	Homo sapiens	INH	%	4.0
	3445712	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	15.0	CHEMBL3920	Homo sapiens	INH	%	15.0
	3445907	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	33.0	CHEMBL3920	Homo sapiens	INH	%	33.0
	3446097	CHEMBL1244265	Inhibition of PKCtheta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	11.0	CHEMBL3920	Homo sapiens	INH	%	11.0
	3448041	CHEMBL1249684	Inhibition of human PKCtheta activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	5.0	CHEMBL3920	Homo sapiens	INH	%	5.0
	3448117	CHEMBL1249684	Inhibition of human PKCtheta activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	14.0	CHEMBL3920	Homo sapiens	INH	%	14.0
	3448586	CHEMBL1244939	Binding affinity to PRKCQ	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	3449021	CHEMBL1244939	Binding affinity to PRKCQ	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	920.0	CHEMBL3920	Homo sapiens	Kd	nM	920.0
	3449493	CHEMBL1244939	Binding affinity to PRKCQ	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4300.0	CHEMBL3920	Homo sapiens	Kd	nM	4300.0
	3449817	CHEMBL1244939	Binding affinity to PRKCQ	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	3450211	CHEMBL1244939	Binding affinity to PRKCQ	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	3451123	CHEMBL1244939	Binding affinity to PRKCQ	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	uM	10.0
	3463332	CHEMBL1251592	Inhibition of PRKCQ at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	98.0	CHEMBL3920	Homo sapiens	INH	%	98.0
	3463876	CHEMBL1251592	Inhibition of PRKCQ at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	15.0	CHEMBL3920	Homo sapiens	INH	%	15.0
	3464095	CHEMBL1251592	Inhibition of PRKCQ at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	38.0	CHEMBL3920	Homo sapiens	INH	%	38.0
	3471617	CHEMBL1250658	Inhibition of PKCtheta	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	3502333	CHEMBL1259595	Inhibition of PKCtheta at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c12		CHEMBL1257282	>	Inhibition	%	90.0	CHEMBL3920	Homo sapiens	INH	%	90.0
	3504860	CHEMBL1260400	Inhibition of [3H]PDBu binding to PKCtheta C1B peptide	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cc(O)ccc1Br		CHEMBL1256416	=	Ki	nM	0.16	CHEMBL3920	Homo sapiens	Ki	nM	0.16
	3504868	CHEMBL1260400	Inhibition of [3H]PDBu binding to PKCtheta C1B peptide	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.72	CHEMBL3920	Homo sapiens	Kd	nM	0.72
	3504876	CHEMBL1260400	Inhibition of [3H]PDBu binding to PKCtheta C1B peptide	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4ccccc4)O[C@@]1(C3)O2		CHEMBL1258117	=	Ki	nM	8.1	CHEMBL3920	Homo sapiens	Ki	nM	8.1
	3504884	CHEMBL1260400	Inhibition of [3H]PDBu binding to PKCtheta C1B peptide	B	O=C1C[C@H]2CCC[C@]3(C[C@@H](C[C@@H](CCCCc4ccccc4)O3)OC(=O)C[C@H](CO)O1)O2		CHEMBL1258349	=	Ki	nM	170.0	CHEMBL3920	Homo sapiens	Ki	nM	170.0
	3504895	CHEMBL1260400	Inhibition of [3H]PDBu binding to PKCtheta C1B peptide	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4cccc(O)c4)O[C@@]1(C3)O2		CHEMBL1258348	=	Ki	nM	4.0	CHEMBL3920	Homo sapiens	Ki	nM	4.0
	3601442	CHEMBL1292416	Inhibition of PKC-theta	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	22400.0	CHEMBL3920	Homo sapiens	IC50	uM	22.4
Not Active	3802141	CHEMBL1613831	PUBCHEM_BIOASSAY: In Vitro Kinase Assay Using Purified Enzyme PKC-theta. (Class of assay: confirmatory) [Related pubchem assays: 1299, 1270, 1295, 1375, 1287, 1281, 1293, 1291, 1289, 1280, 465, 1364, 1282, 1372, 1365, 1370, 1367, 1366, 1266, 1269, 1373, 1292, 1290, 1302, 1371, 1271, 1294, 1374, 1368, 1369 ]	B	Br.Cc1cc2nc(NCCCO)n(CC(=O)c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)c2cc1C		CHEMBL1427791	>	EC50	nM	4000.0	CHEMBL3920	Homo sapiens	EC50	um	4.0
	5121146	CHEMBL1648686	Inhibition of human PKCtheta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	114.0	CHEMBL3920	Homo sapiens	INH	%	114.0
	5146709	CHEMBL1657032	Inhibition of PKCtheta	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	68.0	CHEMBL3920	Homo sapiens	IC50	nM	68.0
	5243755	CHEMBL1685859	Inhibition of PKCtheta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	45.0	CHEMBL3920	Homo sapiens	INH	%	45.0
	5243863	CHEMBL1686075	Inhibition of PKCtheta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	6.0	CHEMBL3920	Homo sapiens	INH	%	6.0
	5243976	CHEMBL1685859	Inhibition of PKCtheta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	74.0	CHEMBL3920	Homo sapiens	INH	%	74.0
	5244084	CHEMBL1686075	Inhibition of PKCtheta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	23.0	CHEMBL3920	Homo sapiens	INH	%	23.0
	5244957	CHEMBL1685859	Inhibition of PKCtheta at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	95.0	CHEMBL3920	Homo sapiens	INH	%	95.0
	5245065	CHEMBL1686075	Inhibition of PKCtheta at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	118.0	CHEMBL3920	Homo sapiens	INH	%	118.0
	5245216	CHEMBL1685859	Inhibition of PKCtheta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	116.0	CHEMBL3920	Homo sapiens	INH	%	116.0
	5246046	CHEMBL1686075	Inhibition of PKCtheta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	102.0	CHEMBL3920	Homo sapiens	INH	%	102.0
	6166998	CHEMBL1768884	Inhibition of PKCtheta	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	2000.0	CHEMBL3920	Homo sapiens	Ki	uM	2.0
	6169201	CHEMBL1768979	Inhibition of human PKCtheta assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	29.0	CHEMBL3920	Homo sapiens	Activity	%	29.0
	6299691	CHEMBL1811588	Inhibition of PKCtheta	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	>	IC50	nM	25000.0	CHEMBL3920	Homo sapiens	IC50	uM	25.0
	6335504	CHEMBL1821098	Inhibition of N-terminal GST-fused PKCtheta (1-706) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@@H]1O		CHEMBL447577	=	Inhibition	%	39.8	CHEMBL3920	Homo sapiens	INH	%	39.8
	6335516	CHEMBL1821098	Inhibition of N-terminal GST-fused PKCtheta (1-706) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Inhibition	%	47.1	CHEMBL3920	Homo sapiens	INH	%	47.1
	6335530	CHEMBL1821098	Inhibition of N-terminal GST-fused PKCtheta (1-706) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	Inhibition	%	37.1	CHEMBL3920	Homo sapiens	INH	%	37.1
	6335544	CHEMBL1821098	Inhibition of N-terminal GST-fused PKCtheta (1-706) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819204	=	Inhibition	%	51.2	CHEMBL3920	Homo sapiens	INH	%	51.2
	6340949	CHEMBL1827273	Activity of PRKCQ kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	93.0	CHEMBL3920	Homo sapiens	Activity	%	93.0
	6386323	CHEMBL1839918	Inhibition of recombinant PKCtheta	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	7567449	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7567937	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7568405	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7568837	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	7200.0	CHEMBL3920	Homo sapiens	Kd	nM	7200.0
	7569440	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7569912	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7570375	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7570802	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4300.0	CHEMBL3920	Homo sapiens	Kd	nM	4300.0
	7570956	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7571413	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7571889	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7572352	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7572768	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1500.0	CHEMBL3920	Homo sapiens	Kd	nM	1500.0
	7572937	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7573394	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7573870	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7574339	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	920.0	CHEMBL3920	Homo sapiens	Kd	nM	920.0
	7574747	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7574915	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	5500.0	CHEMBL3920	Homo sapiens	Kd	nM	5500.0
	7575376	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7575847	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7576889	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7577348	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7577826	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7577854	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7578259	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7578897	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	12.0	CHEMBL3920	Homo sapiens	Kd	nM	12.0
	7579271	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7579721	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	350.0	CHEMBL3920	Homo sapiens	Kd	nM	350.0
	7580222	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7580625	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7581255	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7581640	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7582114	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7582578	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7582978	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5300.0	CHEMBL3920	Homo sapiens	Kd	nM	5300.0
	7584001	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7584472	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	36.0	CHEMBL3920	Homo sapiens	Kd	nM	36.0
	7584934	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7585338	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7585489	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7585897	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7586343	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7586814	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2.5	CHEMBL3920	Homo sapiens	Kd	nM	2.5
	7587268	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7587450	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7587869	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7588322	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7588793	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7589244	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7589415	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7589839	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	100.0	CHEMBL3920	Homo sapiens	Kd	nM	100.0
	7590306	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7590780	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7591231	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7591388	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7591810	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3200.0	CHEMBL3920	Homo sapiens	Kd	nM	3200.0
	7592282	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7592755	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7593355	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2200.0	CHEMBL3920	Homo sapiens	Kd	nM	2200.0
	7593790	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7594262	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	16.0	CHEMBL3920	Homo sapiens	Kd	nM	16.0
	7594745	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	910.0	CHEMBL3920	Homo sapiens	Kd	nM	910.0
	7595323	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7595767	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7596270	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7596717	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7597295	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7597748	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7597779	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7598249	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3920	Homo sapiens	Kd	nM	10000.0
	7598691	CHEMBL1908748	Binding constant for PRKCQ kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.5	CHEMBL3920	Homo sapiens	Kd	nM	8.5
	7922674	CHEMBL1918827	Inhibition of human recombinant PRKCT at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	61.0	CHEMBL3920	Homo sapiens	INH	%	61.0
	7935627	CHEMBL1919488	Binding affinity to PKCtheta C1B subdomain after 1 hr by fluorescence quenching analysis	B	COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O		CHEMBL180239	=	EC50	nM	7250.0	CHEMBL3920	Homo sapiens	EC50	uM	7.25
	7935628	CHEMBL1919488	Binding affinity to PKCtheta C1B subdomain after 1 hr by fluorescence quenching analysis	B	CCCCOc1ccc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n[nH]2)cc1OC		CHEMBL1914609	=	EC50	nM	15840.0	CHEMBL3920	Homo sapiens	EC50	uM	15.84
	7935629	CHEMBL1919488	Binding affinity to PKCtheta C1B subdomain after 1 hr by fluorescence quenching analysis	B	COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O		CHEMBL181529	=	EC50	nM	3160.0	CHEMBL3920	Homo sapiens	EC50	uM	3.16
	7935630	CHEMBL1919488	Binding affinity to PKCtheta C1B subdomain after 1 hr by fluorescence quenching analysis	B	CCCCOc1ccc(/C=C/c2cc(/C=C/c3ccc(OCCCC)c(OC)c3)on2)cc1OC		CHEMBL1914610	=	EC50	nM	7140.0	CHEMBL3920	Homo sapiens	EC50	uM	7.14
	7956242	CHEMBL1925201	Inhibition of N-terminus flag-tagged PKCtheta expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	7961125	CHEMBL1931544	Inhibition of PKCtheta	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3920	Homo sapiens	IC50	uM	30.0
	7961126	CHEMBL1931544	Inhibition of PKCtheta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL3920	Homo sapiens	IC50	uM	30.0
	8013073	CHEMBL1947860	Inhibition of PKCtheta using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	1400.0	CHEMBL3920	Homo sapiens	IC50	uM	1.4
	8018879	CHEMBL1948965	Inhibition of PKC-theta assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	82.0	CHEMBL3920	Homo sapiens	Activity	%	82.0
	8018880	CHEMBL1948965	Inhibition of PKC-theta assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	80.0	CHEMBL3920	Homo sapiens	Activity	%	80.0
	8018881	CHEMBL1948965	Inhibition of PKC-theta assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	73.0	CHEMBL3920	Homo sapiens	Activity	%	73.0
	8061235	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.02	CHEMBL3920	Homo sapiens	Inhibition	%	-0.02
	8061412	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.99	CHEMBL3920	Homo sapiens	Inhibition	%	1.99
	8061636	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.56	CHEMBL3920	Homo sapiens	Inhibition	%	1.56
	8061743	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.03	CHEMBL3920	Homo sapiens	Inhibition	%	4.03
	8061934	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-0.39	CHEMBL3920	Homo sapiens	Inhibition	%	-0.39
	8062158	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.22	CHEMBL3920	Homo sapiens	Inhibition	%	0.22
	8062274	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.13	CHEMBL3920	Homo sapiens	Inhibition	%	1.13
	8062660	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.93	CHEMBL3920	Homo sapiens	Inhibition	%	2.93
	8062758	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.0	CHEMBL3920	Homo sapiens	Inhibition	%	0.0
	8062982	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.8	CHEMBL3920	Homo sapiens	Inhibition	%	-0.8
	8063114	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.18	CHEMBL3920	Homo sapiens	Inhibition	%	-0.18
	8063505	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.55	CHEMBL3920	Homo sapiens	Inhibition	%	2.55
	8063613	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.77	CHEMBL3920	Homo sapiens	Inhibition	%	0.77
	8063837	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.31	CHEMBL3920	Homo sapiens	Inhibition	%	1.31
	8064019	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.59	CHEMBL3920	Homo sapiens	Inhibition	%	0.59
	8064134	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.08	CHEMBL3920	Homo sapiens	Inhibition	%	3.08
	8064358	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	5.55	CHEMBL3920	Homo sapiens	Inhibition	%	5.55
	8064568	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.63	CHEMBL3920	Homo sapiens	Inhibition	%	-1.63
	8064706	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.85	CHEMBL3920	Homo sapiens	Inhibition	%	-0.85
	8064930	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.93	CHEMBL3920	Homo sapiens	Inhibition	%	-0.93
	8065096	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.39	CHEMBL3920	Homo sapiens	Inhibition	%	1.39
	8065436	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.7	CHEMBL3920	Homo sapiens	Inhibition	%	1.7
	8065611	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-0.24	CHEMBL3920	Homo sapiens	Inhibition	%	-0.24
	8065950	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	32.33	CHEMBL3920	Homo sapiens	Inhibition	%	32.33
	8066160	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.41	CHEMBL3920	Homo sapiens	Inhibition	%	-0.41
	8066520	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.09	CHEMBL3920	Homo sapiens	Inhibition	%	0.09
	8066686	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.97	CHEMBL3920	Homo sapiens	Inhibition	%	2.97
	8067034	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.69	CHEMBL3920	Homo sapiens	Inhibition	%	1.69
	8067209	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.7	CHEMBL3920	Homo sapiens	Inhibition	%	0.7
	8067554	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.74	CHEMBL3920	Homo sapiens	Inhibition	%	0.74
	8067764	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.94	CHEMBL3920	Homo sapiens	Inhibition	%	0.94
	8068123	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.77	CHEMBL3920	Homo sapiens	Inhibition	%	6.77
	8068287	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.33	CHEMBL3920	Homo sapiens	Inhibition	%	1.33
	8068511	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.57	CHEMBL3920	Homo sapiens	Inhibition	%	3.57
	8068636	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.53	CHEMBL3920	Homo sapiens	Inhibition	%	0.53
	8068810	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.17	CHEMBL3920	Homo sapiens	Inhibition	%	-0.17
	8069034	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.01	CHEMBL3920	Homo sapiens	Inhibition	%	1.01
	8069159	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.07	CHEMBL3920	Homo sapiens	Inhibition	%	2.07
	8069454	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	12.44	CHEMBL3920	Homo sapiens	Inhibition	%	12.44
	8069839	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.67	CHEMBL3920	Homo sapiens	Inhibition	%	1.67
	8069965	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.01	CHEMBL3920	Homo sapiens	Inhibition	%	-0.01
	8070361	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.27	CHEMBL3920	Homo sapiens	Inhibition	%	0.27
	8070486	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.13	CHEMBL3920	Homo sapiens	Inhibition	%	0.13
	8070710	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.28	CHEMBL3920	Homo sapiens	Inhibition	%	-0.28
	8070784	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	57.16	CHEMBL3920	Homo sapiens	Inhibition	%	57.16
	8071165	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.19	CHEMBL3920	Homo sapiens	Inhibition	%	3.19
	8071291	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.33	CHEMBL3920	Homo sapiens	Inhibition	%	0.33
	8071515	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.49	CHEMBL3920	Homo sapiens	Inhibition	%	-0.49
	8071688	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.29	CHEMBL3920	Homo sapiens	Inhibition	%	1.29
	8072037	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.27	CHEMBL3920	Homo sapiens	Inhibition	%	-0.27
	8072127	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.27	CHEMBL3920	Homo sapiens	Inhibition	%	-0.27
	8072351	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.91	CHEMBL3920	Homo sapiens	Inhibition	%	-0.91
	8072508	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.38	CHEMBL3920	Homo sapiens	Inhibition	%	1.38
	8072857	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.14	CHEMBL3920	Homo sapiens	Inhibition	%	0.14
	8073024	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.79	CHEMBL3920	Homo sapiens	Inhibition	%	0.79
	8073373	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.1	CHEMBL3920	Homo sapiens	Inhibition	%	-1.1
	8073492	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.6	CHEMBL3920	Homo sapiens	Inhibition	%	-0.6
	8073716	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.65	CHEMBL3920	Homo sapiens	Inhibition	%	-1.65
	8073949	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.28	CHEMBL3920	Homo sapiens	Inhibition	%	2.28
	8074101	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.87	CHEMBL3920	Homo sapiens	Inhibition	%	2.87
	8074455	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.71	CHEMBL3920	Homo sapiens	Inhibition	%	-0.71
	8074612	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.43	CHEMBL3920	Homo sapiens	Inhibition	%	0.43
	8074836	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.38	CHEMBL3920	Homo sapiens	Inhibition	%	-0.38
	8074963	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.84	CHEMBL3920	Homo sapiens	Inhibition	%	-0.84
	8075298	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.92	CHEMBL3920	Homo sapiens	Inhibition	%	-0.92
	8075535	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	7.85	CHEMBL3920	Homo sapiens	Inhibition	%	7.85
	8075676	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.72	CHEMBL3920	Homo sapiens	Inhibition	%	1.72
	8075900	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.51	CHEMBL3920	Homo sapiens	Inhibition	%	3.51
	8076042	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.16	CHEMBL3920	Homo sapiens	Inhibition	%	-0.16
	8076414	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.51	CHEMBL3920	Homo sapiens	Inhibition	%	0.51
	8076548	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.07	CHEMBL3920	Homo sapiens	Inhibition	%	-1.07
	8076874	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.08	CHEMBL3920	Homo sapiens	Inhibition	%	-2.08
	8077121	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	73.49	CHEMBL3920	Homo sapiens	Inhibition	%	73.49
	8077473	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.0	CHEMBL3920	Homo sapiens	Inhibition	%	1.0
	8077624	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.58	CHEMBL3920	Homo sapiens	Inhibition	%	-0.58
	8077991	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.63	CHEMBL3920	Homo sapiens	Inhibition	%	-0.63
	8078130	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.75	CHEMBL3920	Homo sapiens	Inhibition	%	-1.75
	8078354	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.1	CHEMBL3920	Homo sapiens	Inhibition	%	-1.1
	8078456	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.55	CHEMBL3920	Homo sapiens	Inhibition	%	-0.55
	8078706	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	84.79	CHEMBL3920	Homo sapiens	Inhibition	%	84.79
	8079046	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.47	CHEMBL3920	Homo sapiens	Inhibition	%	1.47
	8079204	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.9	CHEMBL3920	Homo sapiens	Inhibition	%	-0.9
	8079428	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.85	CHEMBL3920	Homo sapiens	Inhibition	%	0.85
	8079570	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.77	CHEMBL3920	Homo sapiens	Inhibition	%	0.77
	8079933	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.2	CHEMBL3920	Homo sapiens	Inhibition	%	2.2
	8080038	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.23	CHEMBL3920	Homo sapiens	Inhibition	%	1.23
	8080262	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.0	CHEMBL3920	Homo sapiens	Inhibition	%	0.0
	8080290	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.36	CHEMBL3920	Homo sapiens	Inhibition	%	2.36
	8080514	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	7.78	CHEMBL3920	Homo sapiens	Inhibition	%	7.78
	8080629	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.21	CHEMBL3920	Homo sapiens	Inhibition	%	1.21
	8081017	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.64	CHEMBL3920	Homo sapiens	Inhibition	%	-1.64
	8081152	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.73	CHEMBL3920	Homo sapiens	Inhibition	%	-0.73
	8081520	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.87	CHEMBL3920	Homo sapiens	Inhibition	%	8.87
	8081847	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.79	CHEMBL3920	Homo sapiens	Inhibition	%	4.79
	8082099	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	10.32	CHEMBL3920	Homo sapiens	Inhibition	%	10.32
	8082212	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.19	CHEMBL3920	Homo sapiens	Inhibition	%	1.19
	8082436	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.72	CHEMBL3920	Homo sapiens	Inhibition	%	1.72
	8082609	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.41	CHEMBL3920	Homo sapiens	Inhibition	%	-0.41
	8082732	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.68	CHEMBL3920	Homo sapiens	Inhibition	%	0.68
	8082956	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.42	CHEMBL3920	Homo sapiens	Inhibition	%	-0.42
	8083112	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.3	CHEMBL3920	Homo sapiens	Inhibition	%	2.3
	8083435	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.5	CHEMBL3920	Homo sapiens	Inhibition	%	-0.5
	8083689	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	55.2	CHEMBL3920	Homo sapiens	Inhibition	%	55.2
	8084023	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.61	CHEMBL3920	Homo sapiens	Inhibition	%	3.61
	8084208	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.1	CHEMBL3920	Homo sapiens	Inhibition	%	2.1
	8084550	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.5	CHEMBL3920	Homo sapiens	Inhibition	%	0.5
	8084711	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.44	CHEMBL3920	Homo sapiens	Inhibition	%	6.44
	8085033	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.76	CHEMBL3920	Homo sapiens	Inhibition	%	-0.76
	8085289	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.05	CHEMBL3920	Homo sapiens	Inhibition	%	-1.05
	8085621	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.16	CHEMBL3920	Homo sapiens	Inhibition	%	1.16
	8085810	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	11.83	CHEMBL3920	Homo sapiens	Inhibition	%	11.83
	8086149	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.28	CHEMBL3920	Homo sapiens	Inhibition	%	0.28
	8086311	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.17	CHEMBL3920	Homo sapiens	Inhibition	%	2.17
	8086535	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.83	CHEMBL3920	Homo sapiens	Inhibition	%	7.83
	8086634	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.28	CHEMBL3920	Homo sapiens	Inhibition	%	-0.28
	8087069	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.94	CHEMBL3920	Homo sapiens	Inhibition	%	1.94
	8087227	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.23	CHEMBL3920	Homo sapiens	Inhibition	%	1.23
	8087565	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.4	CHEMBL3920	Homo sapiens	Inhibition	%	3.4
	8087703	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.89	CHEMBL3920	Homo sapiens	Inhibition	%	0.89
	8087927	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.21	CHEMBL3920	Homo sapiens	Inhibition	%	1.21
	8088069	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.7	CHEMBL3920	Homo sapiens	Inhibition	%	3.7
	8088441	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.71	CHEMBL3920	Homo sapiens	Inhibition	%	0.71
	8088569	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.16	CHEMBL3920	Homo sapiens	Inhibition	%	2.16
	8088886	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	6.38	CHEMBL3920	Homo sapiens	Inhibition	%	6.38
	8089238	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.05	CHEMBL3920	Homo sapiens	Inhibition	%	7.05
	8089386	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.24	CHEMBL3920	Homo sapiens	Inhibition	%	1.24
	8089730	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.01	CHEMBL3920	Homo sapiens	Inhibition	%	-0.01
	8089910	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.16	CHEMBL3920	Homo sapiens	Inhibition	%	-0.16
	8090134	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.29	CHEMBL3920	Homo sapiens	Inhibition	%	0.29
	8090299	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.05	CHEMBL3920	Homo sapiens	Inhibition	%	5.05
	8090466	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.47	CHEMBL3920	Homo sapiens	Inhibition	%	1.47
	8090829	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.61	CHEMBL3920	Homo sapiens	Inhibition	%	0.61
	8091034	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.49	CHEMBL3920	Homo sapiens	Inhibition	%	1.49
	8091395	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.34	CHEMBL3920	Homo sapiens	Inhibition	%	2.34
	8091550	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.92	CHEMBL3920	Homo sapiens	Inhibition	%	1.92
	8091774	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.78	CHEMBL3920	Homo sapiens	Inhibition	%	0.78
	8091890	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.02	CHEMBL3920	Homo sapiens	Inhibition	%	3.02
	8092251	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.59	CHEMBL3920	Homo sapiens	Inhibition	%	1.59
	8092402	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.91	CHEMBL3920	Homo sapiens	Inhibition	%	2.91
	8092774	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.32	CHEMBL3920	Homo sapiens	Inhibition	%	0.32
	8092903	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.24	CHEMBL3920	Homo sapiens	Inhibition	%	3.24
	8093127	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.43	CHEMBL3920	Homo sapiens	Inhibition	%	2.43
	8093215	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.12	CHEMBL3920	Homo sapiens	Inhibition	%	0.12
	8093579	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	11.89	CHEMBL3920	Homo sapiens	Inhibition	%	11.89
	8093718	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	6.89	CHEMBL3920	Homo sapiens	Inhibition	%	6.89
	8093942	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.18	CHEMBL3920	Homo sapiens	Inhibition	%	0.18
	8094062	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.29	CHEMBL3920	Homo sapiens	Inhibition	%	2.29
	8094466	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.04	CHEMBL3920	Homo sapiens	Inhibition	%	-0.04
	8094641	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.56	CHEMBL3920	Homo sapiens	Inhibition	%	2.56
	8094797	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.08	CHEMBL3920	Homo sapiens	Inhibition	%	-0.08
	8095021	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.31	CHEMBL3920	Homo sapiens	Inhibition	%	1.31
	8095161	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.96	CHEMBL3920	Homo sapiens	Inhibition	%	0.96
	8095364	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.01	CHEMBL3920	Homo sapiens	Inhibition	%	2.01
	8095588	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.35	CHEMBL3920	Homo sapiens	Inhibition	%	1.35
	8095729	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.28	CHEMBL3920	Homo sapiens	Inhibition	%	3.28
	8096101	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.99	CHEMBL3920	Homo sapiens	Inhibition	%	0.99
	8096218	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.88	CHEMBL3920	Homo sapiens	Inhibition	%	2.88
	8096581	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.06	CHEMBL3920	Homo sapiens	Inhibition	%	1.06
	8096737	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.44	CHEMBL3920	Homo sapiens	Inhibition	%	4.44
	8096961	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.73	CHEMBL3920	Homo sapiens	Inhibition	%	2.73
	8097108	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.01	CHEMBL3920	Homo sapiens	Inhibition	%	0.01
	8097415	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.91	CHEMBL3920	Homo sapiens	Inhibition	%	0.91
	8097639	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.91	CHEMBL3920	Homo sapiens	Inhibition	%	0.91
	8097789	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	52.52	CHEMBL3920	Homo sapiens	Inhibition	%	52.52
	8098146	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.02	CHEMBL3920	Homo sapiens	Inhibition	%	2.02
	8098266	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.23	CHEMBL3920	Homo sapiens	Inhibition	%	1.23
	8098490	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.18	CHEMBL3920	Homo sapiens	Inhibition	%	1.18
	8098670	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-2.6	CHEMBL3920	Homo sapiens	Inhibition	%	-2.6
	8098855	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.69	CHEMBL3920	Homo sapiens	Inhibition	%	4.69
	8099223	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.25	CHEMBL3920	Homo sapiens	Inhibition	%	1.25
	8099365	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.39	CHEMBL3920	Homo sapiens	Inhibition	%	1.39
	8099783	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.42	CHEMBL3920	Homo sapiens	Inhibition	%	1.42
	8099930	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.03	CHEMBL3920	Homo sapiens	Inhibition	%	3.03
	8100300	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.05	CHEMBL3920	Homo sapiens	Inhibition	%	1.05
	8100416	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.89	CHEMBL3920	Homo sapiens	Inhibition	%	2.89
	8100640	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.28	CHEMBL3920	Homo sapiens	Inhibition	%	2.28
	8100780	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.03	CHEMBL3920	Homo sapiens	Inhibition	%	1.03
	8101164	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.84	CHEMBL3920	Homo sapiens	Inhibition	%	4.84
	8101306	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.7	CHEMBL3920	Homo sapiens	Inhibition	%	-0.7
	8101715	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.69	CHEMBL3920	Homo sapiens	Inhibition	%	2.69
	8101968	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.99	CHEMBL3920	Homo sapiens	Inhibition	%	0.99
	8102123	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.02	CHEMBL3920	Homo sapiens	Inhibition	%	0.02
	8102478	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.36	CHEMBL3920	Homo sapiens	Inhibition	%	1.36
	8102822	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.93	CHEMBL3920	Homo sapiens	Inhibition	%	0.93
	8103000	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.62	CHEMBL3920	Homo sapiens	Inhibition	%	-0.62
	8103196	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	55.08	CHEMBL3920	Homo sapiens	Inhibition	%	55.08
	8103420	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	82.65	CHEMBL3920	Homo sapiens	Inhibition	%	82.65
	8103558	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.79	CHEMBL3920	Homo sapiens	Inhibition	%	0.79
	8103708	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.74	CHEMBL3920	Homo sapiens	Inhibition	%	0.74
	8103932	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.36	CHEMBL3920	Homo sapiens	Inhibition	%	2.36
	8104117	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.36	CHEMBL3920	Homo sapiens	Inhibition	%	0.36
	8104265	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.16	CHEMBL3920	Homo sapiens	Inhibition	%	4.16
	8104489	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.47	CHEMBL3920	Homo sapiens	Inhibition	%	4.47
	8104635	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.96	CHEMBL3920	Homo sapiens	Inhibition	%	2.96
	8104973	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.89	CHEMBL3920	Homo sapiens	Inhibition	%	3.89
	8105113	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.79	CHEMBL3920	Homo sapiens	Inhibition	%	0.79
	8105337	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.16	CHEMBL3920	Homo sapiens	Inhibition	%	2.16
	8105503	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.08	CHEMBL3920	Homo sapiens	Inhibition	%	3.08
	8105641	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.9	CHEMBL3920	Homo sapiens	Inhibition	%	-0.9
	8105865	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.43	CHEMBL3920	Homo sapiens	Inhibition	%	2.43
	8105921	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.62	CHEMBL3920	Homo sapiens	Inhibition	%	0.62
	8106145	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.6	CHEMBL3920	Homo sapiens	Inhibition	%	-0.6
	8106310	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.23	CHEMBL3920	Homo sapiens	Inhibition	%	0.23
	8106466	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	6.28	CHEMBL3920	Homo sapiens	Inhibition	%	6.28
	8106690	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.73	CHEMBL3920	Homo sapiens	Inhibition	%	6.73
	8106819	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.38	CHEMBL3920	Homo sapiens	Inhibition	%	1.38
	8107164	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.88	CHEMBL3920	Homo sapiens	Inhibition	%	1.88
	8107336	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.18	CHEMBL3920	Homo sapiens	Inhibition	%	0.18
	8107761	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.9	CHEMBL3920	Homo sapiens	Inhibition	%	4.9
	8107896	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.72	CHEMBL3920	Homo sapiens	Inhibition	%	0.72
	8108278	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.67	CHEMBL3920	Homo sapiens	Inhibition	%	0.67
	8108453	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.17	CHEMBL3920	Homo sapiens	Inhibition	%	0.17
	8108824	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	15.35	CHEMBL3920	Homo sapiens	Inhibition	%	15.35
	8108966	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.62	CHEMBL3920	Homo sapiens	Inhibition	%	0.62
	8109304	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.35	CHEMBL3920	Homo sapiens	Inhibition	%	2.35
	8109658	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.31	CHEMBL3920	Homo sapiens	Inhibition	%	-0.31
	8109829	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.67	CHEMBL3920	Homo sapiens	Inhibition	%	9.67
	8110185	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.38	CHEMBL3920	Homo sapiens	Inhibition	%	3.38
	8110464	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.39	CHEMBL3920	Homo sapiens	Inhibition	%	1.39
	8110630	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.19	CHEMBL3920	Homo sapiens	Inhibition	%	0.19
	8111012	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	38.63	CHEMBL3920	Homo sapiens	Inhibition	%	38.63
	8111135	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.42	CHEMBL3920	Homo sapiens	Inhibition	%	0.42
	8111359	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.12	CHEMBL3920	Homo sapiens	Inhibition	%	1.12
	8111486	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	29.99	CHEMBL3920	Homo sapiens	Inhibition	%	29.99
	8111652	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.55	CHEMBL3920	Homo sapiens	Inhibition	%	0.55
	8111876	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.56	CHEMBL3920	Homo sapiens	Inhibition	%	0.56
	8112081	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.83	CHEMBL3920	Homo sapiens	Inhibition	%	6.83
	8112218	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.03	CHEMBL3920	Homo sapiens	Inhibition	%	-0.03
	8112442	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.11	CHEMBL3920	Homo sapiens	Inhibition	%	-0.11
	8112610	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.73	CHEMBL3920	Homo sapiens	Inhibition	%	1.73
	8112782	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.2	CHEMBL3920	Homo sapiens	Inhibition	%	-0.2
	8113006	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.08	CHEMBL3920	Homo sapiens	Inhibition	%	0.08
	8113158	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	15.74	CHEMBL3920	Homo sapiens	Inhibition	%	15.74
	8113294	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.48	CHEMBL3920	Homo sapiens	Inhibition	%	0.48
	8113518	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.62	CHEMBL3920	Homo sapiens	Inhibition	%	0.62
	8113642	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.35	CHEMBL3920	Homo sapiens	Inhibition	%	3.35
	8113982	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.78	CHEMBL3920	Homo sapiens	Inhibition	%	-0.78
	8114158	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.36	CHEMBL3920	Homo sapiens	Inhibition	%	2.36
	8114514	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.0	CHEMBL3920	Homo sapiens	Inhibition	%	2.0
	8114790	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.58	CHEMBL3920	Homo sapiens	Inhibition	%	0.58
	8114956	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.8	CHEMBL3920	Homo sapiens	Inhibition	%	0.8
	8115180	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.69	CHEMBL3920	Homo sapiens	Inhibition	%	-0.69
	8115345	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.96	CHEMBL3920	Homo sapiens	Inhibition	%	1.96
	8115689	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.64	CHEMBL3920	Homo sapiens	Inhibition	%	0.64
	8115822	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	72.29	CHEMBL3920	Homo sapiens	Inhibition	%	72.29
	8116205	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.9	CHEMBL3920	Homo sapiens	Inhibition	%	0.9
	8116408	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	38.05	CHEMBL3920	Homo sapiens	Inhibition	%	38.05
	8116766	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.41	CHEMBL3920	Homo sapiens	Inhibition	%	-0.41
	8116938	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.11	CHEMBL3920	Homo sapiens	Inhibition	%	2.11
	8117333	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.33	CHEMBL3920	Homo sapiens	Inhibition	%	0.33
	8117491	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	61.11	CHEMBL3920	Homo sapiens	Inhibition	%	61.11
	8117845	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.16	CHEMBL3920	Homo sapiens	Inhibition	%	0.16
	8117983	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.61	CHEMBL3920	Homo sapiens	Inhibition	%	2.61
	8118207	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.43	CHEMBL3920	Homo sapiens	Inhibition	%	2.43
	8118323	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.35	CHEMBL3920	Homo sapiens	Inhibition	%	2.35
	8118495	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.13	CHEMBL3920	Homo sapiens	Inhibition	%	5.13
	8118719	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.01	CHEMBL3920	Homo sapiens	Inhibition	%	3.01
	8118855	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.39	CHEMBL3920	Homo sapiens	Inhibition	%	2.39
	8119126	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.13	CHEMBL3920	Homo sapiens	Inhibition	%	0.13
	8119509	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.44	CHEMBL3920	Homo sapiens	Inhibition	%	0.44
	8119676	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.96	CHEMBL3920	Homo sapiens	Inhibition	%	3.96
	8120019	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.27	CHEMBL3920	Homo sapiens	Inhibition	%	2.27
	8120158	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.61	CHEMBL3920	Homo sapiens	Inhibition	%	1.61
	8120382	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.73	CHEMBL3920	Homo sapiens	Inhibition	%	2.73
	8120542	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.32	CHEMBL3920	Homo sapiens	Inhibition	%	-0.32
	8120743	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	81.46	CHEMBL3920	Homo sapiens	Inhibition	%	81.46
	8121095	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.44	CHEMBL3920	Homo sapiens	Inhibition	%	-0.44
	8121267	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.84	CHEMBL3920	Homo sapiens	Inhibition	%	1.84
	8121491	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.2	CHEMBL3920	Homo sapiens	Inhibition	%	2.2
	8121658	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.34	CHEMBL3920	Homo sapiens	Inhibition	%	-0.34
	8121821	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.86	CHEMBL3920	Homo sapiens	Inhibition	%	1.86
	8122166	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.06	CHEMBL3920	Homo sapiens	Inhibition	%	-1.06
	8122528	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.02	CHEMBL3920	Homo sapiens	Inhibition	%	3.02
	8122648	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.92	CHEMBL3920	Homo sapiens	Inhibition	%	3.92
	8123039	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.32	CHEMBL3920	Homo sapiens	Inhibition	%	5.32
	8123181	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.16	CHEMBL3920	Homo sapiens	Inhibition	%	2.16
	8123405	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.1	CHEMBL3920	Homo sapiens	Inhibition	%	3.1
	8123459	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.13	CHEMBL3920	Homo sapiens	Inhibition	%	0.13
	8123833	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.62	CHEMBL3920	Homo sapiens	Inhibition	%	0.62
	8124000	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.62	CHEMBL3920	Homo sapiens	Inhibition	%	0.62
	8124224	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	4.42	CHEMBL3920	Homo sapiens	Inhibition	%	4.42
	8124343	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.2	CHEMBL3920	Homo sapiens	Inhibition	%	0.2
	8124706	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.09	CHEMBL3920	Homo sapiens	Inhibition	%	0.09
	8124871	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.1	CHEMBL3920	Homo sapiens	Inhibition	%	-1.1
	8125072	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.0	CHEMBL3920	Homo sapiens	Inhibition	%	4.0
	8125296	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.13	CHEMBL3920	Homo sapiens	Inhibition	%	8.13
	8125426	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.08	CHEMBL3920	Homo sapiens	Inhibition	%	-0.08
	8125818	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.1	CHEMBL3920	Homo sapiens	Inhibition	%	1.1
	8125982	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.26	CHEMBL3920	Homo sapiens	Inhibition	%	0.26
	8126146	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.63	CHEMBL3920	Homo sapiens	Inhibition	%	2.63
	8126370	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.37	CHEMBL3920	Homo sapiens	Inhibition	%	2.37
	8126485	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.44	CHEMBL3920	Homo sapiens	Inhibition	%	-1.44
	8126845	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.57	CHEMBL3920	Homo sapiens	Inhibition	%	6.57
	8126967	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.9	CHEMBL3920	Homo sapiens	Inhibition	%	1.9
	8127191	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.54	CHEMBL3920	Homo sapiens	Inhibition	%	3.54
	8127358	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.72	CHEMBL3920	Homo sapiens	Inhibition	%	2.72
	8127724	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.55	CHEMBL3920	Homo sapiens	Inhibition	%	2.55
	8127788	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.31	CHEMBL3920	Homo sapiens	Inhibition	%	0.31
	8128012	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.72	CHEMBL3920	Homo sapiens	Inhibition	%	-0.72
	8128164	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.96	CHEMBL3920	Homo sapiens	Inhibition	%	0.96
	8128555	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.22	CHEMBL3920	Homo sapiens	Inhibition	%	1.22
	8128674	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.75	CHEMBL3920	Homo sapiens	Inhibition	%	4.75
	8129035	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.93	CHEMBL3920	Homo sapiens	Inhibition	%	0.93
	8129206	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.06	CHEMBL3920	Homo sapiens	Inhibition	%	-1.06
	8129430	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.42	CHEMBL3920	Homo sapiens	Inhibition	%	-0.42
	8129619	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.17	CHEMBL3920	Homo sapiens	Inhibition	%	1.17
	8129758	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.79	CHEMBL3920	Homo sapiens	Inhibition	%	0.79
	8130143	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.36	CHEMBL3920	Homo sapiens	Inhibition	%	1.36
	8130315	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.11	CHEMBL3920	Homo sapiens	Inhibition	%	-1.11
	8130699	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.84	CHEMBL3920	Homo sapiens	Inhibition	%	4.84
	8130815	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.46	CHEMBL3920	Homo sapiens	Inhibition	%	2.46
	8131039	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.24	CHEMBL3920	Homo sapiens	Inhibition	%	3.24
	8131178	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.73	CHEMBL3920	Homo sapiens	Inhibition	%	3.73
	8131522	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.43	CHEMBL3920	Homo sapiens	Inhibition	%	2.43
	8131689	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.21	CHEMBL3920	Homo sapiens	Inhibition	%	4.21
	8132054	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.66	CHEMBL3920	Homo sapiens	Inhibition	%	2.66
	8132340	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.27	CHEMBL3920	Homo sapiens	Inhibition	%	-0.27
	8132487	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.78	CHEMBL3920	Homo sapiens	Inhibition	%	0.78
	8132711	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.6	CHEMBL3920	Homo sapiens	Inhibition	%	0.6
	8132879	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.14	CHEMBL3920	Homo sapiens	Inhibition	%	3.14
	8133000	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.01	CHEMBL3920	Homo sapiens	Inhibition	%	1.01
	8133224	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.73	CHEMBL3920	Homo sapiens	Inhibition	%	1.73
	8133362	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.68	CHEMBL3920	Homo sapiens	Inhibition	%	0.68
	8133758	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.76	CHEMBL3920	Homo sapiens	Inhibition	%	-0.76
	8133938	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.43	CHEMBL3920	Homo sapiens	Inhibition	%	1.43
	8134086	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.21	CHEMBL3920	Homo sapiens	Inhibition	%	-1.21
	8134310	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.64	CHEMBL3920	Homo sapiens	Inhibition	%	-1.64
	8134470	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.79	CHEMBL3920	Homo sapiens	Inhibition	%	0.79
	8134654	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.09	CHEMBL3920	Homo sapiens	Inhibition	%	-1.09
	8134878	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.74	CHEMBL3920	Homo sapiens	Inhibition	%	-0.74
	8135038	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.86	CHEMBL3920	Homo sapiens	Inhibition	%	1.86
	8135377	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.99	CHEMBL3920	Homo sapiens	Inhibition	%	1.99
	8135518	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.31	CHEMBL3920	Homo sapiens	Inhibition	%	4.31
	8135863	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.77	CHEMBL3920	Homo sapiens	Inhibition	%	2.77
	8136031	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.69	CHEMBL3920	Homo sapiens	Inhibition	%	1.69
	8136255	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.0	CHEMBL3920	Homo sapiens	Inhibition	%	4.0
	8136399	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.38	CHEMBL3920	Homo sapiens	Inhibition	%	3.38
	8136689	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.14	CHEMBL3920	Homo sapiens	Inhibition	%	-0.14
	8137048	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.07	CHEMBL3920	Homo sapiens	Inhibition	%	5.07
	8137211	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.36	CHEMBL3920	Homo sapiens	Inhibition	%	1.36
	8137555	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.68	CHEMBL3920	Homo sapiens	Inhibition	%	-0.68
	8137703	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.31	CHEMBL3920	Homo sapiens	Inhibition	%	1.31
	8138093	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.86	CHEMBL3920	Homo sapiens	Inhibition	%	-0.86
	8138272	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.61	CHEMBL3920	Homo sapiens	Inhibition	%	0.61
	8138644	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.25	CHEMBL3920	Homo sapiens	Inhibition	%	-1.25
	8138802	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.76	CHEMBL3920	Homo sapiens	Inhibition	%	0.76
	8139211	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.74	CHEMBL3920	Homo sapiens	Inhibition	%	1.74
	8139370	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.08	CHEMBL3920	Homo sapiens	Inhibition	%	3.08
	8139708	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.95	CHEMBL3920	Homo sapiens	Inhibition	%	1.95
	8139849	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.17	CHEMBL3920	Homo sapiens	Inhibition	%	2.17
	8140073	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.74	CHEMBL3920	Homo sapiens	Inhibition	%	2.74
	8140196	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.88	CHEMBL3920	Homo sapiens	Inhibition	%	2.88
	8140579	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.84	CHEMBL3920	Homo sapiens	Inhibition	%	0.84
	8140722	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.39	CHEMBL3920	Homo sapiens	Inhibition	%	3.39
	8141024	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.03	CHEMBL3920	Homo sapiens	Inhibition	%	1.03
	8141378	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.24	CHEMBL3920	Homo sapiens	Inhibition	%	0.24
	8141538	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.98	CHEMBL3920	Homo sapiens	Inhibition	%	2.98
	8141881	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.76	CHEMBL3920	Homo sapiens	Inhibition	%	0.76
	8142042	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.69	CHEMBL3920	Homo sapiens	Inhibition	%	0.69
	8142266	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.58	CHEMBL3920	Homo sapiens	Inhibition	%	2.58
	8142434	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.09	CHEMBL3920	Homo sapiens	Inhibition	%	2.09
	8142610	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.48	CHEMBL3920	Homo sapiens	Inhibition	%	0.48
	8142834	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.5	CHEMBL3920	Homo sapiens	Inhibition	%	0.5
	8142983	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.29	CHEMBL3920	Homo sapiens	Inhibition	%	-1.29
	8143138	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.3	CHEMBL3920	Homo sapiens	Inhibition	%	1.3
	8143362	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.13	CHEMBL3920	Homo sapiens	Inhibition	%	1.13
	8143549	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.5	CHEMBL3920	Homo sapiens	Inhibition	%	2.5
	8143708	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.13	CHEMBL3920	Homo sapiens	Inhibition	%	2.13
	8143932	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.7	CHEMBL3920	Homo sapiens	Inhibition	%	3.7
	8144046	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.31	CHEMBL3920	Homo sapiens	Inhibition	%	2.31
	8144409	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.98	CHEMBL3920	Homo sapiens	Inhibition	%	1.98
	8144539	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.16	CHEMBL3920	Homo sapiens	Inhibition	%	3.16
	8144763	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.83	CHEMBL3920	Homo sapiens	Inhibition	%	3.83
	8144916	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.4	CHEMBL3920	Homo sapiens	Inhibition	%	1.4
	8145053	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.33	CHEMBL3920	Homo sapiens	Inhibition	%	2.33
	8145277	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.85	CHEMBL3920	Homo sapiens	Inhibition	%	2.85
	8145366	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-0.74	CHEMBL3920	Homo sapiens	Inhibition	%	-0.74
	8145590	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.64	CHEMBL3920	Homo sapiens	Inhibition	%	0.64
	8145714	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.12	CHEMBL3920	Homo sapiens	Inhibition	%	-0.12
	8145875	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.22	CHEMBL3920	Homo sapiens	Inhibition	%	2.22
	8146099	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.24	CHEMBL3920	Homo sapiens	Inhibition	%	3.24
	8146219	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.15	CHEMBL3920	Homo sapiens	Inhibition	%	0.15
	8146603	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.39	CHEMBL3920	Homo sapiens	Inhibition	%	4.39
	8146770	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	19.45	CHEMBL3920	Homo sapiens	Inhibition	%	19.45
	8147163	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.97	CHEMBL3920	Homo sapiens	Inhibition	%	2.97
	8147305	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.79	CHEMBL3920	Homo sapiens	Inhibition	%	1.79
	8147682	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.65	CHEMBL3920	Homo sapiens	Inhibition	%	1.65
	8147869	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.25	CHEMBL3920	Homo sapiens	Inhibition	%	1.25
	8148251	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.93	CHEMBL3920	Homo sapiens	Inhibition	%	1.93
	8148365	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.41	CHEMBL3920	Homo sapiens	Inhibition	%	2.41
	8148589	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.68	CHEMBL3920	Homo sapiens	Inhibition	%	2.68
	8148728	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.16	CHEMBL3920	Homo sapiens	Inhibition	%	3.16
	8149090	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.82	CHEMBL3920	Homo sapiens	Inhibition	%	3.82
	8149249	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.98	CHEMBL3920	Homo sapiens	Inhibition	%	0.98
	8149607	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	8.91	CHEMBL3920	Homo sapiens	Inhibition	%	8.91
	8149929	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-0.84	CHEMBL3920	Homo sapiens	Inhibition	%	-0.84
	8150054	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.73	CHEMBL3920	Homo sapiens	Inhibition	%	-0.73
	8150438	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.09	CHEMBL3920	Homo sapiens	Inhibition	%	0.09
	8150558	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.22	CHEMBL3920	Homo sapiens	Inhibition	%	0.22
	8150782	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.19	CHEMBL3920	Homo sapiens	Inhibition	%	-0.19
	8150947	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	10.15	CHEMBL3920	Homo sapiens	Inhibition	%	10.15
	8151110	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.64	CHEMBL3920	Homo sapiens	Inhibition	%	-1.64
	8151334	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.05	CHEMBL3920	Homo sapiens	Inhibition	%	0.05
	8151511	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.97	CHEMBL3920	Homo sapiens	Inhibition	%	0.97
	8151649	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.39	CHEMBL3920	Homo sapiens	Inhibition	%	2.39
	8151873	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.84	CHEMBL3920	Homo sapiens	Inhibition	%	0.84
	8152027	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.8	CHEMBL3920	Homo sapiens	Inhibition	%	0.8
	8152215	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.86	CHEMBL3920	Homo sapiens	Inhibition	%	1.86
	8152439	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.94	CHEMBL3920	Homo sapiens	Inhibition	%	1.94
	8152597	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.27	CHEMBL3920	Homo sapiens	Inhibition	%	2.27
	8152935	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.9	CHEMBL3920	Homo sapiens	Inhibition	%	2.9
	8153074	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.25	CHEMBL3920	Homo sapiens	Inhibition	%	1.25
	8153435	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.06	CHEMBL3920	Homo sapiens	Inhibition	%	3.06
	8153592	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.92	CHEMBL3920	Homo sapiens	Inhibition	%	0.92
	8153816	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.69	CHEMBL3920	Homo sapiens	Inhibition	%	0.69
	8153949	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	39.24	CHEMBL3920	Homo sapiens	Inhibition	%	39.24
	8154270	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.58	CHEMBL3920	Homo sapiens	Inhibition	%	1.58
	8154396	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.78	CHEMBL3920	Homo sapiens	Inhibition	%	1.78
	8154620	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.35	CHEMBL3920	Homo sapiens	Inhibition	%	1.35
	8154779	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.85	CHEMBL3920	Homo sapiens	Inhibition	%	1.85
	8155123	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.17	CHEMBL3920	Homo sapiens	Inhibition	%	-0.17
	8155299	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.19	CHEMBL3920	Homo sapiens	Inhibition	%	-0.19
	8155684	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.08	CHEMBL3920	Homo sapiens	Inhibition	%	2.08
	8155862	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.63	CHEMBL3920	Homo sapiens	Inhibition	%	1.63
	8156224	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.7	CHEMBL3920	Homo sapiens	Inhibition	%	0.7
	8156436	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.02	CHEMBL3920	Homo sapiens	Inhibition	%	2.02
	8156586	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.34	CHEMBL3920	Homo sapiens	Inhibition	%	3.34
	8156810	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.63	CHEMBL3920	Homo sapiens	Inhibition	%	2.63
	8156953	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.14	CHEMBL3920	Homo sapiens	Inhibition	%	3.14
	8157297	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.09	CHEMBL3920	Homo sapiens	Inhibition	%	6.09
	8157438	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.87	CHEMBL3920	Homo sapiens	Inhibition	%	1.87
	8157662	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.29	CHEMBL3920	Homo sapiens	Inhibition	%	5.29
	8157792	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.01	CHEMBL3920	Homo sapiens	Inhibition	%	2.01
	8157953	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.58	CHEMBL3920	Homo sapiens	Inhibition	%	-0.58
	8158177	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.2	CHEMBL3920	Homo sapiens	Inhibition	%	-0.2
	8158427	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.26	CHEMBL3920	Homo sapiens	Inhibition	%	5.26
	8158585	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.17	CHEMBL3920	Homo sapiens	Inhibition	%	3.17
	8158978	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.51	CHEMBL3920	Homo sapiens	Inhibition	%	1.51
	8159113	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.84	CHEMBL3920	Homo sapiens	Inhibition	%	3.84
	8159457	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.55	CHEMBL3920	Homo sapiens	Inhibition	%	1.55
	8159812	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.64	CHEMBL3920	Homo sapiens	Inhibition	%	1.64
	8159953	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.83	CHEMBL3920	Homo sapiens	Inhibition	%	3.83
	8160314	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.7	CHEMBL3920	Homo sapiens	Inhibition	%	3.7
	8160464	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.81	CHEMBL3920	Homo sapiens	Inhibition	%	-0.81
	8160758	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.79	CHEMBL3920	Homo sapiens	Inhibition	%	1.79
	8161132	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.43	CHEMBL3920	Homo sapiens	Inhibition	%	3.43
	8161275	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.63	CHEMBL3920	Homo sapiens	Inhibition	%	2.63
	8161499	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.92	CHEMBL3920	Homo sapiens	Inhibition	%	5.92
	8161624	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.38	CHEMBL3920	Homo sapiens	Inhibition	%	1.38
	8161986	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.52	CHEMBL3920	Homo sapiens	Inhibition	%	3.52
	8162116	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.77	CHEMBL3920	Homo sapiens	Inhibition	%	7.77
	8162500	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.32	CHEMBL3920	Homo sapiens	Inhibition	%	-0.32
	8162753	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	23.76	CHEMBL3920	Homo sapiens	Inhibition	%	23.76
	8162901	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.44	CHEMBL3920	Homo sapiens	Inhibition	%	3.44
	8163125	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	11.8	CHEMBL3920	Homo sapiens	Inhibition	%	11.8
	8163294	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.69	CHEMBL3920	Homo sapiens	Inhibition	%	1.69
	8163428	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.14	CHEMBL3920	Homo sapiens	Inhibition	%	5.14
	8163652	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.58	CHEMBL3920	Homo sapiens	Inhibition	%	4.58
	8163775	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.99	CHEMBL3920	Homo sapiens	Inhibition	%	4.99
	8164133	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.89	CHEMBL3920	Homo sapiens	Inhibition	%	4.89
	8164273	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.49	CHEMBL3920	Homo sapiens	Inhibition	%	0.49
	8164497	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.27	CHEMBL3920	Homo sapiens	Inhibition	%	1.27
	8164652	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.95	CHEMBL3920	Homo sapiens	Inhibition	%	3.95
	8164796	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.4	CHEMBL3920	Homo sapiens	Inhibition	%	0.4
	8165020	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.56	CHEMBL3920	Homo sapiens	Inhibition	%	1.56
	8165090	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.94	CHEMBL3920	Homo sapiens	Inhibition	%	1.94
	8165314	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.49	CHEMBL3920	Homo sapiens	Inhibition	%	5.49
	8165455	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.67	CHEMBL3920	Homo sapiens	Inhibition	%	2.67
	8165822	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.72	CHEMBL3920	Homo sapiens	Inhibition	%	0.72
	8165948	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.85	CHEMBL3920	Homo sapiens	Inhibition	%	3.85
	8166310	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.77	CHEMBL3920	Homo sapiens	Inhibition	%	8.77
	8166440	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.11	CHEMBL3920	Homo sapiens	Inhibition	%	2.11
	8166664	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.65	CHEMBL3920	Homo sapiens	Inhibition	%	3.65
	8166765	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.29	CHEMBL3920	Homo sapiens	Inhibition	%	-0.29
	8167077	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	20.04	CHEMBL3920	Homo sapiens	Inhibition	%	20.04
	8167442	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.59	CHEMBL3920	Homo sapiens	Inhibition	%	4.59
	8167606	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.74	CHEMBL3920	Homo sapiens	Inhibition	%	0.74
	8167963	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.97	CHEMBL3920	Homo sapiens	Inhibition	%	6.97
	8168087	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.63	CHEMBL3920	Homo sapiens	Inhibition	%	1.63
	8168311	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.15	CHEMBL3920	Homo sapiens	Inhibition	%	3.15
	8168452	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.7	CHEMBL3920	Homo sapiens	Inhibition	%	2.7
	8168812	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.17	CHEMBL3920	Homo sapiens	Inhibition	%	0.17
	8168976	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	14.17	CHEMBL3920	Homo sapiens	Inhibition	%	14.17
	8169342	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.36	CHEMBL3920	Homo sapiens	Inhibition	%	-0.36
	8169646	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.03	CHEMBL3920	Homo sapiens	Inhibition	%	2.03
	8169780	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.4	CHEMBL3920	Homo sapiens	Inhibition	%	4.4
	8170149	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-1.36	CHEMBL3920	Homo sapiens	Inhibition	%	-1.36
	8170274	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.85	CHEMBL3920	Homo sapiens	Inhibition	%	0.85
	8170498	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.4	CHEMBL3920	Homo sapiens	Inhibition	%	0.4
	8170638	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	21.51	CHEMBL3920	Homo sapiens	Inhibition	%	21.51
	8170997	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.56	CHEMBL3920	Homo sapiens	Inhibition	%	0.56
	8171194	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.17	CHEMBL3920	Homo sapiens	Inhibition	%	1.17
	8171411	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	67.43	CHEMBL3920	Homo sapiens	Inhibition	%	67.43
	8171776	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	16.19	CHEMBL3920	Homo sapiens	Inhibition	%	16.19
	8171929	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.55	CHEMBL3920	Homo sapiens	Inhibition	%	0.55
	8172153	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.23	CHEMBL3920	Homo sapiens	Inhibition	%	2.23
	8172285	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.03	CHEMBL3920	Homo sapiens	Inhibition	%	2.03
	8172637	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.23	CHEMBL3920	Homo sapiens	Inhibition	%	0.23
	8172779	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.63	CHEMBL3920	Homo sapiens	Inhibition	%	2.63
	8173139	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.88	CHEMBL3920	Homo sapiens	Inhibition	%	0.88
	8173304	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.97	CHEMBL3920	Homo sapiens	Inhibition	%	2.97
	8173528	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.71	CHEMBL3920	Homo sapiens	Inhibition	%	5.71
	8173669	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.77	CHEMBL3920	Homo sapiens	Inhibition	%	1.77
	8173980	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.63	CHEMBL3920	Homo sapiens	Inhibition	%	3.63
	8174112	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.55	CHEMBL3920	Homo sapiens	Inhibition	%	2.55
	8174336	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.44	CHEMBL3920	Homo sapiens	Inhibition	%	3.44
	8174484	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.24	CHEMBL3920	Homo sapiens	Inhibition	%	1.24
	8174830	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.01	CHEMBL3920	Homo sapiens	Inhibition	%	1.01
	8174973	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	65.47	CHEMBL3920	Homo sapiens	Inhibition	%	65.47
	8175333	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.84	CHEMBL3920	Homo sapiens	Inhibition	%	2.84
	8175589	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.7	CHEMBL3920	Homo sapiens	Inhibition	%	4.7
	8175752	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.21	CHEMBL3920	Homo sapiens	Inhibition	%	1.21
	8175976	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.49	CHEMBL3920	Homo sapiens	Inhibition	%	2.49
	8176129	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	17.17	CHEMBL3920	Homo sapiens	Inhibition	%	17.17
	8176502	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.16	CHEMBL3920	Homo sapiens	Inhibition	%	1.16
	8176634	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.75	CHEMBL3920	Homo sapiens	Inhibition	%	4.75
	8176988	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.98	CHEMBL3920	Homo sapiens	Inhibition	%	0.98
	8177130	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.61	CHEMBL3920	Homo sapiens	Inhibition	%	2.61
	8177354	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.08	CHEMBL3920	Homo sapiens	Inhibition	%	3.08
	8177492	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.69	CHEMBL3920	Homo sapiens	Inhibition	%	4.69
	8177880	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.69	CHEMBL3920	Homo sapiens	Inhibition	%	1.69
	8178020	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.57	CHEMBL3920	Homo sapiens	Inhibition	%	2.57
	8178332	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.43	CHEMBL3920	Homo sapiens	Inhibition	%	1.43
	8178683	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.53	CHEMBL3920	Homo sapiens	Inhibition	%	2.53
	8178832	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.68	CHEMBL3920	Homo sapiens	Inhibition	%	-0.68
	8179179	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.75	CHEMBL3920	Homo sapiens	Inhibition	%	0.75
	8179323	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.98	CHEMBL3920	Homo sapiens	Inhibition	%	3.98
	8179547	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	8.38	CHEMBL3920	Homo sapiens	Inhibition	%	8.38
	8179684	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.4	CHEMBL3920	Homo sapiens	Inhibition	%	0.4
	8179941	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.64	CHEMBL3920	Homo sapiens	Inhibition	%	2.64
	8180319	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.25	CHEMBL3920	Homo sapiens	Inhibition	%	0.25
	8180475	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	59.43	CHEMBL3920	Homo sapiens	Inhibition	%	59.43
	8180847	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.84	CHEMBL3920	Homo sapiens	Inhibition	%	0.84
	8180980	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.39	CHEMBL3920	Homo sapiens	Inhibition	%	3.39
	8181204	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.6	CHEMBL3920	Homo sapiens	Inhibition	%	7.6
	8181335	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.23	CHEMBL3920	Homo sapiens	Inhibition	%	-0.23
	8181699	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.7	CHEMBL3920	Homo sapiens	Inhibition	%	2.7
	8181838	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	20.85	CHEMBL3920	Homo sapiens	Inhibition	%	20.85
	8182225	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.74	CHEMBL3920	Homo sapiens	Inhibition	%	3.74
	8182365	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.71	CHEMBL3920	Homo sapiens	Inhibition	%	1.71
	8182589	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.47	CHEMBL3920	Homo sapiens	Inhibition	%	0.47
	8182681	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.06	CHEMBL3920	Homo sapiens	Inhibition	%	0.06
	8183027	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.19	CHEMBL3920	Homo sapiens	Inhibition	%	4.19
	8183176	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.22	CHEMBL3920	Homo sapiens	Inhibition	%	1.22
	8183400	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.3	CHEMBL3920	Homo sapiens	Inhibition	%	0.3
	8183529	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.52	CHEMBL3920	Homo sapiens	Inhibition	%	2.52
	8183895	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.29	CHEMBL3920	Homo sapiens	Inhibition	%	2.29
	8184031	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.62	CHEMBL3920	Homo sapiens	Inhibition	%	0.62
	8184255	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.11	CHEMBL3920	Homo sapiens	Inhibition	%	-0.11
	8184297	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.84	CHEMBL3920	Homo sapiens	Inhibition	%	3.84
	8184521	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.92	CHEMBL3920	Homo sapiens	Inhibition	%	2.92
	8184668	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.17	CHEMBL3920	Homo sapiens	Inhibition	%	2.17
	8184825	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.22	CHEMBL3920	Homo sapiens	Inhibition	%	1.22
	8185049	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.8	CHEMBL3920	Homo sapiens	Inhibition	%	3.8
	8185198	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.15	CHEMBL3920	Homo sapiens	Inhibition	%	0.15
	8185553	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.71	CHEMBL3920	Homo sapiens	Inhibition	%	3.71
	8185684	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.24	CHEMBL3920	Homo sapiens	Inhibition	%	3.24
	8185908	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.61	CHEMBL3920	Homo sapiens	Inhibition	%	1.61
	8186047	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.97	CHEMBL3920	Homo sapiens	Inhibition	%	1.97
	8186188	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.86	CHEMBL3920	Homo sapiens	Inhibition	%	2.86
	8186412	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.77	CHEMBL3920	Homo sapiens	Inhibition	%	7.77
	8186576	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.55	CHEMBL3920	Homo sapiens	Inhibition	%	2.55
	8186939	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.29	CHEMBL3920	Homo sapiens	Inhibition	%	2.29
	8187037	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.21	CHEMBL3920	Homo sapiens	Inhibition	%	1.21
	8187261	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.54	CHEMBL3920	Homo sapiens	Inhibition	%	0.54
	8187385	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.59	CHEMBL3920	Homo sapiens	Inhibition	%	2.59
	8187757	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.41	CHEMBL3920	Homo sapiens	Inhibition	%	1.41
	8187886	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.32	CHEMBL3920	Homo sapiens	Inhibition	%	5.32
	8188110	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.86	CHEMBL3920	Homo sapiens	Inhibition	%	2.86
	8188253	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.86	CHEMBL3920	Homo sapiens	Inhibition	%	4.86
	8188612	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.19	CHEMBL3920	Homo sapiens	Inhibition	%	1.19
	8188886	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.95	CHEMBL3920	Homo sapiens	Inhibition	%	4.95
	8189034	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.33	CHEMBL3920	Homo sapiens	Inhibition	%	1.33
	8189414	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.17	CHEMBL3920	Homo sapiens	Inhibition	%	2.17
	8189563	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.29	CHEMBL3920	Homo sapiens	Inhibition	%	-0.29
	8189919	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.27	CHEMBL3920	Homo sapiens	Inhibition	%	5.27
	8190275	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.73	CHEMBL3920	Homo sapiens	Inhibition	%	1.73
	8190415	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.27	CHEMBL3920	Homo sapiens	Inhibition	%	2.27
	8190776	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.59	CHEMBL3920	Homo sapiens	Inhibition	%	3.59
	8190940	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.71	CHEMBL3920	Homo sapiens	Inhibition	%	5.71
	8191302	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.96	CHEMBL3920	Homo sapiens	Inhibition	%	2.96
	8191622	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.3	CHEMBL3920	Homo sapiens	Inhibition	%	1.3
	8191744	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.8	CHEMBL3920	Homo sapiens	Inhibition	%	4.8
	8191968	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.76	CHEMBL3920	Homo sapiens	Inhibition	%	1.76
	8192117	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.25	CHEMBL3920	Homo sapiens	Inhibition	%	-0.25
	8192470	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.52	CHEMBL3920	Homo sapiens	Inhibition	%	5.52
	8192614	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.42	CHEMBL3920	Homo sapiens	Inhibition	%	2.42
	8192974	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.28	CHEMBL3920	Homo sapiens	Inhibition	%	0.28
	8193246	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.84	CHEMBL3920	Homo sapiens	Inhibition	%	1.84
	8193391	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.03	CHEMBL3920	Homo sapiens	Inhibition	%	4.03
	8193615	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.26	CHEMBL3920	Homo sapiens	Inhibition	%	-0.26
	8193772	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.6	CHEMBL3920	Homo sapiens	Inhibition	%	1.6
	8193921	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.32	CHEMBL3920	Homo sapiens	Inhibition	%	-0.32
	8194145	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.44	CHEMBL3920	Homo sapiens	Inhibition	%	0.44
	8194276	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.41	CHEMBL3920	Homo sapiens	Inhibition	%	3.41
	8194631	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.06	CHEMBL3920	Homo sapiens	Inhibition	%	2.06
	8194774	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.49	CHEMBL3920	Homo sapiens	Inhibition	%	4.49
	8194998	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.25	CHEMBL3920	Homo sapiens	Inhibition	%	2.25
	8195131	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.13	CHEMBL3920	Homo sapiens	Inhibition	%	5.13
	8195295	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.45	CHEMBL3920	Homo sapiens	Inhibition	%	2.45
	8195519	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.59	CHEMBL3920	Homo sapiens	Inhibition	%	7.59
	8195658	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.3	CHEMBL3920	Homo sapiens	Inhibition	%	2.3
	8195980	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.01	CHEMBL3920	Homo sapiens	Inhibition	%	1.01
	8196321	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.47	CHEMBL3920	Homo sapiens	Inhibition	%	2.47
	8196471	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.21	CHEMBL3920	Homo sapiens	Inhibition	%	1.21
	8196823	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.98	CHEMBL3920	Homo sapiens	Inhibition	%	1.98
	8196964	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.04	CHEMBL3920	Homo sapiens	Inhibition	%	5.04
	8197188	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.18	CHEMBL3920	Homo sapiens	Inhibition	%	1.18
	8197325	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.68	CHEMBL3920	Homo sapiens	Inhibition	%	-0.68
	8197600	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.65	CHEMBL3920	Homo sapiens	Inhibition	%	3.65
	8197964	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.66	CHEMBL3920	Homo sapiens	Inhibition	%	0.66
	8198121	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.87	CHEMBL3920	Homo sapiens	Inhibition	%	1.87
	8198483	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.15	CHEMBL3920	Homo sapiens	Inhibition	%	3.15
	8198613	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.28	CHEMBL3920	Homo sapiens	Inhibition	%	5.28
	8198837	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.77	CHEMBL3920	Homo sapiens	Inhibition	%	4.77
	8198968	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.93	CHEMBL3920	Homo sapiens	Inhibition	%	1.93
	8199340	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.22	CHEMBL3920	Homo sapiens	Inhibition	%	4.22
	8199474	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.42	CHEMBL3920	Homo sapiens	Inhibition	%	3.42
	8199861	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.48	CHEMBL3920	Homo sapiens	Inhibition	%	1.48
	8199999	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.86	CHEMBL3920	Homo sapiens	Inhibition	%	0.86
	8200223	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.6	CHEMBL3920	Homo sapiens	Inhibition	%	2.6
	8200327	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.91	CHEMBL3920	Homo sapiens	Inhibition	%	0.91
	8200666	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.3	CHEMBL3920	Homo sapiens	Inhibition	%	2.3
	8200816	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.16	CHEMBL3920	Homo sapiens	Inhibition	%	1.16
	8201040	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.39	CHEMBL3920	Homo sapiens	Inhibition	%	1.39
	8201170	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	6.01	CHEMBL3920	Homo sapiens	Inhibition	%	6.01
	8201529	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.98	CHEMBL3920	Homo sapiens	Inhibition	%	2.98
	8201662	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.05	CHEMBL3920	Homo sapiens	Inhibition	%	-1.05
	8201941	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.4	CHEMBL3920	Homo sapiens	Inhibition	%	2.4
	8202305	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.06	CHEMBL3920	Homo sapiens	Inhibition	%	-1.06
	8202472	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.91	CHEMBL3920	Homo sapiens	Inhibition	%	1.91
	8202821	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.06	CHEMBL3920	Homo sapiens	Inhibition	%	5.06
	8203175	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.9	CHEMBL3920	Homo sapiens	Inhibition	%	8.9
	8203306	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.34	CHEMBL3920	Homo sapiens	Inhibition	%	1.34
	8203676	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.07	CHEMBL3920	Homo sapiens	Inhibition	%	2.07
	8203810	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.89	CHEMBL3920	Homo sapiens	Inhibition	%	4.89
	8204034	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.82	CHEMBL3920	Homo sapiens	Inhibition	%	2.82
	8204200	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.91	CHEMBL3920	Homo sapiens	Inhibition	%	1.91
	8204561	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.93	CHEMBL3920	Homo sapiens	Inhibition	%	1.93
	8204666	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.72	CHEMBL3920	Homo sapiens	Inhibition	%	-0.72
	8204890	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.12	CHEMBL3920	Homo sapiens	Inhibition	%	-0.12
	8205005	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.29	CHEMBL3920	Homo sapiens	Inhibition	%	4.29
	8205378	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.61	CHEMBL3920	Homo sapiens	Inhibition	%	1.61
	8205514	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.98	CHEMBL3920	Homo sapiens	Inhibition	%	2.98
	8205877	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.09	CHEMBL3920	Homo sapiens	Inhibition	%	2.09
	8206009	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.26	CHEMBL3920	Homo sapiens	Inhibition	%	-1.26
	8206233	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.26	CHEMBL3920	Homo sapiens	Inhibition	%	-1.26
	8206285	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.71	CHEMBL3920	Homo sapiens	Inhibition	%	2.71
	8206509	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.83	CHEMBL3920	Homo sapiens	Inhibition	%	1.83
	8206652	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.33	CHEMBL3920	Homo sapiens	Inhibition	%	0.33
	8206832	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.2	CHEMBL3920	Homo sapiens	Inhibition	%	2.2
	8207056	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.32	CHEMBL3920	Homo sapiens	Inhibition	%	1.32
	8207182	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.95	CHEMBL3920	Homo sapiens	Inhibition	%	4.95
	8207536	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.68	CHEMBL3920	Homo sapiens	Inhibition	%	7.68
	8207668	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.51	CHEMBL3920	Homo sapiens	Inhibition	%	2.51
	8207892	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.29	CHEMBL3920	Homo sapiens	Inhibition	%	2.29
	8208037	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.41	CHEMBL3920	Homo sapiens	Inhibition	%	2.41
	8208393	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.05	CHEMBL3920	Homo sapiens	Inhibition	%	5.05
	8208559	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.49	CHEMBL3920	Homo sapiens	Inhibition	%	1.49
	8208916	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.24	CHEMBL3920	Homo sapiens	Inhibition	%	8.24
	8209245	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.52	CHEMBL3920	Homo sapiens	Inhibition	%	2.52
	8209361	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.24	CHEMBL3920	Homo sapiens	Inhibition	%	2.24
	8209735	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.13	CHEMBL3920	Homo sapiens	Inhibition	%	1.13
	8209871	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.45	CHEMBL3920	Homo sapiens	Inhibition	%	6.45
	8210095	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.41	CHEMBL3920	Homo sapiens	Inhibition	%	3.41
	8210236	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.23	CHEMBL3920	Homo sapiens	Inhibition	%	2.23
	8210596	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.68	CHEMBL3920	Homo sapiens	Inhibition	%	-0.68
	8210855	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.97	CHEMBL3920	Homo sapiens	Inhibition	%	3.97
	8210999	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.11	CHEMBL3920	Homo sapiens	Inhibition	%	1.11
	8211393	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.84	CHEMBL3920	Homo sapiens	Inhibition	%	1.84
	8211516	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.67	CHEMBL3920	Homo sapiens	Inhibition	%	5.67
	8211740	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.85	CHEMBL3920	Homo sapiens	Inhibition	%	3.85
	8211869	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	33.19	CHEMBL3920	Homo sapiens	Inhibition	%	33.19
	8212225	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.87	CHEMBL3920	Homo sapiens	Inhibition	%	1.87
	8212366	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.0	CHEMBL3920	Homo sapiens	Inhibition	%	3.0
	8212723	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.27	CHEMBL3920	Homo sapiens	Inhibition	%	3.27
	8212893	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.0	CHEMBL3920	Homo sapiens	Inhibition	%	3.0
	8213117	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.08	CHEMBL3920	Homo sapiens	Inhibition	%	1.08
	8213246	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	38.74	CHEMBL3920	Homo sapiens	Inhibition	%	38.74
	8213574	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.99	CHEMBL3920	Homo sapiens	Inhibition	%	-0.99
	8213687	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.34	CHEMBL3920	Homo sapiens	Inhibition	%	3.34
	8213911	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.07	CHEMBL3920	Homo sapiens	Inhibition	%	2.07
	8214058	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.43	CHEMBL3920	Homo sapiens	Inhibition	%	-0.43
	8214419	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.9	CHEMBL3920	Homo sapiens	Inhibition	%	4.9
	8214553	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.93	CHEMBL3920	Homo sapiens	Inhibition	%	0.93
	8214777	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.94	CHEMBL3920	Homo sapiens	Inhibition	%	2.94
	8214929	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.5	CHEMBL3920	Homo sapiens	Inhibition	%	0.5
	8215180	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.24	CHEMBL3920	Homo sapiens	Inhibition	%	2.24
	8215333	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.41	CHEMBL3920	Homo sapiens	Inhibition	%	0.41
	8215557	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.7	CHEMBL3920	Homo sapiens	Inhibition	%	1.7
	8215721	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.91	CHEMBL3920	Homo sapiens	Inhibition	%	0.91
	8216064	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.2	CHEMBL3920	Homo sapiens	Inhibition	%	6.2
	8216183	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.63	CHEMBL3920	Homo sapiens	Inhibition	%	1.63
	8216543	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.42	CHEMBL3920	Homo sapiens	Inhibition	%	2.42
	8216681	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.04	CHEMBL3920	Homo sapiens	Inhibition	%	5.04
	8216905	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.85	CHEMBL3920	Homo sapiens	Inhibition	%	7.85
	8217039	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.18	CHEMBL3920	Homo sapiens	Inhibition	%	5.18
	8217437	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.33	CHEMBL3920	Homo sapiens	Inhibition	%	0.33
	8217568	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.44	CHEMBL3920	Homo sapiens	Inhibition	%	2.44
	8217893	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.44	CHEMBL3920	Homo sapiens	Inhibition	%	-0.44
	8218232	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.93	CHEMBL3920	Homo sapiens	Inhibition	%	2.93
	8218359	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.61	CHEMBL3920	Homo sapiens	Inhibition	%	1.61
	8218583	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.46	CHEMBL3920	Homo sapiens	Inhibition	%	1.46
	8218726	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.51	CHEMBL3920	Homo sapiens	Inhibition	%	3.51
	8219081	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.79	CHEMBL3920	Homo sapiens	Inhibition	%	1.79
	8219241	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.12	CHEMBL3920	Homo sapiens	Inhibition	%	-0.12
	8219491	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.31	CHEMBL3920	Homo sapiens	Inhibition	%	3.31
	8219876	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.28	CHEMBL3920	Homo sapiens	Inhibition	%	1.28
	8220045	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.37	CHEMBL3920	Homo sapiens	Inhibition	%	2.37
	8220398	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.79	CHEMBL3920	Homo sapiens	Inhibition	%	4.79
	8220512	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.57	CHEMBL3920	Homo sapiens	Inhibition	%	2.57
	8220736	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.67	CHEMBL3920	Homo sapiens	Inhibition	%	5.67
	8220874	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.05	CHEMBL3920	Homo sapiens	Inhibition	%	4.05
	8221234	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	40.06	CHEMBL3920	Homo sapiens	Inhibition	%	40.06
	8221367	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.48	CHEMBL3920	Homo sapiens	Inhibition	%	2.48
	8221591	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.08	CHEMBL3920	Homo sapiens	Inhibition	%	3.08
	8221756	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.14	CHEMBL3920	Homo sapiens	Inhibition	%	-0.14
	8221887	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.61	CHEMBL3920	Homo sapiens	Inhibition	%	3.61
	8222111	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.44	CHEMBL3920	Homo sapiens	Inhibition	%	2.44
	8222209	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.27	CHEMBL3920	Homo sapiens	Inhibition	%	2.27
	8222567	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.68	CHEMBL3920	Homo sapiens	Inhibition	%	1.68
	8222909	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.33	CHEMBL3920	Homo sapiens	Inhibition	%	2.33
	8223053	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.06	CHEMBL3920	Homo sapiens	Inhibition	%	5.06
	8223406	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.18	CHEMBL3920	Homo sapiens	Inhibition	%	2.18
	8223567	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.95	CHEMBL3920	Homo sapiens	Inhibition	%	0.95
	8223817	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.19	CHEMBL3920	Homo sapiens	Inhibition	%	2.19
	8224041	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.03	CHEMBL3920	Homo sapiens	Inhibition	%	5.03
	8224203	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.28	CHEMBL3920	Homo sapiens	Inhibition	%	1.28
	8224373	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.85	CHEMBL3920	Homo sapiens	Inhibition	%	1.85
	8224597	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.32	CHEMBL3920	Homo sapiens	Inhibition	%	1.32
	8224732	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.93	CHEMBL3920	Homo sapiens	Inhibition	%	4.93
	8225070	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	28.33	CHEMBL3920	Homo sapiens	Inhibition	%	28.33
	8225204	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.09	CHEMBL3920	Homo sapiens	Inhibition	%	3.09
	8225428	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.2	CHEMBL3920	Homo sapiens	Inhibition	%	3.2
	8225566	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.78	CHEMBL3920	Homo sapiens	Inhibition	%	1.78
	8225925	CHEMBL1961908	GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.07	CHEMBL3920	Homo sapiens	Inhibition	%	3.07
	8226083	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.45	CHEMBL3920	Homo sapiens	Inhibition	%	0.45
	8226432	CHEMBL1961909	GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.22	CHEMBL3920	Homo sapiens	Inhibition	%	1.22
inactive	9519751	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519752	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519753	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519754	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519755	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519756	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	63095.73	CHEMBL3920	Homo sapiens	pKi		4.2
inactive	9519757	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519758	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	398.11	CHEMBL3920	Homo sapiens	pKi		6.4
inactive	9519759	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519760	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	398.11	CHEMBL3920	Homo sapiens	pKi		6.4
active	9519761	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
inactive	9519762	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1ccccc1)Nc1ccccn1		CHEMBL143703	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9519763	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	3.981	CHEMBL3920	Homo sapiens	pKi		8.4
inactive	9519764	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519765	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519766	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	15848.93	CHEMBL3920	Homo sapiens	pKi		4.8
active	9519767	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9519768	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519769	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519770	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	501.19	CHEMBL3920	Homo sapiens	pKi		6.3
inactive	9519771	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519772	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	15.85	CHEMBL3920	Homo sapiens	pKi		7.8
inactive	9519773	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9519774	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	15848.93	CHEMBL3920	Homo sapiens	pKi		4.8
active	9519775	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	316.23	CHEMBL3920	Homo sapiens	pKi		6.5
inactive	9519776	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519777	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519778	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	316.23	CHEMBL3920	Homo sapiens	pKi		6.5
active	9519779	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	7943.28	CHEMBL3920	Homo sapiens	pKi		5.1
active	9519780	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
inactive	9519781	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519782	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9519783	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	398.11	CHEMBL3920	Homo sapiens	pKi		6.4
active	9519784	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
active	9519785	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	316.23	CHEMBL3920	Homo sapiens	pKi		6.5
active	9519786	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9519787	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519788	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	50118.72	CHEMBL3920	Homo sapiens	pKi		4.3
inactive	9519789	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519790	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519791	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519792	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	251.19	CHEMBL3920	Homo sapiens	pKi		6.6
inactive	9519793	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cccc(-c2ccc3c(c2)C(=O)NC3)c1		CHEMBL1968394	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9519794	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
inactive	9519795	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519796	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519797	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519798	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9519799	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9519800	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519801	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519802	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519803	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519804	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519805	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519806	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
active	9519807	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	0.3162	CHEMBL3920	Homo sapiens	pKi		9.5
active	9519808	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	12.59	CHEMBL3920	Homo sapiens	pKi		7.9
inactive	9519809	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	50118.72	CHEMBL3920	Homo sapiens	pKi		4.3
inactive	9519810	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519811	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519812	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
active	9519813	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9519814	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519815	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519816	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
active	9519817	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
inactive	9519818	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519819	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
inactive	9519820	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519821	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519822	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519823	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519824	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519825	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9519826	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519827	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9519828	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519829	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519830	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519831	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519832	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	100.0	CHEMBL3920	Homo sapiens	pKi		7.0
active	9519833	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	158.49	CHEMBL3920	Homo sapiens	pKi		6.8
active	9519834	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	39810.72	CHEMBL3920	Homo sapiens	pKi		4.4
inactive	9519835	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519836	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519837	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519838	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519839	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9519840	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519841	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519842	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9519843	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519844	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519845	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519846	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
active	9519847	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	=	Ki	nM	199.53	CHEMBL3920	Homo sapiens	pKi		6.7
active	9519848	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
active	9519849	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	19952.62	CHEMBL3920	Homo sapiens	pKi		4.7
active	9519850	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
inactive	9519851	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519852	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	501.19	CHEMBL3920	Homo sapiens	pKi		6.3
inactive	9519853	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519854	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
inactive	9519855	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519856	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
active	9519857	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	398.11	CHEMBL3920	Homo sapiens	pKi		6.4
inactive	9519858	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519859	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	39810.72	CHEMBL3920	Homo sapiens	pKi		4.4
inactive	9519860	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519861	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519862	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519863	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519864	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519865	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519866	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519867	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	7.943	CHEMBL3920	Homo sapiens	pKi		8.1
inactive	9519868	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519869	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519870	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519871	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
inactive	9519872	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9519873	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1nccc2nc(-c3ccccc3)cn12		CHEMBL2004887	=	Ki	nM	50118.72	CHEMBL3920	Homo sapiens	pKi		4.3
inactive	9519874	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519875	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519876	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519877	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519878	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9519879	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519880	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519881	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519882	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1972583	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9519883	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519884	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	50118.72	CHEMBL3920	Homo sapiens	pKi		4.3
active	9519885	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	0.7943	CHEMBL3920	Homo sapiens	pKi		9.1
inactive	9519886	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519887	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519888	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519889	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519890	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9519891	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519892	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	19952.62	CHEMBL3920	Homo sapiens	pKi		4.7
active	9519893	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
inactive	9519894	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519895	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	=	Ki	nM	316.23	CHEMBL3920	Homo sapiens	pKi		6.5
inactive	9519896	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519897	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519898	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	=	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
inactive	9519899	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519900	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519901	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	Ki	nM	3981.07	CHEMBL3920	Homo sapiens	pKi		5.4
active	9519902	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
inactive	9519903	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519904	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	=	Ki	nM	125.89	CHEMBL3920	Homo sapiens	pKi		6.9
inactive	9519905	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519906	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519907	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	0.7943	CHEMBL3920	Homo sapiens	pKi		9.1
inactive	9519908	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519909	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519910	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519911	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519912	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	63.1	CHEMBL3920	Homo sapiens	pKi		7.2
active	9519913	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	199.53	CHEMBL3920	Homo sapiens	pKi		6.7
active	9519914	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	63.1	CHEMBL3920	Homo sapiens	pKi		7.2
active	9519915	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
active	9519916	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	63095.73	CHEMBL3920	Homo sapiens	pKi		4.2
inactive	9519917	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519918	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9519919	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9519920	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	31622.78	CHEMBL3920	Homo sapiens	pKi		4.5
inactive	9519921	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523842	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
active	9523843	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	=	Ki	nM	50118.72	CHEMBL3920	Homo sapiens	pKi		4.3
inactive	9523844	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523845	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523846	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523847	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523848	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	3162.28	CHEMBL3920	Homo sapiens	pKi		5.5
inactive	9523849	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523850	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523851	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523852	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523853	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523854	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
active	9523855	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
inactive	9523856	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523857	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523858	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
inactive	9523859	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)n1ncc2cc(N)ccc21		CHEMBL1972454	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9523860	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	12589.25	CHEMBL3920	Homo sapiens	pKi		4.9
inactive	9523861	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523862	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	63.1	CHEMBL3920	Homo sapiens	pKi		7.2
active	9523863	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
inactive	9523864	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9523865	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523866	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9523867	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523868	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9523869	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	1.995	CHEMBL3920	Homo sapiens	pKi		8.7
active	9523870	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	10000.0	CHEMBL3920	Homo sapiens	pKi		5.0
inactive	9523871	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523872	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523873	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523874	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523875	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523876	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
inactive	9523877	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523878	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	25118.86	CHEMBL3920	Homo sapiens	pKi		4.6
active	9523879	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9523880	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523881	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523882	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523883	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	7943.28	CHEMBL3920	Homo sapiens	pKi		5.1
inactive	9523884	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523885	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523886	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523887	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523888	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523889	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523890	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523891	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	251.19	CHEMBL3920	Homo sapiens	pKi		6.6
active	9523892	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	125.89	CHEMBL3920	Homo sapiens	pKi		6.9
inactive	9523893	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523894	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
active	9523895	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	15.85	CHEMBL3920	Homo sapiens	pKi		7.8
active	9523896	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9523897	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
active	9523898	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
inactive	9523899	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523900	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	79.43	CHEMBL3920	Homo sapiens	pKi		7.1
inactive	9523901	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523902	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	39.81	CHEMBL3920	Homo sapiens	pKi		7.4
active	9523903	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	63095.73	CHEMBL3920	Homo sapiens	pKi		4.2
inactive	9523904	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523905	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C(=Cc1ccc2nccn2n1)c1ccccc1		CHEMBL1988622	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9523906	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9523907	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523908	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523909	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9523910	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523911	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523912	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523913	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	63095.73	CHEMBL3920	Homo sapiens	pKi		4.2
inactive	9523914	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523915	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1NCc2ccc(-c3ccccc3)cc21		CHEMBL1973795	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523916	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523917	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523918	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523919	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523920	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523921	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(-c2ccc3c(c2)CNC3=O)ccc1F		CHEMBL1976290	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523922	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523923	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	19952.62	CHEMBL3920	Homo sapiens	pKi		4.7
inactive	9523924	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523925	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523926	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523927	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	1.585	CHEMBL3920	Homo sapiens	pKi		8.8
active	9523928	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
inactive	9523929	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523930	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9523931	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9523932	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	794.33	CHEMBL3920	Homo sapiens	pKi		6.1
inactive	9523933	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523934	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523935	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523936	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523937	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523938	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523939	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523940	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	<	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
inactive	9523941	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9523942	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	31622.78	CHEMBL3920	Homo sapiens	pKi		4.5
inactive	9523943	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523944	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523945	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	0.631	CHEMBL3920	Homo sapiens	pKi		9.2
active	9523946	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
inactive	9523947	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523948	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523949	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523950	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	63.1	CHEMBL3920	Homo sapiens	pKi		7.2
active	9523951	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9523952	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523953	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523954	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523955	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523956	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523957	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	39810.72	CHEMBL3920	Homo sapiens	pKi		4.4
inactive	9523958	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523959	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523960	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	3.162	CHEMBL3920	Homo sapiens	pKi		8.5
inactive	9523961	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523962	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	501.19	CHEMBL3920	Homo sapiens	pKi		6.3
inactive	9523963	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523964	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523965	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	79432.82	CHEMBL3920	Homo sapiens	pKi		4.1
active	9523966	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	1584.89	CHEMBL3920	Homo sapiens	pKi		5.8
active	9523967	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	7.943	CHEMBL3920	Homo sapiens	pKi		8.1
active	9523968	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	125.89	CHEMBL3920	Homo sapiens	pKi		6.9
active	9523969	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9523970	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9523971	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	125.89	CHEMBL3920	Homo sapiens	pKi		6.9
inactive	9523972	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523973	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	501.19	CHEMBL3920	Homo sapiens	pKi		6.3
inactive	9523974	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523975	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523976	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
active	9523977	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	=	Ki	nM	79.43	CHEMBL3920	Homo sapiens	pKi		7.1
inactive	9523978	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523979	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	1000.0	CHEMBL3920	Homo sapiens	pKi		6.0
inactive	9523980	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523981	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
inactive	9523982	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ccc(-c2cccn3c(=O)[nH]nc23)cc1		CHEMBL1975503	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523983	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523984	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523985	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523986	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523987	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523988	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	100.0	CHEMBL3920	Homo sapiens	pKi		7.0
inactive	9523989	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523990	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523991	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1258.93	CHEMBL3920	Homo sapiens	pKi		5.9
active	9523992	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	5011.87	CHEMBL3920	Homo sapiens	pKi		5.3
inactive	9523993	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523994	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523995	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	NC(=O)c1csc2c1NCCC2=O		CHEMBL1973399	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
inactive	9523996	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
active	9523997	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	=	Ki	nM	63095.73	CHEMBL3920	Homo sapiens	pKi		4.2
inactive	9523998	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9523999	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9524000	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	63.1	CHEMBL3920	Homo sapiens	pKi		7.2
active	9524001	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	630.96	CHEMBL3920	Homo sapiens	pKi		6.2
inactive	9524002	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9524003	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9524004	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	2511.89	CHEMBL3920	Homo sapiens	pKi		5.6
inactive	9524005	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	Cc1cc(C(N)=O)n2nc(C(C)(C)C)cc2n1		CHEMBL1986684	<	Ki	nM	100000.0	CHEMBL3920	Homo sapiens	pKi		4.0
active	9524006	CHEMBL1963687	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKCQ	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	1995.26	CHEMBL3920	Homo sapiens	pKi		5.7
	10839462	CHEMBL2015493	Inhibition of PKCq at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	42.0	CHEMBL3920	Homo sapiens	INH	%	42.0
	10849726	CHEMBL2019685	Inhibition of PKCtheta	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL3920	Homo sapiens	IC50	uM	40.0
	10867541	CHEMBL2027431	Inhibition of PKCtheta at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL3920	Homo sapiens	INH	%	0.0
	10898376	CHEMBL2039491	Inhibition of human PKC theta assessed as inhibition of [33P] incorporation into substrate after 60 mins by scintillation counting	B	COc1cc(O)c(CC=C(C)C)c2c1C(=O)CC(c1ccc(O)cc1)O2		CHEMBL492828	=	IC50	nM	31600.0	CHEMBL3920	Homo sapiens	IC50	uM	31.6
	10898377	CHEMBL2039491	Inhibition of human PKC theta assessed as inhibition of [33P] incorporation into substrate after 60 mins by scintillation counting	B	COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1		CHEMBL253896	>	IC50	nM	100000.0	CHEMBL3920	Homo sapiens	IC50	uM	100.0
	10926134	CHEMBL2046216	Inhibition of human PKCtheta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	95.0	CHEMBL3920	Homo sapiens	Activity	%	95.0
	10926135	CHEMBL2046216	Inhibition of human PKCtheta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	102.0	CHEMBL3920	Homo sapiens	Activity	%	102.0
	10941186	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCCNCC2)n1		CHEMBL2046624	=	Ki	nM	164.0	CHEMBL3920	Homo sapiens	Ki	uM	0.164
	10941187	CHEMBL2049835	Inhibition of PKCtheta	B	CN1CCCN(c2cccc(C(=O)c3cccnc3N)n2)CC1		CHEMBL2046625	=	Ki	nM	375.0	CHEMBL3920	Homo sapiens	Ki	uM	0.375
	10941188	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCNCC2)n1		CHEMBL2046626	=	Ki	nM	32.0	CHEMBL3920	Homo sapiens	Ki	uM	0.032
	10941189	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCC(N)C2)n1		CHEMBL2046627	=	Ki	nM	1520.0	CHEMBL3920	Homo sapiens	Ki	uM	1.52
	10941190	CHEMBL2049835	Inhibition of PKCtheta	B	NCC1CCN(c2cccc(C(=O)c3cccnc3N)n2)C1		CHEMBL2046628	=	Ki	nM	745.0	CHEMBL3920	Homo sapiens	Ki	uM	0.745
	10941191	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCC(N)CC2)n1		CHEMBL2046629	=	Ki	nM	76.0	CHEMBL3920	Homo sapiens	Ki	uM	0.076
	10941192	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCCC(N)C2)n1		CHEMBL2046630	=	Ki	nM	1975.0	CHEMBL3920	Homo sapiens	Ki	uM	1.975
	10941193	CHEMBL2049835	Inhibition of PKCtheta	B	NCC1CCN(c2cccc(C(=O)c3cccnc3N)n2)CC1		CHEMBL2046631	=	Ki	nM	1390.0	CHEMBL3920	Homo sapiens	Ki	uM	1.39
	10941194	CHEMBL2049835	Inhibition of PKCtheta	B	NCC1CCCN(c2cccc(C(=O)c3cccnc3N)n2)C1		CHEMBL2046632	>	Ki	nM	2800.0	CHEMBL3920	Homo sapiens	Ki	uM	2.8
	10941195	CHEMBL2049835	Inhibition of PKCtheta	B	NCC1CN(c2cccc(C(=O)c3cccnc3N)n2)C1		CHEMBL2046633	=	Ki	nM	1010.0	CHEMBL3920	Homo sapiens	Ki	uM	1.01
	10941196	CHEMBL2049835	Inhibition of PKCtheta	B	C[C@@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046634	=	Ki	nM	182.0	CHEMBL3920	Homo sapiens	Ki	uM	0.182
	10941197	CHEMBL2049835	Inhibition of PKCtheta	B	C[C@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046635	=	Ki	nM	67.0	CHEMBL3920	Homo sapiens	Ki	uM	0.067
	10941198	CHEMBL2049835	Inhibition of PKCtheta	B	CC1(C)CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046636	=	Ki	nM	85.0	CHEMBL3920	Homo sapiens	Ki	uM	0.085
	10941199	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)[C@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046637	=	Ki	nM	4.0	CHEMBL3920	Homo sapiens	Ki	uM	0.004
	10941200	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)[C@@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046638	=	Ki	nM	275.0	CHEMBL3920	Homo sapiens	Ki	uM	0.275
	10941201	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)(C)[C@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046639	=	Ki	nM	38.0	CHEMBL3920	Homo sapiens	Ki	uM	0.038
	10941202	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046640	=	Ki	nM	3.0	CHEMBL3920	Homo sapiens	Ki	uM	0.003
	10941203	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCN[C@H](c3ccccc3)C2)n1		CHEMBL2046641	=	Ki	nM	238.0	CHEMBL3920	Homo sapiens	Ki	uM	0.238
	10941204	CHEMBL2049835	Inhibition of PKCtheta	B	Nc1ncccc1C(=O)c1cccc(N2CCN[C@@H](c3ccccc3)C2)n1		CHEMBL2046642	=	Ki	nM	6.0	CHEMBL3920	Homo sapiens	Ki	uM	0.006
	10941205	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(C(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046643	=	Ki	nM	3.0	CHEMBL3920	Homo sapiens	Ki	uM	0.003
	10941206	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(Cl)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046644	=	Ki	nM	2.0	CHEMBL3920	Homo sapiens	Ki	uM	0.002
	10941207	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(C3CC3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046645	=	Ki	nM	28.0	CHEMBL3920	Homo sapiens	Ki	uM	0.028
	10941208	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(OC(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046646	=	Ki	nM	7.0	CHEMBL3920	Homo sapiens	Ki	uM	0.007
	10941209	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(OCC(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046647	=	Ki	nM	290.0	CHEMBL3920	Homo sapiens	Ki	uM	0.29
	10941210	CHEMBL2049835	Inhibition of PKCtheta	B	CCCc1ccc(N2CCN[C@@H](CC(C)C)C2)nc1C(=O)c1cccnc1N		CHEMBL2046648	=	Ki	nM	20.0	CHEMBL3920	Homo sapiens	Ki	uM	0.02
	10941211	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(-c3ccccc3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046649	=	Ki	nM	0.6	CHEMBL3920	Homo sapiens	Ki	uM	0.0006
	10941212	CHEMBL2049835	Inhibition of PKCtheta	B	CC(C)C[C@H]1CN(c2ccc(Cc3ccccc3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046650	>	Ki	nM	700.0	CHEMBL3920	Homo sapiens	Ki	uM	0.7
	10941213	CHEMBL2049835	Inhibition of PKCtheta	B	Cc1cc(C(=O)c2cccnc2N)nc(N2CCN[C@@H](CC(C)C)C2)c1		CHEMBL2046651	=	Ki	nM	24.0	CHEMBL3920	Homo sapiens	Ki	uM	0.024
	10941236	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046640	=	IC50	nM	165.0	CHEMBL3920	Homo sapiens	IC50	uM	0.165
	10941237	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(C(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046643	=	IC50	nM	52.0	CHEMBL3920	Homo sapiens	IC50	uM	0.052
	10941238	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(Cl)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046644	=	IC50	nM	58.0	CHEMBL3920	Homo sapiens	IC50	uM	0.058
	10941239	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(C3CC3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046645	=	IC50	nM	2600.0	CHEMBL3920	Homo sapiens	IC50	uM	2.6
	10941240	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(OC(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046646	=	IC50	nM	229.0	CHEMBL3920	Homo sapiens	IC50	uM	0.229
Not Determined	10941241	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(OCC(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046647		IC50			CHEMBL3920	Homo sapiens	IC50		
	10941242	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CCCc1ccc(N2CCN[C@@H](CC(C)C)C2)nc1C(=O)c1cccnc1N		CHEMBL2046648	=	IC50	nM	410.0	CHEMBL3920	Homo sapiens	IC50	uM	0.41
	10941243	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(-c3ccccc3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046649	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	uM	0.005
Not Determined	10941244	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	CC(C)C[C@H]1CN(c2ccc(Cc3ccccc3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046650		IC50			CHEMBL3920	Homo sapiens	IC50		
	10941245	CHEMBL2049840	Inhibition of PKCtheta-mediated IL-2 production by cell based assay	B	Cc1cc(C(=O)c2cccnc2N)nc(N2CCN[C@@H](CC(C)C)C2)c1		CHEMBL2046651	=	IC50	nM	410.0	CHEMBL3920	Homo sapiens	IC50	uM	0.41
	10949926	CHEMBL2049458	Inhibition of N-terminus FLAG-tagged PKCtheta expressed in baculovirus expression system using [gamma-33P]-ATP measured after 60 mins by scintillation counting	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	10980282	CHEMBL2065130	Inhibition of PRKCQ at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL3920	Homo sapiens	INH	%	25.0
	10980283	CHEMBL2065130	Inhibition of PRKCQ at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL3920	Homo sapiens	INH	%	15.0
	10980316	CHEMBL2065160	Inhibition of PRKCQ by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
Not Active	11011591	CHEMBL2091243	Inhibition of Protein kinase C theta type at 10 uM by luciferase assay	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	11011594	CHEMBL2091243	Inhibition of Protein kinase C theta type at 10 uM by luciferase assay	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	47.0	CHEMBL3920	Homo sapiens	INH	%	47.0
	11011609	CHEMBL2091243	Inhibition of Protein kinase C theta type at 10 uM by luciferase assay	B	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1		CHEMBL238125	>	Inhibition	%	25.0	CHEMBL3920	Homo sapiens	INH	%	25.0
	11011620	CHEMBL2091243	Inhibition of Protein kinase C theta type at 10 uM by luciferase assay	B	O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1		CHEMBL200027	>	Inhibition	%	29.0	CHEMBL3920	Homo sapiens	INH	%	29.0
	11011643	CHEMBL2091243	Inhibition of Protein kinase C theta type at 10 uM by luciferase assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	20.0	CHEMBL3920	Homo sapiens	INH	%	20.0
	12035157	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	77.0	CHEMBL3920	Homo sapiens	IC50	nM	77.0
	12035158	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ccccc12		CHEMBL2147531	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035159	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ncccc12		CHEMBL2147532	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035160	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ccncc12		CHEMBL2147533	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035161	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1cc(-c2ccncc2)cc2cnccc12		CHEMBL2147534	=	IC50	nM	355.0	CHEMBL3920	Homo sapiens	IC50	nM	355.0
	12035162	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL2147535	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035163	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCOc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147536	=	IC50	nM	948.0	CHEMBL3920	Homo sapiens	IC50	nM	948.0
	12035164	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	=	IC50	nM	55.0	CHEMBL3920	Homo sapiens	IC50	nM	55.0
	12035165	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147538	=	IC50	nM	141.0	CHEMBL3920	Homo sapiens	IC50	nM	141.0
	12035166	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NC(CNc1nc(-c2ccncc2)cc2cnccc12)Cc1ccccc1		CHEMBL2147539	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035167	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CN(CCN)c1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147540	=	IC50	nM	350.0	CHEMBL3920	Homo sapiens	IC50	nM	350.0
	12035168	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CNCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147541	=	IC50	nM	997.0	CHEMBL3920	Homo sapiens	IC50	nM	997.0
	12035169	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	c1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214932	=	IC50	nM	109.0	CHEMBL3920	Homo sapiens	IC50	nM	109.0
	12035170	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	c1cc(-c2cc3cnccc3c(N3CCCNCC3)n2)ccn1		CHEMBL2147542	=	IC50	nM	77.0	CHEMBL3920	Homo sapiens	IC50	nM	77.0
	12035171	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NC1CCCN(c2nc(-c3ccncc3)cc3cnccc23)C1		CHEMBL2147543	=	IC50	nM	132.0	CHEMBL3920	Homo sapiens	IC50	nM	132.0
	12035172	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147544	=	IC50	nM	97.0	CHEMBL3920	Homo sapiens	IC50	nM	97.0
	12035173	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	OCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147545	=	IC50	nM	743.0	CHEMBL3920	Homo sapiens	IC50	nM	743.0
	12035174	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	O=C1CN(c2nc(-c3ccncc3)cc3cnccc23)CCN1		CHEMBL2147546	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035175	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2cccnc2)cc2cnccc12		CHEMBL2147547	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035176	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccnc(N)c2)cc2cnccc12		CHEMBL2147548	=	IC50	nM	496.0	CHEMBL3920	Homo sapiens	IC50	nM	496.0
	12035177	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)Nc1cc(-c2cc3cnccc3c(NCC(C)(C)N)n2)ccn1		CHEMBL2147549	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	12035178	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2F)cc2cnccc12		CHEMBL2147550	=	IC50	nM	140.0	CHEMBL3920	Homo sapiens	IC50	nM	140.0
	12035179	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2Cl)cc2cnccc12		CHEMBL2147551	=	IC50	nM	93.0	CHEMBL3920	Homo sapiens	IC50	nM	93.0
	12035180	CHEMBL2150525	Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	Cc1cnccc1-c1cc2cnccc2c(NCC(C)(C)N)n1		CHEMBL2147552	=	IC50	nM	738.0	CHEMBL3920	Homo sapiens	IC50	nM	738.0
	12035189	CHEMBL2150532	Inhibition of recombinant human PKCtheta at 1 uM	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	>	Inhibition	%	80.0	CHEMBL3920	Homo sapiens	INH	%	80.0
	12036440	CHEMBL2150411	Inhibition of N-terminal FLAG-tagged PKCtheta expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	12039656	CHEMBL2148243	Inhibition of [3H]PDBu binding to PKCtheta C1B domain	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cccc(O)c1		CHEMBL2148106	=	Ki	nM	0.11	CHEMBL3920	Homo sapiens	Ki	nM	0.11
	12039678	CHEMBL2148243	Inhibition of [3H]PDBu binding to PKCtheta C1B domain	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4cccc(O)c4)O[C@@]1(C3)O2		CHEMBL1258348	=	Ki	nM	4.0	CHEMBL3920	Homo sapiens	Ki	nM	4.0
	12039695	CHEMBL2148243	Inhibition of [3H]PDBu binding to PKCtheta C1B domain	B	C[C@@H]1CC(C)(C)[C@@]23C[C@@H](C[C@@H](CCCCc4cccc(O)c4)O2)OC(=O)C[C@H](CO)OC(=O)C[C@@H]1O3		CHEMBL2148107	=	Ki	nM	2.9	CHEMBL3920	Homo sapiens	Ki	nM	2.9
	12039713	CHEMBL2148243	Inhibition of [3H]PDBu binding to PKCtheta C1B domain	B	C[C@H]1[C@@H]2C[C@@]3(O[C@H](CCC3(C)C)CC(=O)O[C@@H](CO)CC(=O)O2)O[C@@H]1CCCCc1cccc(O)c1		CHEMBL2148108	=	Ki	nM	0.54	CHEMBL3920	Homo sapiens	Ki	nM	0.54
	12047320	CHEMBL2157431	Inhibition of PKCtheta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-2.4	CHEMBL3920	Homo sapiens	INH	%	-2.4
	12049495	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	1.0	CHEMBL3920	Homo sapiens	IC50	nM	1.0
	12049504	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3c2)CC1		CHEMBL568580	=	IC50	nM	4.8	CHEMBL3920	Homo sapiens	IC50	nM	4.8
	12049513	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2153747	=	IC50	nM	31.0	CHEMBL3920	Homo sapiens	IC50	nM	31.0
	12049522	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2cc3ccccc3c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1		CHEMBL2153748	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
	12049531	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	Cc1cccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c12		CHEMBL2153749	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
	12049537	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(F)ccc3n2)CC1		CHEMBL2153750	=	IC50	nM	0.6	CHEMBL3920	Homo sapiens	IC50	nM	0.6
	12049543	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(Cl)ccc3n2)CC1		CHEMBL2153751	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
	12049549	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	Cc1ccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL2153752	=	IC50	nM	5.1	CHEMBL3920	Homo sapiens	IC50	nM	5.1
	12049555	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CC(C)c1ccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL2153753	=	IC50	nM	71.0	CHEMBL3920	Homo sapiens	IC50	nM	71.0
	12049561	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(C(C)(C)C)ccc3n2)CC1		CHEMBL2153754	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	12049567	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccc(F)cc3n2)CC1		CHEMBL2153755	=	IC50	nM	7.8	CHEMBL3920	Homo sapiens	IC50	nM	7.8
	12049573	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccc(Cl)cc3n2)CC1		CHEMBL2153756	=	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	12049579	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	Cc1cccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)nc(N3CCN(C)CC3)nc12		CHEMBL2151406	=	IC50	nM	67.0	CHEMBL3920	Homo sapiens	IC50	nM	67.0
	12049585	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5cccc(Cl)c45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151407	=	IC50	nM	221.0	CHEMBL3920	Homo sapiens	IC50	nM	221.0
	12049591	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccc(Cl)cc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151408	=	IC50	nM	8.3	CHEMBL3920	Homo sapiens	IC50	nM	8.3
	12049597	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5cc(Cl)ccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151409	=	IC50	nM	9.8	CHEMBL3920	Homo sapiens	IC50	nM	9.8
	12049603	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5c(Cl)cccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151410	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	nM	7.0
	12050499	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	Cc1cccc2c(C3=C(c4nc(N5CCN(C)CC5)nc5ccccc45)C(=O)NC3=O)c[nH]c12		CHEMBL2151411	=	IC50	nM	0.1	CHEMBL3920	Homo sapiens	IC50	nM	0.1
	12050505	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151412	=	IC50	nM	5.8	CHEMBL3920	Homo sapiens	IC50	nM	5.8
	12050511	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	CC(C)n1cc(C2=C(c3nc(N4CCN(C)CC4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2151413	=	IC50	nM	3.8	CHEMBL3920	Homo sapiens	IC50	nM	3.8
	12050517	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	Cc1[nH]c2ccccc2c1C1=C(c2nc(N3CCN(C)CC3)nc3ccccc23)C(=O)NC1=O		CHEMBL2151414	=	IC50	nM	26.0	CHEMBL3920	Homo sapiens	IC50	nM	26.0
	12050525	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	IC50	nM	0.5	CHEMBL3920	Homo sapiens	IC50	nM	0.5
	12050533	CHEMBL2156016	Inhibition of PKCtheta by scintillation proximity assay	B	Cn1cc(C2=C(c3nc(N4CCNCC4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2151415	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
	12074658	CHEMBL2161220	Inhibition of PKCtheta at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	12145297	CHEMBL2186673	Inhibition of PKCtheta using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL3920	Homo sapiens	INH	%	25.0
	12145298	CHEMBL2186673	Inhibition of PKCtheta using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL3920	Homo sapiens	INH	%	25.0
	12150577	CHEMBL2188513	Inhibition of human recombinant PKCtheta by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	3600.0	CHEMBL3920	Homo sapiens	IC50	uM	3.6
	12172249	CHEMBL2212479	Inhibition of PRKCQ assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	88.0	CHEMBL3920	Homo sapiens	Activity	%	88.0
	12175188	CHEMBL2210714	Inhibition of PKCtheta	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	12183826	CHEMBL2214434	Inhibition of PRKCQ	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	pIC50		5.0
	12194103	CHEMBL2214706	Inhibition of PKCtheta	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1.Cl		CHEMBL2205637	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	12252460	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL3920	Homo sapiens	Residual Activity	%	103.0
	12252461	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	5.0	CHEMBL3920	Homo sapiens	Residual Activity	%	5.0
	12252462	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12252463	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12252464	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252465	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL3920	Homo sapiens	Residual Activity	%	98.0
	12252466	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	84.0	CHEMBL3920	Homo sapiens	Residual Activity	%	84.0
	12252467	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12252468	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	110.0	CHEMBL3920	Homo sapiens	Residual Activity	%	110.0
	12252469	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	99.0	CHEMBL3920	Homo sapiens	Residual Activity	%	99.0
	12252470	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12252471	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12252472	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12252473	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	98.0	CHEMBL3920	Homo sapiens	Residual Activity	%	98.0
	12252474	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12252475	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	103.0	CHEMBL3920	Homo sapiens	Residual Activity	%	103.0
	12252476	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12252477	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12252478	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12252479	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	45.0	CHEMBL3920	Homo sapiens	Residual Activity	%	45.0
	12252480	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12252481	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	87.0	CHEMBL3920	Homo sapiens	Residual Activity	%	87.0
	12252482	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	95.0	CHEMBL3920	Homo sapiens	Residual Activity	%	95.0
	12252483	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252484	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	112.0	CHEMBL3920	Homo sapiens	Residual Activity	%	112.0
	12252485	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	116.0	CHEMBL3920	Homo sapiens	Residual Activity	%	116.0
	12252486	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	83.0	CHEMBL3920	Homo sapiens	Residual Activity	%	83.0
	12252487	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	83.0	CHEMBL3920	Homo sapiens	Residual Activity	%	83.0
	12252488	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12252489	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	3.0	CHEMBL3920	Homo sapiens	Residual Activity	%	3.0
	12252490	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252491	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252492	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12252493	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12252494	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL3920	Homo sapiens	Residual Activity	%	88.0
	12252495	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252496	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12252497	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12252498	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12252499	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252500	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	123.0	CHEMBL3920	Homo sapiens	Residual Activity	%	123.0
	12252501	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12252502	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	29.0	CHEMBL3920	Homo sapiens	Residual Activity	%	29.0
	12252503	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	28.0	CHEMBL3920	Homo sapiens	Residual Activity	%	28.0
	12252504	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12252505	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	88.0	CHEMBL3920	Homo sapiens	Residual Activity	%	88.0
	12252506	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	95.0	CHEMBL3920	Homo sapiens	Residual Activity	%	95.0
	12252507	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	103.0	CHEMBL3920	Homo sapiens	Residual Activity	%	103.0
	12252508	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12252509	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	84.0	CHEMBL3920	Homo sapiens	Residual Activity	%	84.0
	12252510	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	3.0	CHEMBL3920	Homo sapiens	Residual Activity	%	3.0
	12252511	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12252512	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	49.0	CHEMBL3920	Homo sapiens	Residual Activity	%	49.0
	12252513	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	21.0	CHEMBL3920	Homo sapiens	Residual Activity	%	21.0
	12252514	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12252515	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252516	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	120.0	CHEMBL3920	Homo sapiens	Residual Activity	%	120.0
	12252517	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	110.0	CHEMBL3920	Homo sapiens	Residual Activity	%	110.0
	12252518	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL3920	Homo sapiens	Residual Activity	%	98.0
	12252519	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252520	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	99.0	CHEMBL3920	Homo sapiens	Residual Activity	%	99.0
	12252521	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	15.0	CHEMBL3920	Homo sapiens	Residual Activity	%	15.0
	12252522	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12252523	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12252524	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	120.0	CHEMBL3920	Homo sapiens	Residual Activity	%	120.0
	12252525	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	117.0	CHEMBL3920	Homo sapiens	Residual Activity	%	117.0
	12252526	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252527	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12252528	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12252529	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12252530	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	110.0	CHEMBL3920	Homo sapiens	Residual Activity	%	110.0
	12252531	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12252532	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	3.0	CHEMBL3920	Homo sapiens	Residual Activity	%	3.0
	12252533	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	124.0	CHEMBL3920	Homo sapiens	Residual Activity	%	124.0
	12252534	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	115.0	CHEMBL3920	Homo sapiens	Residual Activity	%	115.0
	12252535	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	106.0	CHEMBL3920	Homo sapiens	Residual Activity	%	106.0
	12252536	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12252537	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12252538	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12252539	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3920	Homo sapiens	Residual Activity	%	0.0
	12252540	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252541	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	30.0	CHEMBL3920	Homo sapiens	Residual Activity	%	30.0
	12252542	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	80.0	CHEMBL3920	Homo sapiens	Residual Activity	%	80.0
	12252543	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	63.0	CHEMBL3920	Homo sapiens	Residual Activity	%	63.0
	12252544	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12252545	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12252546	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12252547	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12252548	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252549	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12252550	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12252551	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	47.0	CHEMBL3920	Homo sapiens	Residual Activity	%	47.0
	12252552	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	64.0	CHEMBL3920	Homo sapiens	Residual Activity	%	64.0
	12252553	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	98.0	CHEMBL3920	Homo sapiens	Residual Activity	%	98.0
	12252554	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12252555	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252556	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252557	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12252558	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	88.0	CHEMBL3920	Homo sapiens	Residual Activity	%	88.0
	12252559	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12252560	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	71.0	CHEMBL3920	Homo sapiens	Residual Activity	%	71.0
	12252561	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	10.0	CHEMBL3920	Homo sapiens	Residual Activity	%	10.0
	12252562	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12252563	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	7.0	CHEMBL3920	Homo sapiens	Residual Activity	%	7.0
	12252564	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12252565	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12252566	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12252567	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12252568	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12253975	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	49.0	CHEMBL3920	Homo sapiens	Residual Activity	%	49.0
	12253976	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12253977	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	107.0	CHEMBL3920	Homo sapiens	Residual Activity	%	107.0
	12253978	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	83.0	CHEMBL3920	Homo sapiens	Residual Activity	%	83.0
	12253979	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12253980	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12253981	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12253982	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	83.0	CHEMBL3920	Homo sapiens	Residual Activity	%	83.0
	12253983	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12253984	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12253985	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12253986	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	106.0	CHEMBL3920	Homo sapiens	Residual Activity	%	106.0
	12253987	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	71.0	CHEMBL3920	Homo sapiens	Residual Activity	%	71.0
	12253988	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	69.0	CHEMBL3920	Homo sapiens	Residual Activity	%	69.0
	12253989	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	68.0	CHEMBL3920	Homo sapiens	Residual Activity	%	68.0
	12253990	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	66.0	CHEMBL3920	Homo sapiens	Residual Activity	%	66.0
	12253991	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL3920	Homo sapiens	Residual Activity	%	99.0
	12253992	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	70.0	CHEMBL3920	Homo sapiens	Residual Activity	%	70.0
	12253993	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12253994	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12253995	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	10.0	CHEMBL3920	Homo sapiens	Residual Activity	%	10.0
	12253996	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	4.0	CHEMBL3920	Homo sapiens	Residual Activity	%	4.0
	12253997	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12253998	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12253999	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12254000	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	88.0	CHEMBL3920	Homo sapiens	Residual Activity	%	88.0
	12254001	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	77.0	CHEMBL3920	Homo sapiens	Residual Activity	%	77.0
	12254002	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12254003	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	78.0	CHEMBL3920	Homo sapiens	Residual Activity	%	78.0
	12254004	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	87.0	CHEMBL3920	Homo sapiens	Residual Activity	%	87.0
	12254005	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254006	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	84.0	CHEMBL3920	Homo sapiens	Residual Activity	%	84.0
	12254007	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	61.0	CHEMBL3920	Homo sapiens	Residual Activity	%	61.0
	12254008	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12254009	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12254010	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12254011	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12254012	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254013	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	95.0	CHEMBL3920	Homo sapiens	Residual Activity	%	95.0
	12254014	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	107.0	CHEMBL3920	Homo sapiens	Residual Activity	%	107.0
	12254015	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12254016	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12254017	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12254018	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12254019	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254020	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	106.0	CHEMBL3920	Homo sapiens	Residual Activity	%	106.0
	12254021	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12254022	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12254023	CHEMBL2219115	Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	4.0	CHEMBL3920	Homo sapiens	Residual Activity	%	4.0
	12254024	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	75.0	CHEMBL3920	Homo sapiens	Residual Activity	%	75.0
	12254025	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	2.0	CHEMBL3920	Homo sapiens	Residual Activity	%	2.0
	12254026	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	80.0	CHEMBL3920	Homo sapiens	Residual Activity	%	80.0
	12254027	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12254028	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12254029	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254030	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	49.0	CHEMBL3920	Homo sapiens	Residual Activity	%	49.0
	12254031	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12254032	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	110.0	CHEMBL3920	Homo sapiens	Residual Activity	%	110.0
	12254033	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12254034	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12254035	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12254036	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	95.0	CHEMBL3920	Homo sapiens	Residual Activity	%	95.0
	12254037	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12254038	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	44.0	CHEMBL3920	Homo sapiens	Residual Activity	%	44.0
	12254039	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12254040	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	84.0	CHEMBL3920	Homo sapiens	Residual Activity	%	84.0
	12254041	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	66.0	CHEMBL3920	Homo sapiens	Residual Activity	%	66.0
	12254042	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	84.0	CHEMBL3920	Homo sapiens	Residual Activity	%	84.0
	12254043	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	17.0	CHEMBL3920	Homo sapiens	Residual Activity	%	17.0
	12254044	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	75.0	CHEMBL3920	Homo sapiens	Residual Activity	%	75.0
	12254045	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	62.0	CHEMBL3920	Homo sapiens	Residual Activity	%	62.0
	12254046	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12254047	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	111.0	CHEMBL3920	Homo sapiens	Residual Activity	%	111.0
	12254048	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12254049	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	106.0	CHEMBL3920	Homo sapiens	Residual Activity	%	106.0
	12254050	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	67.0	CHEMBL3920	Homo sapiens	Residual Activity	%	67.0
	12254051	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12254052	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12254053	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	2.0	CHEMBL3920	Homo sapiens	Residual Activity	%	2.0
	12254054	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	86.0	CHEMBL3920	Homo sapiens	Residual Activity	%	86.0
	12254055	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL3920	Homo sapiens	Residual Activity	%	98.0
	12254056	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12254057	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254058	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12254059	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254060	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12254061	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	113.0	CHEMBL3920	Homo sapiens	Residual Activity	%	113.0
	12254062	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	95.0	CHEMBL3920	Homo sapiens	Residual Activity	%	95.0
	12254063	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL3920	Homo sapiens	Residual Activity	%	99.0
	12254064	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12254065	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12254066	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	17.0	CHEMBL3920	Homo sapiens	Residual Activity	%	17.0
	12254067	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	5.0	CHEMBL3920	Homo sapiens	Residual Activity	%	5.0
	12254068	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254069	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	70.0	CHEMBL3920	Homo sapiens	Residual Activity	%	70.0
	12254070	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254071	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12254072	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	99.0	CHEMBL3920	Homo sapiens	Residual Activity	%	99.0
	12254073	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	86.0	CHEMBL3920	Homo sapiens	Residual Activity	%	86.0
	12254074	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	1.0	CHEMBL3920	Homo sapiens	Residual Activity	%	1.0
	12254075	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12254076	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	10.0	CHEMBL3920	Homo sapiens	Residual Activity	%	10.0
	12254077	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	3.0	CHEMBL3920	Homo sapiens	Residual Activity	%	3.0
	12254078	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12254079	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12254080	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	101.0	CHEMBL3920	Homo sapiens	Residual Activity	%	101.0
	12254081	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	109.0	CHEMBL3920	Homo sapiens	Residual Activity	%	109.0
	12254082	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12254083	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12254084	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	76.0	CHEMBL3920	Homo sapiens	Residual Activity	%	76.0
	12254085	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	11.0	CHEMBL3920	Homo sapiens	Residual Activity	%	11.0
	12254086	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254087	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	113.0	CHEMBL3920	Homo sapiens	Residual Activity	%	113.0
	12254088	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	117.0	CHEMBL3920	Homo sapiens	Residual Activity	%	117.0
	12254089	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12254090	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	98.0	CHEMBL3920	Homo sapiens	Residual Activity	%	98.0
	12254091	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12254092	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	81.0	CHEMBL3920	Homo sapiens	Residual Activity	%	81.0
	12254093	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	112.0	CHEMBL3920	Homo sapiens	Residual Activity	%	112.0
	12254094	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12254095	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	82.0	CHEMBL3920	Homo sapiens	Residual Activity	%	82.0
	12254096	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL3920	Homo sapiens	Residual Activity	%	1.0
	12254097	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	114.0	CHEMBL3920	Homo sapiens	Residual Activity	%	114.0
	12254098	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	102.0	CHEMBL3920	Homo sapiens	Residual Activity	%	102.0
	12254099	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12254100	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	100.0	CHEMBL3920	Homo sapiens	Residual Activity	%	100.0
	12254101	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	65.0	CHEMBL3920	Homo sapiens	Residual Activity	%	65.0
	12254102	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	106.0	CHEMBL3920	Homo sapiens	Residual Activity	%	106.0
	12254103	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3920	Homo sapiens	Residual Activity	%	0.0
	12254104	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12254105	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	20.0	CHEMBL3920	Homo sapiens	Residual Activity	%	20.0
	12254106	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12254107	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	17.0	CHEMBL3920	Homo sapiens	Residual Activity	%	17.0
	12254108	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	72.0	CHEMBL3920	Homo sapiens	Residual Activity	%	72.0
	12254109	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254110	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	72.0	CHEMBL3920	Homo sapiens	Residual Activity	%	72.0
	12254111	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12254112	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12254113	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	55.0	CHEMBL3920	Homo sapiens	Residual Activity	%	55.0
	12254114	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL3920	Homo sapiens	Residual Activity	%	89.0
	12254115	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	16.0	CHEMBL3920	Homo sapiens	Residual Activity	%	16.0
	12254116	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	26.0	CHEMBL3920	Homo sapiens	Residual Activity	%	26.0
	12254117	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	91.0	CHEMBL3920	Homo sapiens	Residual Activity	%	91.0
	12254118	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	71.0	CHEMBL3920	Homo sapiens	Residual Activity	%	71.0
	12254119	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	67.0	CHEMBL3920	Homo sapiens	Residual Activity	%	67.0
	12254120	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	104.0	CHEMBL3920	Homo sapiens	Residual Activity	%	104.0
	12254121	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	77.0	CHEMBL3920	Homo sapiens	Residual Activity	%	77.0
	12254122	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL3920	Homo sapiens	Residual Activity	%	87.0
	12254123	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	75.0	CHEMBL3920	Homo sapiens	Residual Activity	%	75.0
	12254124	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	59.0	CHEMBL3920	Homo sapiens	Residual Activity	%	59.0
	12254125	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	5.0	CHEMBL3920	Homo sapiens	Residual Activity	%	5.0
	12254126	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	97.0	CHEMBL3920	Homo sapiens	Residual Activity	%	97.0
	12254127	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	13.0	CHEMBL3920	Homo sapiens	Residual Activity	%	13.0
	12254128	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12254129	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	94.0	CHEMBL3920	Homo sapiens	Residual Activity	%	94.0
	12254130	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12254131	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	99.0	CHEMBL3920	Homo sapiens	Residual Activity	%	99.0
	12254132	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12254133	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	31.0	CHEMBL3920	Homo sapiens	Residual Activity	%	31.0
	12254134	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	68.0	CHEMBL3920	Homo sapiens	Residual Activity	%	68.0
	12254135	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL3920	Homo sapiens	Residual Activity	%	103.0
	12254136	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	49.0	CHEMBL3920	Homo sapiens	Residual Activity	%	49.0
	12254137	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	71.0	CHEMBL3920	Homo sapiens	Residual Activity	%	71.0
	12254138	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254139	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12254140	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	50.0	CHEMBL3920	Homo sapiens	Residual Activity	%	50.0
	12254141	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12254142	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	78.0	CHEMBL3920	Homo sapiens	Residual Activity	%	78.0
	12254143	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL3920	Homo sapiens	Residual Activity	%	107.0
	12254144	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	88.0	CHEMBL3920	Homo sapiens	Residual Activity	%	88.0
	12254145	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	23.0	CHEMBL3920	Homo sapiens	Residual Activity	%	23.0
	12254146	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	35.0	CHEMBL3920	Homo sapiens	Residual Activity	%	35.0
	12254147	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	58.0	CHEMBL3920	Homo sapiens	Residual Activity	%	58.0
	12254148	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	29.0	CHEMBL3920	Homo sapiens	Residual Activity	%	29.0
	12254149	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	93.0	CHEMBL3920	Homo sapiens	Residual Activity	%	93.0
	12254150	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	26.0	CHEMBL3920	Homo sapiens	Residual Activity	%	26.0
	12254151	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	114.0	CHEMBL3920	Homo sapiens	Residual Activity	%	114.0
	12254152	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	83.0	CHEMBL3920	Homo sapiens	Residual Activity	%	83.0
	12254153	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL3920	Homo sapiens	Residual Activity	%	2.0
	12254154	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	5.0	CHEMBL3920	Homo sapiens	Residual Activity	%	5.0
	12254155	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	82.0	CHEMBL3920	Homo sapiens	Residual Activity	%	82.0
	12254156	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	76.0	CHEMBL3920	Homo sapiens	Residual Activity	%	76.0
	12254157	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12254158	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	57.0	CHEMBL3920	Homo sapiens	Residual Activity	%	57.0
	12254159	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	23.0	CHEMBL3920	Homo sapiens	Residual Activity	%	23.0
	12254160	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	85.0	CHEMBL3920	Homo sapiens	Residual Activity	%	85.0
	12254161	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	39.0	CHEMBL3920	Homo sapiens	Residual Activity	%	39.0
	12254162	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	75.0	CHEMBL3920	Homo sapiens	Residual Activity	%	75.0
	12254163	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	86.0	CHEMBL3920	Homo sapiens	Residual Activity	%	86.0
	12254164	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	77.0	CHEMBL3920	Homo sapiens	Residual Activity	%	77.0
	12254165	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	17.0	CHEMBL3920	Homo sapiens	Residual Activity	%	17.0
	12254166	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	107.0	CHEMBL3920	Homo sapiens	Residual Activity	%	107.0
	12254167	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	108.0	CHEMBL3920	Homo sapiens	Residual Activity	%	108.0
	12254168	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12254169	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	80.0	CHEMBL3920	Homo sapiens	Residual Activity	%	80.0
	12254170	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	96.0	CHEMBL3920	Homo sapiens	Residual Activity	%	96.0
	12254171	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	72.0	CHEMBL3920	Homo sapiens	Residual Activity	%	72.0
	12254172	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	92.0	CHEMBL3920	Homo sapiens	Residual Activity	%	92.0
	12254173	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254174	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	78.0	CHEMBL3920	Homo sapiens	Residual Activity	%	78.0
	12254175	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	90.0	CHEMBL3920	Homo sapiens	Residual Activity	%	90.0
	12254176	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	112.0	CHEMBL3920	Homo sapiens	Residual Activity	%	112.0
	12254177	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	77.0	CHEMBL3920	Homo sapiens	Residual Activity	%	77.0
	12254178	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	107.0	CHEMBL3920	Homo sapiens	Residual Activity	%	107.0
	12254179	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	105.0	CHEMBL3920	Homo sapiens	Residual Activity	%	105.0
	12254180	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	75.0	CHEMBL3920	Homo sapiens	Residual Activity	%	75.0
	12254181	CHEMBL2219116	Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	5.0	CHEMBL3920	Homo sapiens	Residual Activity	%	5.0
	12626668	CHEMBL2317116	Inhibition of PKCtheta (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	12662223	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1		CHEMBL2326002	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	12662224	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2F)CCN1		CHEMBL2326001	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	nM	2.0
	12662225	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2CO)CCN1		CHEMBL2326000	=	IC50	nM	1.0	CHEMBL3920	Homo sapiens	IC50	nM	1.0
	12662226	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2C#N)CCN1		CHEMBL2325999	=	IC50	nM	120.0	CHEMBL3920	Homo sapiens	IC50	nM	120.0
	12662227	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2O)CCN1		CHEMBL2325998	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
	12663445	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(C(F)(F)F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326013	=	IC50	nM	420.0	CHEMBL3920	Homo sapiens	IC50	nM	420.0
	12663446	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(Cl)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326012	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	12663447	CHEMBL2330912	Inhibition of PKC-theta in human PBMC cells assessed as inhibition of IL-2 after 24 hrs by bead-based FLISA assay	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326007	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
	12663503	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1		CHEMBL2326002	=	Ki	nM	0.08	CHEMBL3920	Homo sapiens	Ki	nM	0.08
	12663504	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2F)CCN1		CHEMBL2326001	=	Ki	nM	0.1	CHEMBL3920	Homo sapiens	Ki	nM	0.1
	12663505	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2CO)CCN1		CHEMBL2326000	=	Ki	nM	0.1	CHEMBL3920	Homo sapiens	Ki	nM	0.1
	12663506	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2C#N)CCN1		CHEMBL2325999	=	Ki	nM	1.0	CHEMBL3920	Homo sapiens	Ki	nM	1.0
	12663507	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2O)CCN1		CHEMBL2325998	=	Ki	nM	0.1	CHEMBL3920	Homo sapiens	Ki	nM	0.1
	12663508	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(C(F)(F)F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326013	=	Ki	nM	20.0	CHEMBL3920	Homo sapiens	Ki	nM	20.0
	12663509	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(Cl)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326012	=	Ki	nM	21.0	CHEMBL3920	Homo sapiens	Ki	nM	21.0
	12663510	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	COC(C)(C(C)C)C1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326011	=	Ki	nM	10.0	CHEMBL3920	Homo sapiens	Ki	nM	10.0
	12663511	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326010	=	Ki	nM	21.0	CHEMBL3920	Homo sapiens	Ki	nM	21.0
	12663512	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@](C)(O)[C@@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326009	=	Ki	nM	1.0	CHEMBL3920	Homo sapiens	Ki	nM	1.0
	12663513	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@](C)(O)[C@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326008	=	Ki	nM	133.0	CHEMBL3920	Homo sapiens	Ki	nM	133.0
	12663514	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326007	=	Ki	nM	0.2	CHEMBL3920	Homo sapiens	Ki	nM	0.2
	12663515	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	COC[C@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326006	=	Ki	nM	51.0	CHEMBL3920	Homo sapiens	Ki	nM	51.0
	12663516	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)C[C@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)C[C@H](C)N1		CHEMBL2326005	>	Ki	nM	700.0	CHEMBL3920	Homo sapiens	Ki	nM	700.0
	12663517	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)C[C@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)C[C@@H](C)N1		CHEMBL2326004	=	Ki	nM	5.0	CHEMBL3920	Homo sapiens	Ki	nM	5.0
	12663518	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)C[C@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326003	=	Ki	nM	4.0	CHEMBL3920	Homo sapiens	Ki	nM	4.0
	12663519	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)C[C@@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326021	=	Ki	nM	9.0	CHEMBL3920	Homo sapiens	Ki	nM	9.0
	12663520	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	c1ccc([C@@H]2CN(c3cccc(-c4n[nH]c5ncccc45)n3)CCN2)cc1		CHEMBL2326020	=	Ki	nM	5.0	CHEMBL3920	Homo sapiens	Ki	nM	5.0
	12663521	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)C[C@H]1CN(c2cccc(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326019	=	Ki	nM	2.0	CHEMBL3920	Homo sapiens	Ki	nM	2.0
	12663522	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)C[C@@H]1CN(c2cccc(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326018	=	Ki	nM	5.0	CHEMBL3920	Homo sapiens	Ki	nM	5.0
	12663523	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)[C@H]1CN(c2cccc(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326017	=	Ki	nM	15.0	CHEMBL3920	Homo sapiens	Ki	nM	15.0
	12663524	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC[C@@H]1CN(c2cccc(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326016	=	Ki	nM	12.0	CHEMBL3920	Homo sapiens	Ki	nM	12.0
	12663525	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	C[C@@H]1CN(c2cccc(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2321918	=	Ki	nM	68.0	CHEMBL3920	Homo sapiens	Ki	nM	68.0
	12663526	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	Fc1ccc(N2CCNCC2)nc1-c1n[nH]c2ncccc12		CHEMBL2326015	=	Ki	nM	60.0	CHEMBL3920	Homo sapiens	Ki	nM	60.0
	12663527	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	c1cc(-c2n[nH]c3ncccc23)nc(N2CCNCC2)c1		CHEMBL2326014	=	Ki	nM	50.0	CHEMBL3920	Homo sapiens	Ki	nM	50.0
	12663528	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	Nc1ncccc1C(=O)c1cccc(N2CCNCC2)n1		CHEMBL2046626	=	Ki	nM	32.0	CHEMBL3920	Homo sapiens	Ki	nM	32.0
	12663529	CHEMBL2329704	Inhibition of full-length recombinant PKC theta (unknown origin) using ERMRPRKRQGSVRRRV as substrate after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	Nc1ncccc1C(=O)c1cccc(N2CCCNCC2)n1		CHEMBL2046624	=	Ki	nM	164.0	CHEMBL3920	Homo sapiens	Ki	nM	164.0
	12693185	CHEMBL2343427	Inhibition of PKCtheta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	12727682	CHEMBL2351395	Inhibition of PKCtheta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	78.0	CHEMBL3920	Homo sapiens	Activity	%	78.0
	12728071	CHEMBL2351286	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 60 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	12728968	CHEMBL2350145	Inhibition of PKCtheta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL3920	Homo sapiens	Activity	%	98.0
	12729849	CHEMBL2352434	Inhibition of PKCtheta (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	98.0	CHEMBL3920	Homo sapiens	Activity	%	98.0
	12730111	CHEMBL2351395	Inhibition of PKCtheta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL3920	Homo sapiens	Activity	%	103.0
	13374375	CHEMBL2406507	Inhibition of PKCtheta (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	11.0	CHEMBL3920	Homo sapiens	INH	%	11.0
	13389911	CHEMBL2410712	Inhibition of PKCtheta (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	13419733	CHEMBL2422277	Inhibition of PKCtheta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	17.0	CHEMBL3920	Homo sapiens	INH	%	17.0
	13419734	CHEMBL2422277	Inhibition of PKCtheta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	75.0	CHEMBL3920	Homo sapiens	INH	%	75.0
	13419735	CHEMBL2422277	Inhibition of PKCtheta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	77.0	CHEMBL3920	Homo sapiens	INH	%	77.0
	13436875	CHEMBL2421503	Displacement of [3H]PDBu from PKCtheta C1B domain (unknown origin)	B	C[C@@H](CCCc1cccc(O)c1)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C		CHEMBL2418196	=	Ki	nM	0.2	CHEMBL3920	Homo sapiens	Ki	nM	0.2
	13439772	CHEMBL2429013	Competitive binding affinity to PRKCQ (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	13445605	CHEMBL2429013	Competitive binding affinity to PRKCQ (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	13451592	CHEMBL2429013	Competitive binding affinity to PRKCQ (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	13871771	CHEMBL3101125	Inhibition of human PKCtheta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	116.0	CHEMBL3920	Homo sapiens	Activity	%	116.0
	13948201	CHEMBL3132608	Inhibition of C-terminal FLAG-tagged PKC-theta (unknown origin) expressed in Escherichia coli using MBP as substrate after 60 mins	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nmol/L	10000.0
	13953279	CHEMBL3130912	Inhibition of human PKC-theta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	98.0	CHEMBL3920	Homo sapiens	Activity	%	98.0
	13953344	CHEMBL3130912	Inhibition of human PKC-theta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	90.0	CHEMBL3920	Homo sapiens	Activity	%	90.0
	13953349	CHEMBL3130912	Inhibition of human PKC-theta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	89.0	CHEMBL3920	Homo sapiens	Activity	%	89.0
	13965679	CHEMBL3135229	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	67.5	CHEMBL3920	Homo sapiens	INH	%	67.5
	13966057	CHEMBL3136794	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	29.0	CHEMBL3920	Homo sapiens	INH	%	29.0
	13973332	CHEMBL3135070	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	5.0	CHEMBL3920	Homo sapiens	INH	%	5.0
	13974050	CHEMBL3134710	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	4.0	CHEMBL3920	Homo sapiens	INH	%	4.0
	13974141	CHEMBL3136355	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	52.5	CHEMBL3920	Homo sapiens	INH	%	52.5
	13974232	CHEMBL3135457	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	32.0	CHEMBL3920	Homo sapiens	INH	%	32.0
	13974970	CHEMBL3136992	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	67.5	CHEMBL3920	Homo sapiens	INH	%	67.5
	13975061	CHEMBL3136706	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	3.5	CHEMBL3920	Homo sapiens	INH	%	3.5
	13975152	CHEMBL3134935	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	4.5	CHEMBL3920	Homo sapiens	INH	%	4.5
	13975243	CHEMBL3136524	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	13.0	CHEMBL3920	Homo sapiens	INH	%	13.0
	13975886	CHEMBL3135657	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	67.5	CHEMBL3920	Homo sapiens	INH	%	67.5
	13975979	CHEMBL3136288	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	31.5	CHEMBL3920	Homo sapiens	INH	%	31.5
	13976070	CHEMBL3136054	Inhibition of human truncated PKC theta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	72.0	CHEMBL3920	Homo sapiens	INH	%	72.0
	14585301	CHEMBL3241655	Inhibition of human PKCtheta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	97.5	CHEMBL3920	Homo sapiens	Activity	%	97.5
Not Active	14999387	CHEMBL3368683	Inhibition of human PKCtheta at 10 uM relative to control	B	CC(C)(C)C1=NN(c2cccc(Cl)c2)C(c2ccc(F)c(O)c2)C1		CHEMBL3323358		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	15019197	CHEMBL3364390	Inhibition of PKCtheta (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	3.0	CHEMBL3920	Homo sapiens	INH	%	3.0
	15020484	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21		CHEMBL3356475	=	IC50	nM	320.0	CHEMBL3920	Homo sapiens	IC50	uM	0.32
	15020485	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21		CHEMBL3356474	=	IC50	nM	49.0	CHEMBL3920	Homo sapiens	IC50	uM	0.049
	15020486	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1C(=O)NN=C2COc3cc(-c4ccccc4)c(NC4CNC4)cc3N21		CHEMBL3356473	=	IC50	nM	760.0	CHEMBL3920	Homo sapiens	IC50	uM	0.76
	15020487	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4)c(NC4CNC4)cc3N21		CHEMBL3356472	=	IC50	nM	49.0	CHEMBL3920	Homo sapiens	IC50	uM	0.049
	15020488	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1cc2c(cc1NC1CNC1)N1C(=NNC(=O)[C@@H]1C)CO2		CHEMBL3356471	=	IC50	nM	390.0	CHEMBL3920	Homo sapiens	IC50	uM	0.39
	15020489	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1cc2c(cc1NC1CNC1)N1C(=NNC(=O)[C@H]1C)CO2		CHEMBL3356470	=	IC50	nM	55.0	CHEMBL3920	Homo sapiens	IC50	uM	0.055
	15020490	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(C(F)(F)F)c(CC4CNC4)cc3N21		CHEMBL3356469	=	IC50	nM	59.0	CHEMBL3920	Homo sapiens	IC50	uM	0.059
	15020491	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(C(F)(F)F)c(OC4CNC4)cc3N21		CHEMBL3356468	=	IC50	nM	190.0	CHEMBL3920	Homo sapiens	IC50	uM	0.19
	15020492	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21		CHEMBL3356467	=	IC50	nM	67.0	CHEMBL3920	Homo sapiens	IC50	uM	0.067
	15020493	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC(C)c1cc2c(cc1NC1CNC1)N1C(=NNC(=O)C1C)CO2		CHEMBL3356466	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	uM	0.13
	15020494	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(F)c(NC4CNC4)cc3N21		CHEMBL3356465	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	uM	0.1
	15020495	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1cc2c(cc1NC1CNC1)N1C(=NNC(=O)C1C)CO2		CHEMBL3356464	=	IC50	nM	110.0	CHEMBL3920	Homo sapiens	IC50	uM	0.11
	15020496	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1NN=C2COc3ccc(NC4CNC4)cc3N2C1c1ccccc1		CHEMBL3356463	>	IC50	nM	50000.0	CHEMBL3920	Homo sapiens	IC50	uM	50.0
	15020497	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1NN=C2COc3ccc(NC4CNC4)cc3N2C1C1CC1		CHEMBL3356462	=	IC50	nM	3500.0	CHEMBL3920	Homo sapiens	IC50	uM	3.5
	15020498	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CCC1C(=O)NN=C2COc3ccc(NC4CNC4)cc3N21		CHEMBL3352857	=	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	uM	1.0
	15020499	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3ccc(NC4CNC4)cc3N21		CHEMBL3356461	=	IC50	nM	230.0	CHEMBL3920	Homo sapiens	IC50	uM	0.23
	15020500	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC(=O)CC3CCNCC3)cc12		CHEMBL3356460	>	IC50	nM	50000.0	CHEMBL3920	Homo sapiens	IC50	uM	50.0
	15020501	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CN1CCC(C(=O)Nc2ccc3c(c2)N2CC(=O)NN=C2CO3)CC1		CHEMBL3356459	=	IC50	nM	4500.0	CHEMBL3920	Homo sapiens	IC50	uM	4.5
	15020502	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC(=O)C3CCNCC3)cc12		CHEMBL3356458	=	IC50	nM	3500.0	CHEMBL3920	Homo sapiens	IC50	uM	3.5
	15020503	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC(=O)C3CCNC3)cc12		CHEMBL3356457	=	IC50	nM	46000.0	CHEMBL3920	Homo sapiens	IC50	uM	46.0
	15020504	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC(=O)C3CNC3)cc12		CHEMBL3356456	=	IC50	nM	19000.0	CHEMBL3920	Homo sapiens	IC50	uM	19.0
	15020505	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CN(C)CC(=O)Nc1ccc2c(c1)N1CC(=O)NN=C1CO2		CHEMBL3356455	=	IC50	nM	46000.0	CHEMBL3920	Homo sapiens	IC50	uM	46.0
	15020506	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC(N)CNc1ccc2c(c1)N1CC(=O)NN=C1CO2		CHEMBL3356454	=	IC50	nM	18000.0	CHEMBL3920	Homo sapiens	IC50	uM	18.0
	15020507	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NCC3CCNCC3)cc12		CHEMBL3356453	=	IC50	nM	31000.0	CHEMBL3920	Homo sapiens	IC50	uM	31.0
	15020508	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NCC3CCNC3)cc12		CHEMBL3356452	=	IC50	nM	20000.0	CHEMBL3920	Homo sapiens	IC50	uM	20.0
	15020509	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NCC3CNC3)cc12		CHEMBL3356451	=	IC50	nM	17000.0	CHEMBL3920	Homo sapiens	IC50	uM	17.0
	15020510	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CCCNCC3)cc12		CHEMBL3356450	=	IC50	nM	8900.0	CHEMBL3920	Homo sapiens	IC50	uM	8.9
	15020511	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CCNCC3)cc12		CHEMBL3356449	=	IC50	nM	21000.0	CHEMBL3920	Homo sapiens	IC50	uM	21.0
	15020512	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CCCNC3)cc12		CHEMBL3356448	=	IC50	nM	14000.0	CHEMBL3920	Homo sapiens	IC50	uM	14.0
	15020513	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CCNC3)cc12		CHEMBL3356447	=	IC50	nM	3300.0	CHEMBL3920	Homo sapiens	IC50	uM	3.3
	15020514	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3COC3)cc12		CHEMBL3356446	>	IC50	nM	50000.0	CHEMBL3920	Homo sapiens	IC50	uM	50.0
	15020515	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CCC3)cc12		CHEMBL3356086	=	IC50	nM	38000.0	CHEMBL3920	Homo sapiens	IC50	uM	38.0
	15020516	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CNC3)cc12		CHEMBL3356085	=	IC50	nM	1300.0	CHEMBL3920	Homo sapiens	IC50	uM	1.3
	15020517	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CN(C)Cc1ccc2c(c1)OCC1=NNC(=O)CN12		CHEMBL3356084	=	IC50	nM	16000.0	CHEMBL3920	Homo sapiens	IC50	uM	16.0
	15020518	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	IC50	nM	453000.0	CHEMBL3920	Homo sapiens	IC50	uM	453.0
	15020519	CHEMBL3362643	Inhibition of human recombinant PKCtheta by TR-FRET assay	B	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	IC50	nM	19000.0	CHEMBL3920	Homo sapiens	IC50	uM	19.0
	15020617	CHEMBL3362644	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4(C)CNC4)cc3N21		CHEMBL3355112	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	uM	0.023
	15077449	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	77.0	CHEMBL3920	Homo sapiens	IC50	nM	77.0
	15077450	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	CC(C)(N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147538	=	IC50	nM	141.0	CHEMBL3920	Homo sapiens	IC50	nM	141.0
	15077451	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	CC(C)(N)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL3338837	=	IC50	nM	1531.0	CHEMBL3920	Homo sapiens	IC50	nM	1531.0
	15077452	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	CC(C)(N)CNc1nc(-c2ccc3[nH]ncc3c2)nc2cnccc12		CHEMBL3338838	=	IC50	nM	995.0	CHEMBL3920	Homo sapiens	IC50	nM	995.0
	15077453	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	c1cc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2cn1		CHEMBL3338839	=	IC50	nM	785.0	CHEMBL3920	Homo sapiens	IC50	nM	785.0
	15077454	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2c1		CHEMBL3338840	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	15081895	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)cc2c1		CHEMBL3338841	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	15081896	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	NCCNc1nc(-c2ccc3[nH]ncc3c2)nc2ccccc12		CHEMBL3338842	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	15081897	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	NCCCNc1nc(-c2ccc3[nH]ncc3c2)nc2ccccc12		CHEMBL3338843	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	15081898	CHEMBL3387553	Inhibition of human recombinant PKC-theta after 60 mins by 33P-ATP incorporation assay	B	CN1CCN(c2nc(-c3ccc4[nH]ncc4c3)nc3ccccc23)CC1		CHEMBL3338844	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	15101220	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355127	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	uM	0.003
	15101221	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CCN1CC[C@@H](c2cc3c(cc2-c2ccccc2F)OCC2=NNC(=O)[C@@H](C)N23)[C@@H](C)C1		CHEMBL3355126	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	uM	0.005
	15101222	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c(C4CCN(C)CC4(C)C)cc3N21		CHEMBL3355125	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	uM	0.003
	15101223	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1CN(C)CC[C@@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355124	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	uM	0.016
	15101224	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CNCC[C@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355123	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	uM	0.004
	15101289	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c(C4CCN(C)CC4)cc3N21		CHEMBL3355122	=	IC50	nM	43.0	CHEMBL3920	Homo sapiens	IC50	uM	0.043
	15101290	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c([C@H]4CCN(C)C4)cc3N21		CHEMBL3355121	=	IC50	nM	41.0	CHEMBL3920	Homo sapiens	IC50	uM	0.041
	15101291	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c(C4CCN(C)C4)cc3N21		CHEMBL3355120	=	IC50	nM	42.0	CHEMBL3920	Homo sapiens	IC50	uM	0.042
	15101292	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c([C@@H](C)C4(C)CN(C)C4)cc3N21		CHEMBL3355119	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	uM	0.003
	15101296	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(-c4ccccc4)c(NC4(C)CN(C)C4)cc3N21		CHEMBL3355116	=	IC50	nM	52.0	CHEMBL3920	Homo sapiens	IC50	uM	0.052
	15101297	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(N(C)C4(C)CNC4)cc3N21		CHEMBL3355113	=	IC50	nM	59.0	CHEMBL3920	Homo sapiens	IC50	uM	0.059
	15101302	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c(N(C)C4(C)CN(C)C4)cc3N21		CHEMBL3355118	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	uM	0.004
	15101309	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4)c(N(C)C4(C)CN(C)C4)cc3N21		CHEMBL3355117	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	uM	0.004
	15101310	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(N(C)C4(C)CN(C)C4)cc3N21		CHEMBL3355115	=	IC50	nM	700.0	CHEMBL3920	Homo sapiens	IC50	uM	0.7
	15101311	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4(C)CNC4)cc3N21		CHEMBL3355112	=	IC50	nM	23.0	CHEMBL3920	Homo sapiens	IC50	uM	0.023
	15101313	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4(C)CN(C)C4)cc3N21		CHEMBL3355114	=	IC50	nM	57.0	CHEMBL3920	Homo sapiens	IC50	uM	0.057
	15105862	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4F)c([C@H]4CCN(C)CC4(C)C)cc3N21		CHEMBL3355139	=	IC50	nM	190.0	CHEMBL3920	Homo sapiens	IC50	uM	0.19
	15105863	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1cccc(F)c1)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355128	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	uM	0.014
	15105864	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1ccc(F)cc1)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355129	=	IC50	nM	19.0	CHEMBL3920	Homo sapiens	IC50	uM	0.019
	15105865	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1ccccc1-c1cc2c(cc1[C@@H]1CCN(C)C[C@@H]1C)N1C(=NNC(=O)[C@H]1C)CO2		CHEMBL3355130	=	IC50	nM	8.0	CHEMBL3920	Homo sapiens	IC50	uM	0.008
	15105866	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)cc1		CHEMBL3355131	=	IC50	nM	24.0	CHEMBL3920	Homo sapiens	IC50	uM	0.024
	15105867	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	COc1cccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c1		CHEMBL3355132	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	uM	0.007
	15105868	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)cc1		CHEMBL3355133	=	IC50	nM	10.0	CHEMBL3920	Homo sapiens	IC50	uM	0.01
	15105869	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1c(F)cccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355134	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	uM	0.002
	15105870	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)cc1OC		CHEMBL3355135	=	IC50	nM	240.0	CHEMBL3920	Homo sapiens	IC50	uM	0.24
	15105871	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1ccc3c(c1)OCCO3)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355136	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	uM	0.005
	15105872	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1		CHEMBL3355137	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	uM	0.002
	15105873	CHEMBL3387797	Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1		CHEMBL3355138	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	uM	0.002
	15150128	CHEMBL3396180	Inhibition of PRKCQ (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	15150129	CHEMBL3396180	Inhibition of PRKCQ (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	15150130	CHEMBL3396180	Inhibition of PRKCQ (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	15150131	CHEMBL3396180	Inhibition of PRKCQ (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	15150132	CHEMBL3396180	Inhibition of PRKCQ (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	15625834	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NC3CC(C)(C)N(C)C(C)(C)C3)n2)cc(-n2nnnc2C)c1		CHEMBL3586034	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
	15625835	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NCC3CC(C)(C)N(C)C(C)(C)C3)n2)cc(-n2nnnc2C)c1		CHEMBL3586035	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
	15625836	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NCC3CCN(C)CC3)n2)cc(-n2nnnc2C)c1		CHEMBL3586036	=	IC50	nM	0.68	CHEMBL3920	Homo sapiens	IC50	nM	0.68
	15625837	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NC[C@H]3CCCN(C)C3)n2)cc(-n2nnnc2C)c1		CHEMBL3586037	=	IC50	nM	5.2	CHEMBL3920	Homo sapiens	IC50	nM	5.2
	15625838	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NC[C@@H]3CCCN(C)C3)n2)cc(-n2nnnc2C)c1		CHEMBL3586038	=	IC50	nM	0.32	CHEMBL3920	Homo sapiens	IC50	nM	0.32
	15625839	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	CCN1CCC[C@@H](CNc2nc(Nc3cc(OC)cc(-n4nnnc4C)c3)ncc2F)C1		CHEMBL3586039	=	IC50	nM	0.14	CHEMBL3920	Homo sapiens	IC50	nM	0.14
	15625840	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COCCN1CCC[C@@H](CNc2nc(Nc3cc(OC)cc(-n4nnnc4C)c3)ncc2F)C1		CHEMBL3586040	=	IC50	nM	0.46	CHEMBL3920	Homo sapiens	IC50	nM	0.46
	15625841	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NC[C@@H]3CCCN(CC(F)F)C3)n2)cc(-n2nnnc2C)c1		CHEMBL3586041	=	IC50	nM	30.0	CHEMBL3920	Homo sapiens	IC50	nM	30.0
	15625842	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	COc1cc(Nc2ncc(F)c(NC[C@@H]3CCCN(CC(F)(F)F)C3)n2)cc(-n2nnnc2C)c1		CHEMBL3586042	>	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	15625843	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	Cc1nnnn1-c1cccc(Nc2ncc(F)c(NC[C@@H]3CCCN(C)C3)n2)c1		CHEMBL3586043	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
	15625844	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	CN1CCC[C@@H](CNc2nc(Nc3cccc(-n4ccnn4)c3)ncc2F)C1		CHEMBL3586044	=	IC50	nM	10.0	CHEMBL3920	Homo sapiens	IC50	nM	10.0
	15625845	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	CN1CCC[C@@H](CNc2nc(Nc3cccc(-c4cnco4)c3)ncc2F)C1		CHEMBL3586045	=	IC50	nM	27.0	CHEMBL3920	Homo sapiens	IC50	nM	27.0
	15625846	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	CN1CCC[C@@H](CNc2nc(Nc3cccc(-n4cccn4)c3)ncc2F)C1		CHEMBL3586046	=	IC50	nM	28.0	CHEMBL3920	Homo sapiens	IC50	nM	28.0
	15625847	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	Cc1cnn(-c2cccc(Nc3ncc(F)c(NC[C@@H]4CCCN(C)C4)n3)c2)c1		CHEMBL3586047	=	IC50	nM	32.0	CHEMBL3920	Homo sapiens	IC50	nM	32.0
	15625848	CHEMBL3587275	Inhibition of human full length PKCtheta assessed as fluorescence intensity after 60 mins	B	CN1CCC[C@@H](CNc2nc(Nc3cccc(-n4cc(Cl)cn4)c3)ncc2F)C1		CHEMBL3586048	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	nM	3.0
	15649109	CHEMBL3595094	Inhibition of PKCtheta (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	=	IC50	nM	320.0	CHEMBL3920	Homo sapiens	IC50	nM	320.0
	15651949	CHEMBL3595332	Inhibition of recombinant human PKCtheta at 1 uM relative to control	B	CCN(C[C@H]1CC[C@H](N)CC1)c1nccc(Nc2cc([C@H]3CCN(C)C3=O)[nH]n2)n1		CHEMBL3594178	>	Inhibition	%	75.0	CHEMBL3920	Homo sapiens	INH	%	75.0
	15651950	CHEMBL3595332	Inhibition of recombinant human PKCtheta at 1 uM relative to control	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	>	Inhibition	%	75.0	CHEMBL3920	Homo sapiens	INH	%	75.0
	15756847	CHEMBL3630936	Inhibition of PKCtheta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-43.56	CHEMBL3920	Homo sapiens	INH	%	-43.56
	15757876	CHEMBL3630936	Inhibition of PKCtheta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-5.48	CHEMBL3920	Homo sapiens	INH	%	-5.48
	15758855	CHEMBL3630936	Inhibition of PKCtheta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-33.41	CHEMBL3920	Homo sapiens	INH	%	-33.41
	16421961	CHEMBL3749780	Inhibition of PKCtheta (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	=	IC50	nM	4100.0	CHEMBL3920	Homo sapiens	IC50	uM	4.1
	16426118	CHEMBL3750445	Inhibition of PKCtheta (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-6.9	CHEMBL3920	Homo sapiens	INH	%	-6.9
	16431971	CHEMBL3750010	Inhibition of human PKCtheta using histone H1 as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	16451578	CHEMBL3760875	Inhibition of PKCtheta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	4.5	CHEMBL3920	Homo sapiens	INH	%	4.5
	16458614	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	-1.0	CHEMBL3920	Homo sapiens	INH	%	-1.0
	16458615	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	-5.0	CHEMBL3920	Homo sapiens	INH	%	-5.0
	16458616	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	12.0	CHEMBL3920	Homo sapiens	INH	%	12.0
	16458617	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	-2.0	CHEMBL3920	Homo sapiens	INH	%	-2.0
	16458618	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	0.0	CHEMBL3920	Homo sapiens	INH	%	0.0
	16458619	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL3920	Homo sapiens	INH	%	1.0
	16458620	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	1.0	CHEMBL3920	Homo sapiens	INH	%	1.0
	16458621	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	-10.0	CHEMBL3920	Homo sapiens	INH	%	-10.0
	16458622	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-5.0	CHEMBL3920	Homo sapiens	INH	%	-5.0
	16458623	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	3.0	CHEMBL3920	Homo sapiens	INH	%	3.0
	16458624	CHEMBL3761600	Inhibition of PRKCQ (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-4.0	CHEMBL3920	Homo sapiens	INH	%	-4.0
	16495202	CHEMBL3777530	Inhibition of N-terminal His6-tagged recombinant human PRKCQ expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-16.0	CHEMBL3920	Homo sapiens	Activity	%	-16.0
	16496121	CHEMBL3777530	Inhibition of N-terminal His6-tagged recombinant human PRKCQ expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-18.0	CHEMBL3920	Homo sapiens	Activity	%	-18.0
	16508911	CHEMBL3777530	Inhibition of N-terminal His6-tagged recombinant human PRKCQ expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-3.0	CHEMBL3920	Homo sapiens	Activity	%	-3.0
	16525666	CHEMBL3790305	Inhibition of PRKCQ (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	230.0	CHEMBL3920	Homo sapiens	IC50	uM	0.23
	16525667	CHEMBL3790305	Inhibition of PRKCQ (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	16525668	CHEMBL3790305	Inhibition of PRKCQ (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	16525669	CHEMBL3790305	Inhibition of PRKCQ (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	16580607	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	16580608	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1CCc1ccccc1		CHEMBL3800116	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	16580609	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1Cc1ccccc1		CHEMBL3798679	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
	16580610	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1CC1CCCC1		CHEMBL3800310	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	16580611	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	CC(C)CN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3799399	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	16580612	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1CC1CC1		CHEMBL3798787	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	16580613	CHEMBL3804232	Inhibition of PKCtheta in human Jurkat cells after overnight incubation by luminescence analysis	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	16580614	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	=	IC50	nM	0.25	CHEMBL3920	Homo sapiens	IC50	nM	0.25
	16580615	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	C[C@@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3800082	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	16580616	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1Cc1cccnc1		CHEMBL3798849	=	IC50	nM	150.0	CHEMBL3920	Homo sapiens	IC50	nM	150.0
	16580617	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1CCc1ccccc1		CHEMBL3800116	=	IC50	nM	300.0	CHEMBL3920	Homo sapiens	IC50	nM	300.0
	16580618	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1Cc1ccccc1		CHEMBL3798679	=	IC50	nM	0.46	CHEMBL3920	Homo sapiens	IC50	nM	0.46
	16580619	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1CC1CCCC1		CHEMBL3800310	=	IC50	nM	4.3	CHEMBL3920	Homo sapiens	IC50	nM	4.3
	16580620	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1c1ccccc1		CHEMBL3798266	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	16580621	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC(C)CN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3799399	=	IC50	nM	45.0	CHEMBL3920	Homo sapiens	IC50	nM	45.0
	16580622	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CC1(C)NC(=O)c2ccc(-n3c(=O)[nH]c4ncccc43)cc2N1CC1CC1		CHEMBL3798787	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	16580623	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	IC50	nM	260.0	CHEMBL3920	Homo sapiens	IC50	nM	260.0
	16580624	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	IC50	nM	60.0	CHEMBL3920	Homo sapiens	IC50	nM	60.0
	16580625	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CCN1c2cc(-c3c(C)n[nH]c3C)ccc2C(=O)NC1(C)C		CHEMBL3799237	=	IC50	nM	1900.0	CHEMBL3920	Homo sapiens	IC50	nM	1900.0
	16580626	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CCN1c2cc(-c3c[nH]nc3C)ccc2C(=O)NC1(C)C		CHEMBL3799887	=	IC50	nM	240.0	CHEMBL3920	Homo sapiens	IC50	nM	240.0
	16580627	CHEMBL3804231	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	CCN1c2cc(-c3cn[nH]c3)ccc2C(=O)NC1(C)C		CHEMBL3798888	=	IC50	nM	930.0	CHEMBL3920	Homo sapiens	IC50	nM	930.0
	16593521	CHEMBL3811356	Inhibition of full length His-tagged human recombinant PKCtheta expressed in baculovirus using Fluorescein-PKC as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL3920	Homo sapiens	INH	%	40.0
	16614601	CHEMBL3815957	Inhibition of human PKCtheta at 1 uM using histone H1 as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-18.0	CHEMBL3920	Homo sapiens	INH	%	-18.0
	16618116	CHEMBL3816502	Inhibition of full length recombinant human His-tagged PKC-theta expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	16619691	CHEMBL3820259	Inhibition of recombinant human full length His-tagged PKCtheta expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL3920	Homo sapiens	INH	%	75.0
	16739528	CHEMBL3857075	Inhibition of His tagged recombinant full length human PRKCQ expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	10.0	CHEMBL3920	Homo sapiens	INH	%	10.0
	16739529	CHEMBL3857075	Inhibition of His tagged recombinant full length human PRKCQ expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	7.0	CHEMBL3920	Homo sapiens	INH	%	7.0
	16739530	CHEMBL3857075	Inhibition of His tagged recombinant full length human PRKCQ expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-4.0	CHEMBL3920	Homo sapiens	INH	%	-4.0
	16781502	CHEMBL3865550	Inhibition of C-terminal 6His-tagged recombinant full length human PKCtheta expressed in fall armyworm Sf21 cells	B	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	nM	7.0
	16781510	CHEMBL3865542	Inhibition of human PKCtheta at 100 nM	B	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	Inhibition	%	91.0	CHEMBL3920	Homo sapiens	INH	%	91.0
	16837462	CHEMBL3876124	Inhibition of human recombinant full length His-tagged PRKCQ expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
438229	17797974	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3890986	=	IC50	nM	2.8	CHEMBL3920	Homo sapiens	IC50	nM	2.8
438230	17797975	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3915489	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
438231	17797976	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3961086	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
438232	17797977	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)cc4ccccc34)cnc2N)CC1		CHEMBL3892099	=	IC50	nM	0.3	CHEMBL3920	Homo sapiens	IC50	nM	0.3
438233	17797978	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3968672	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	nM	2.0
438234	17797979	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3901073	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
438235	17797980	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ncc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3984070	=	IC50	nM	0.27	CHEMBL3920	Homo sapiens	IC50	nM	0.27
438236	17797981	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2csc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3914252	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
438237	17797982	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3982723	=	IC50	nM	0.4	CHEMBL3920	Homo sapiens	IC50	nM	0.4
438238	17797983	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3954062	=	IC50	nM	2.8	CHEMBL3920	Homo sapiens	IC50	nM	2.8
438239	17797984	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)ncc3C(F)(F)F)cnc2N)CC1		CHEMBL3893839	=	IC50	nM	3.1	CHEMBL3920	Homo sapiens	IC50	nM	3.1
438240	17797985	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1nc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c2cc(F)ccc2n1		CHEMBL3959314	=	IC50	nM	1.8	CHEMBL3920	Homo sapiens	IC50	nM	1.8
438241	17797986	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3899197	=	IC50	nM	0.45	CHEMBL3920	Homo sapiens	IC50	nM	0.45
438242	17797987	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C4CC(F)(F)C4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3970381	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
438243	17797988	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C4CC4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3908251	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
438244	17797989	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3981769	=	IC50	nM	0.69	CHEMBL3920	Homo sapiens	IC50	nM	0.69
438245	17797990	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3920740	=	IC50	nM	1.1	CHEMBL3920	Homo sapiens	IC50	nM	1.1
438246	17797991	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3Cl)cnc2N)CC1		CHEMBL3892736	=	IC50	nM	0.9	CHEMBL3920	Homo sapiens	IC50	nM	0.9
438247	17797992	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3F)cnc2N)CC1		CHEMBL3896642	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
438248	17797993	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CC[C@H](C1)[C@H]2N		CHEMBL3928145	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
438249	17797994	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3891166	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
438250	17797995	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3F)cnc2N)CC1		CHEMBL3919244	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
438251	17797996	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C#N)ccc3F)cnc2N)CC1		CHEMBL3918138	=	IC50	nM	3.9	CHEMBL3920	Homo sapiens	IC50	nM	3.9
438252	17797997	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C#N)cnc2N)CC1		CHEMBL3942560	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
438253	17797998	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3905583	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
438254	17797999	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3933598	=	IC50	nM	4.7	CHEMBL3920	Homo sapiens	IC50	nM	4.7
438255	17798000	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3932525	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
438256	17798001	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CCO)CC1		CHEMBL3935905	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
438257	17798002	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CO[C@H](C1)[C@H]2N		CHEMBL4115475	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
438258	17798003	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncnc3c2CCCC3)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3909349	=	IC50	nM	7.9	CHEMBL3920	Homo sapiens	IC50	nM	7.9
438259	17798004	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncnc3sccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3924825	=	IC50	nM	7.4	CHEMBL3920	Homo sapiens	IC50	nM	7.4
438260	17798005	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2F)nc1C(=O)Nc1ncccc1N1CCC(N)(CCO)CC1		CHEMBL3933423	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
438261	17798006	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CN(C)c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3919379	=	IC50	nM	3.8	CHEMBL3920	Homo sapiens	IC50	nM	3.8
438262	17798007	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CC[C@H](C1)[C@H]2N		CHEMBL3928145	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
438263	17798008	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(C#N)c3F)cnc2N)CC1		CHEMBL3943631	=	IC50	nM	3.4	CHEMBL3920	Homo sapiens	IC50	nM	3.4
438264	17798009	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3964163	=	IC50	nM	29.0	CHEMBL3920	Homo sapiens	IC50	nM	29.0
438265	17798010	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3968875	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
438266	17798011	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncnc4ccc(F)cc34)cnc2N)CC1		CHEMBL3916984	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
438267	17798012	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncnc3[nH]cc(F)c23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3904204	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
438268	17798013	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc(N3CCOCC3)c2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3932204	=	IC50	nM	2.8	CHEMBL3920	Homo sapiens	IC50	nM	2.8
438269	17798014	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(C(F)(F)F)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3909775	=	IC50	nM	2.7	CHEMBL3920	Homo sapiens	IC50	nM	2.7
438270	17798015	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3cc(N4CCOCC4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3970893	=	IC50	nM	2.7	CHEMBL3920	Homo sapiens	IC50	nM	2.7
438271	17798016	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)C(F)C1		CHEMBL3946659	=	IC50	nM	2.2	CHEMBL3920	Homo sapiens	IC50	nM	2.2
438272	17798017	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccnc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3975977	=	IC50	nM	2.2	CHEMBL3920	Homo sapiens	IC50	nM	2.2
438273	17798018	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C4=CCOCC4)ncc3C(F)(F)F)cnc2N)CC1		CHEMBL3958761	=	IC50	nM	2.1	CHEMBL3920	Homo sapiens	IC50	nM	2.1
438274	17798019	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)nc4ccccc34)cnc2N)CC1		CHEMBL3984009	=	IC50	nM	1.7	CHEMBL3920	Homo sapiens	IC50	nM	1.7
438275	17798020	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cn1ncc2c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(N)CC4)n3)ncnc21		CHEMBL3967547	=	IC50	nM	1.6	CHEMBL3920	Homo sapiens	IC50	nM	1.6
438276	17798021	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc4ccc(F)cc34)cnc2N)CC1		CHEMBL3896330	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
438277	17798022	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3950697	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
438278	17798023	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3976541	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
438279	17798024	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc(N3CCOCC3)c2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3932204	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
438280	17798025	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc4ccc(Cl)cc34)cnc2N)CC1		CHEMBL3968031	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
438281	17798026	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3957149	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
438282	17798027	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CC[C@@H](N)[C@@H](F)C1		CHEMBL3960459	=	IC50	nM	1.2	CHEMBL3920	Homo sapiens	IC50	nM	1.2
438283	17798028	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc3[nH]c(C(F)(F)F)cc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3951893	=	IC50	nM	0.99	CHEMBL3920	Homo sapiens	IC50	nM	0.99
438284	17798029	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3980746	=	IC50	nM	0.88	CHEMBL3920	Homo sapiens	IC50	nM	0.88
438285	17798030	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CN(C)c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(N)CC3)n2)n1		CHEMBL3943147	=	IC50	nM	0.87	CHEMBL3920	Homo sapiens	IC50	nM	0.87
438286	17798031	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCC(F)(F)CC4)ncc3F)cnc2N)CC1		CHEMBL3970090	=	IC50	nM	0.85	CHEMBL3920	Homo sapiens	IC50	nM	0.85
438287	17798032	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3F)cnc2N)CC1		CHEMBL3975025	=	IC50	nM	0.71	CHEMBL3920	Homo sapiens	IC50	nM	0.71
438288	17798033	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)ncc3F)cnc2N)CC1		CHEMBL3945647	=	IC50	nM	0.68	CHEMBL3920	Homo sapiens	IC50	nM	0.68
438289	17798034	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cn1ccc2c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(N)CC4)n3)cccc21		CHEMBL3983009	=	IC50	nM	0.68	CHEMBL3920	Homo sapiens	IC50	nM	0.68
438290	17798035	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc3[nH]ncc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3957715	=	IC50	nM	0.67	CHEMBL3920	Homo sapiens	IC50	nM	0.67
438291	17798036	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(C#N)c3C(F)(F)F)cnc2N)CC1		CHEMBL3889877	=	IC50	nM	0.63	CHEMBL3920	Homo sapiens	IC50	nM	0.63
438292	17798037	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)nc3ccc(F)cc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3958917	=	IC50	nM	0.43	CHEMBL3920	Homo sapiens	IC50	nM	0.43
438293	17798038	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1cc2c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(N)CC4)n3)cccc2[nH]1		CHEMBL3969856	=	IC50	nM	0.36	CHEMBL3920	Homo sapiens	IC50	nM	0.36
438294	17798039	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966643	=	IC50	nM	0.36	CHEMBL3920	Homo sapiens	IC50	nM	0.36
438295	17798040	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3967601	=	IC50	nM	0.33	CHEMBL3920	Homo sapiens	IC50	nM	0.33
438296	17798041	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C(N)=O)ncc3F)cnc2N)CC1		CHEMBL3937993	=	IC50	nM	0.27	CHEMBL3920	Homo sapiens	IC50	nM	0.27
438297	17798042	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C#N)ncc3C(F)(F)F)cnc2N)CC1		CHEMBL3977690	=	IC50	nM	1.9	CHEMBL3920	Homo sapiens	IC50	nM	1.9
438298	17798043	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N)ncc3Cl)cnc2N)CC1		CHEMBL3907088	=	IC50	nM	0.24	CHEMBL3920	Homo sapiens	IC50	nM	0.24
438299	17798044	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc3[nH]ccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3982497	=	IC50	nM	0.23	CHEMBL3920	Homo sapiens	IC50	nM	0.23
438300	17798045	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)cc3ccccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966595	=	IC50	nM	0.2	CHEMBL3920	Homo sapiens	IC50	nM	0.2
438301	17798046	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc(N3CCOCC3)cc(C(F)(F)F)c2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3893533	=	IC50	nM	0.16	CHEMBL3920	Homo sapiens	IC50	nM	0.16
438302	17798047	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(Cl)c3C(F)(F)F)cnc2N)CC1		CHEMBL3921551	=	IC50	nM	0.13	CHEMBL3920	Homo sapiens	IC50	nM	0.13
438303	17798048	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3933598	=	IC50	nM	4.7	CHEMBL3920	Homo sapiens	IC50	nM	4.7
438304	17798049	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3980746	=	IC50	nM	0.88	CHEMBL3920	Homo sapiens	IC50	nM	0.88
438305	17798050	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966643	=	IC50	nM	0.36	CHEMBL3920	Homo sapiens	IC50	nM	0.36
438306	17798051	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)cc3ccccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966595	=	IC50	nM	0.2	CHEMBL3920	Homo sapiens	IC50	nM	0.2
438307	17798052	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1ccc(N2CCC(N)CC2)c(NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)n1		CHEMBL3903385	=	IC50	nM	26.0	CHEMBL3920	Homo sapiens	IC50	nM	26.0
438308	17798053	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1ccc(N2CCC(N)CC2)c(NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)n1		CHEMBL3977527	=	IC50	nM	51.0	CHEMBL3920	Homo sapiens	IC50	nM	51.0
438309	17798054	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COC1CN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CCC1N		CHEMBL3965722	=	IC50	nM	19.0	CHEMBL3920	Homo sapiens	IC50	nM	19.0
438310	17798055	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3935812	=	IC50	nM	4.6	CHEMBL3920	Homo sapiens	IC50	nM	4.6
438311	17798056	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3912781	=	IC50	nM	5.3	CHEMBL3920	Homo sapiens	IC50	nM	5.3
438312	17798057	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(CO)c3C(F)(F)F)cnc2N)CC1		CHEMBL3926882	=	IC50	nM	2.9	CHEMBL3920	Homo sapiens	IC50	nM	2.9
438313	17798058	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3949255	=	IC50	nM	2.6	CHEMBL3920	Homo sapiens	IC50	nM	2.6
438314	17798059	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C#N)ccc3F)cnc2N)CC1		CHEMBL3918138	=	IC50	nM	3.9	CHEMBL3920	Homo sapiens	IC50	nM	3.9
438315	17798060	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1CN(c2ccc(C(F)(F)F)c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(C)(N)CC4)n3)n2)CCO1		CHEMBL3939304	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	nM	2.0
438316	17798061	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3914762	=	IC50	nM	0.79	CHEMBL3920	Homo sapiens	IC50	nM	0.79
438317	17798062	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3987185	=	IC50	nM	0.29	CHEMBL3920	Homo sapiens	IC50	nM	0.29
438318	17798063	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(COC(F)F)CC1		CHEMBL3971305	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
438319	17798064	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(COC(F)F)CC1		CHEMBL3981979	=	IC50	nM	15.0	CHEMBL3920	Homo sapiens	IC50	nM	15.0
438320	17798065	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc3ccccc3c(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3912038	=	IC50	nM	3.1	CHEMBL3920	Homo sapiens	IC50	nM	3.1
438321	17798066	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3920517	=	IC50	nM	0.13	CHEMBL3920	Homo sapiens	IC50	nM	0.13
438322	17798067	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC(C)Oc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3935341	=	IC50	nM	0.86	CHEMBL3920	Homo sapiens	IC50	nM	0.86
438323	17798068	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(OC4CC4)c3C#N)cnc2N)CC1		CHEMBL3963597	=	IC50	nM	32.0	CHEMBL3920	Homo sapiens	IC50	nM	32.0
438324	17798069	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(N)(CO)CC3)n2)c1C#N		CHEMBL3925357	=	IC50	nM	8.6	CHEMBL3920	Homo sapiens	IC50	nM	8.6
438325	17798070	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	N#Cc1cccnc1-c1cnc(N)c(C(=O)Nc2ncccc2N2CCC(N)(CO)CC2)n1		CHEMBL3928682	=	IC50	nM	3.6	CHEMBL3920	Homo sapiens	IC50	nM	3.6
438326	17798071	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(OC(F)(F)F)c3C#N)cnc2N)CC1		CHEMBL3919287	=	IC50	nM	1.8	CHEMBL3920	Homo sapiens	IC50	nM	1.8
438327	17798072	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(Oc4ccccc4)c3C#N)cnc2N)CC1		CHEMBL3891200	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
438328	17798073	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1cnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c(C(F)(F)F)c1		CHEMBL3928191	=	IC50	nM	6.6	CHEMBL3920	Homo sapiens	IC50	nM	6.6
438329	17798074	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1F		CHEMBL3896683	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
438330	17798075	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CC(O)C4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3933646	=	IC50	nM	29.0	CHEMBL3920	Homo sapiens	IC50	nM	29.0
438331	17798076	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	N#CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3905625	=	IC50	nM	66.0	CHEMBL3920	Homo sapiens	IC50	nM	66.0
438332	17798077	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	N#CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3942617	=	IC50	nM	27.0	CHEMBL3920	Homo sapiens	IC50	nM	27.0
438333	17798078	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1F		CHEMBL3918192	=	IC50	nM	57.0	CHEMBL3920	Homo sapiens	IC50	nM	57.0
438334	17798079	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@@H]1COCCN1c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL4113858	=	IC50	nM	7.7	CHEMBL3920	Homo sapiens	IC50	nM	7.7
438335	17798080	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@H]1COCCN1c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3893246	=	IC50	nM	3.8	CHEMBL3920	Homo sapiens	IC50	nM	3.8
438336	17798081	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4C5CCC4COC5)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3915095	=	IC50	nM	4.8	CHEMBL3920	Homo sapiens	IC50	nM	4.8
438337	17798082	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@@]1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)C[C@@H]1F		CHEMBL3943074	=	IC50	nM	66.0	CHEMBL3920	Homo sapiens	IC50	nM	66.0
438338	17798083	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3927615	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
438339	17798084	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CCO)C(F)C1		CHEMBL3900688	=	IC50	nM	30.0	CHEMBL3920	Homo sapiens	IC50	nM	30.0
438340	17798085	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(N)(CC#N)CC3)n2)c1C#N		CHEMBL3928668	=	IC50	nM	4.1	CHEMBL3920	Homo sapiens	IC50	nM	4.1
438341	17798086	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@H](CO)Nc1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL4109540	=	IC50	nM	3.9	CHEMBL3920	Homo sapiens	IC50	nM	3.9
438342	17798087	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@@H](CO)Nc1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3892068	=	IC50	nM	18.0	CHEMBL3920	Homo sapiens	IC50	nM	18.0
438343	17798088	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(NCCO)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3922907	=	IC50	nM	2.0	CHEMBL3920	Homo sapiens	IC50	nM	2.0
438344	17798089	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(OCCO)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3889579	=	IC50	nM	28.0	CHEMBL3920	Homo sapiens	IC50	nM	28.0
438345	17798090	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COC1CN(c2ccc(C(F)(F)F)c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(C)(N)CC4)n3)n2)C1		CHEMBL3952413	=	IC50	nM	21.0	CHEMBL3920	Homo sapiens	IC50	nM	21.0
438352	17798097	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1cnccc1N1CCCC(N)C1		CHEMBL3949162	=	IC50	nM	590.0	CHEMBL3920	Homo sapiens	IC50	nM	590.0
438353	17798098	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC(N)CC1		CHEMBL3895998	=	IC50	nM	0.33	CHEMBL3920	Homo sapiens	IC50	nM	0.33
438354	17798099	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1N1CCC(N)CC1		CHEMBL3943813	=	IC50	nM	0.25	CHEMBL3920	Homo sapiens	IC50	nM	0.25
438355	17798100	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1cnccc1N1CCC(N)CC1		CHEMBL3963605	=	IC50	nM	0.84	CHEMBL3920	Homo sapiens	IC50	nM	0.84
438356	17798101	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccc(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC(N)CC3)n2)cc1		CHEMBL3942619	=	IC50	nM	1.5	CHEMBL3920	Homo sapiens	IC50	nM	1.5
438357	17798102	CHEMBL3889159	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCNCC1		CHEMBL3957649	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
Inactive	17930835	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930836	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930837	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930838	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930839	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930840	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17930841	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	=	Kd	nM	6.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	6.0
Inactive	17930842	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930843	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930844	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930845	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930846	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930847	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930848	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930849	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17930850	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	90.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	90.0
Inactive	17930851	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930852	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930853	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930854	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930855	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930856	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930857	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930858	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930859	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930860	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930861	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930862	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930863	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930864	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930865	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930866	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930867	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930868	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930869	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930870	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930871	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930872	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930873	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930874	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930875	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17930876	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	711.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	711.0
Inactive	17930877	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930878	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930879	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930880	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930881	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930882	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930883	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930884	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930885	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930886	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930887	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930888	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930889	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930890	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930891	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930892	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930893	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930894	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930895	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930896	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930897	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930898	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930899	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930900	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930901	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930902	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930903	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930904	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930905	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930906	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930907	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930908	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930909	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930910	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930911	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930912	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930913	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930914	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930915	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930916	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930917	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930918	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930919	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930920	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930921	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930922	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930923	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930924	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930925	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930926	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930927	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930928	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930929	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930930	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930931	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930932	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930933	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930934	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930935	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930936	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930937	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930938	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930939	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17930940	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	1.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	1.0
Inactive	17930941	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930942	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930943	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930944	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930945	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930946	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17930947	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	85.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	85.0
Inactive	17930948	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930949	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930950	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930951	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930952	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930953	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930954	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930955	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930956	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930957	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930958	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930959	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930960	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930961	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930962	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930963	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930964	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930965	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930966	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930967	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17930968	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	1984.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	1984.0
Inactive	17930969	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930970	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930971	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930972	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930973	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930974	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930975	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930976	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930977	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930978	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930979	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930980	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930981	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930982	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930983	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930984	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930985	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930986	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930987	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930988	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17930989	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	4246.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	4246.0
Inactive	17930990	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17930991	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	13.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	13.0
Inactive	17930992	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930993	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930994	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930995	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930996	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930997	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930998	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17930999	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931000	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931001	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931002	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931003	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931004	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931005	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17931006	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	3063.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	3063.0
Inactive	17931007	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931008	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931009	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931010	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931011	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931012	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931013	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931014	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931015	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931016	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931017	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931018	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931019	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931020	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931021	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931022	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931023	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931024	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931025	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931026	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931027	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931028	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931029	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931030	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931031	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931032	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931033	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931034	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931035	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931036	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931037	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931038	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931039	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17931040	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	10.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	10.0
Inactive	17931041	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931042	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931043	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931044	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931045	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931046	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Active	17931047	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	2341.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	2341.0
Inactive	17931048	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931049	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931050	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931051	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931052	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17931053	CHEMBL3991847	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3920	Homo sapiens	Kd apparent	nM	30000.0
	18014676	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3cccc4ccc(CN)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4083182	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014677	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	NCc1ccc2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4061321	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014678	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3cccc4cc(CN)ccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4072709	=	IC50	nM	276.0	CHEMBL3920	Homo sapiens	IC50	nM	276.0
	18014679	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cc1ccc2ccc(CN)cc2c1C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL4099609	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014680	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cc1ccc2ccc(CN)cc2c1C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O		CHEMBL4078759	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014681	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3c(Cl)ccc4ccc(CN)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4089665	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014682	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	=	IC50	nM	263.0	CHEMBL3920	Homo sapiens	IC50	nM	263.0
	18014683	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4102228	=	IC50	nM	216.0	CHEMBL3920	Homo sapiens	IC50	nM	216.0
	18014684	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4085837	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	18014685	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4064291	=	IC50	nM	19.0	CHEMBL3920	Homo sapiens	IC50	nM	19.0
	18014686	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	1.0	CHEMBL3920	Homo sapiens	IC50	nM	1.0
	18014687	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CNCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4072879	=	IC50	nM	21.0	CHEMBL3920	Homo sapiens	IC50	nM	21.0
	18014688	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	COCCNCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4101316	=	IC50	nM	21.0	CHEMBL3920	Homo sapiens	IC50	nM	21.0
	18014689	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CC(C)NCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4083319	=	IC50	nM	101.0	CHEMBL3920	Homo sapiens	IC50	nM	101.0
	18014690	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3c(Cl)ccc4ccc(CN5CCC5)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4089217	=	IC50	nM	254.0	CHEMBL3920	Homo sapiens	IC50	nM	254.0
	18014691	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN1CCN(Cc2ccc3ccc(Cl)c(C4=C(c5cn(C)c6ccccc56)C(=O)NC4=O)c3c2)CC1		CHEMBL4068028	=	IC50	nM	314.0	CHEMBL3920	Homo sapiens	IC50	nM	314.0
	18014692	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CC(=O)N(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4100747	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014693	CHEMBL4004544	Inhibition of PKCtheta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1)C1CC1		CHEMBL4073977	>	IC50	nM	316.0	CHEMBL3920	Homo sapiens	IC50	nM	316.0
	18014706	CHEMBL4004557	Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	=	IC50	nM	402.0	CHEMBL3920	Homo sapiens	IC50	nM	402.0
	18014707	CHEMBL4004557	Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4102228	=	IC50	nM	708.0	CHEMBL3920	Homo sapiens	IC50	nM	708.0
	18014708	CHEMBL4004557	Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay	B	CN(C)Cc1ccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4085837	=	IC50	nM	156.0	CHEMBL3920	Homo sapiens	IC50	nM	156.0
	18014709	CHEMBL4004557	Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay	B	CN(C)Cc1ccc2c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4064291	=	IC50	nM	185.0	CHEMBL3920	Homo sapiens	IC50	nM	185.0
	18014710	CHEMBL4004557	Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	81.0	CHEMBL3920	Homo sapiens	IC50	nM	81.0
	18014711	CHEMBL4004557	Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay	B	CN(Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1)C1CC1		CHEMBL4073977	>	IC50	nM	3555.0	CHEMBL3920	Homo sapiens	IC50	nM	3555.0
	18031834	CHEMBL4007737	Inhibition of PKCtheta (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	7510.0	CHEMBL3920	Homo sapiens	IC50	uM	7.51
	18031835	CHEMBL4007737	Inhibition of PKCtheta (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	18031836	CHEMBL4007737	Inhibition of PKCtheta (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	18031837	CHEMBL4007737	Inhibition of PKCtheta (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	18031838	CHEMBL4007737	Inhibition of PKCtheta (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	18082875	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	N#Cc1ccc(N2CCNCC2c2ccccc2)nc1-n1c(=O)[nH]c2ncccc21		CHEMBL4100381	=	IC50	nM	6.3	CHEMBL3920	Homo sapiens	IC50	nM	6.3
	18082876	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	CCOc1ccnc2[nH]c(=O)n(-c3nc(N4CCCNCC4)ccc3Cl)c12		CHEMBL4082370	=	IC50	nM	0.086	CHEMBL3920	Homo sapiens	IC50	nM	0.086
	18082877	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	CN1CCCCOc2ccnc3[nH]c(=O)n(c23)-c2nc1ccc2Cl		CHEMBL4092652	=	IC50	nM	0.87	CHEMBL3920	Homo sapiens	IC50	nM	0.87
	18082878	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	O=c1[nH]c2ncccc2n1-c1nc(N2CCCNCC2)ccc1F		CHEMBL4071874	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	18082879	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	O=c1[nH]c2ncccc2n1-c1nc(N2CCCC(C(O)C3CC3)C2)ccc1F		CHEMBL4084895	>	IC50	nM	1000.0	CHEMBL3920	Homo sapiens	IC50	nM	1000.0
	18082880	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	CC(C)CC1CCCN1c1ccc(F)c(-n2c(=O)[nH]c3ncccc32)n1		CHEMBL4063243	=	IC50	nM	250.0	CHEMBL3920	Homo sapiens	IC50	nM	250.0
	18082881	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	O=c1[nH]c2ncccc2n1-c1nc(N2CCCNCC2)ccc1Cl		CHEMBL4074629	=	IC50	nM	18.0	CHEMBL3920	Homo sapiens	IC50	nM	18.0
	18082882	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	COc1ccnc2[nH]c(=O)n(-c3nc(N4CCNC(c5ccccc5)C4)ccc3Cl)c12		CHEMBL4101327	=	IC50	nM	33.0	CHEMBL3920	Homo sapiens	IC50	nM	33.0
	18082883	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	CC(C)(C)OC(=O)N1CCN(c2ccc([N+](=O)[O-])c(-n3c(=O)[nH]c4ncccc43)n2)C(c2ccccc2)C1		CHEMBL4065996	=	IC50	nM	0.18	CHEMBL3920	Homo sapiens	IC50	nM	0.18
	18082884	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	CN1CCCOc2ccnc3[nH]c(=O)n(c23)-c2nc1ccc2Cl		CHEMBL4093591	=	IC50	nM	6.7	CHEMBL3920	Homo sapiens	IC50	nM	6.7
	18082885	CHEMBL4017958	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system using fluorescein-PKC as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of ATP by Lathascreen TR-FRET assay	B	O=c1[nH]c2nccc3c2n1-c1nc(ccc1Cl)OCCCCO3		CHEMBL4099368	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	18114812	CHEMBL4025342	Inhibition of wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	91.0	CHEMBL3920	Homo sapiens	Activity	%	91.0
	18134480	CHEMBL4029526	Inhibition of PKCtheta (unknown origin) at 1 uM using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819	=	Inhibition	%	2.0	CHEMBL3920	Homo sapiens	INH	%	2.0
	18134507	CHEMBL4029526	Inhibition of PKCtheta (unknown origin) at 1 uM using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469	=	Inhibition	%	77.0	CHEMBL3920	Homo sapiens	INH	%	77.0
Active	18194829	CHEMBL4042061	Induction of PKC-theta translocation from cytosol to plasma membrane in human platelet at 0.1 uM measured after 1 min by Western blot analysis	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115		Activity			CHEMBL3920	Homo sapiens	Activity		
Active	18194830	CHEMBL4042062	Induction of PKC-theta translocation from cytosol to plasma membrane in human platelet at 1 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL1863513		Activity			CHEMBL3920	Homo sapiens	Activity		
Active	18194831	CHEMBL4042063	Induction of PKC-theta translocation from cytosol to plasma membrane in human platelet at 10 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)OC[C@]1(C)[C@H]2[C@@H]3C=C(COC(C)=O)C[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]3(O)[C@H](C)C[C@]21OCC(C)C		CHEMBL4104319		Activity			CHEMBL3920	Homo sapiens	Activity		
Active	18194832	CHEMBL4042063	Induction of PKC-theta translocation from cytosol to plasma membrane in human platelet at 10 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(C)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL4071723		Activity			CHEMBL3920	Homo sapiens	Activity		
Active	18194833	CHEMBL4042063	Induction of PKC-theta translocation from cytosol to plasma membrane in human platelet at 10 uM measured after 1 min by Western blot analysis	B	CC(=O)O[C@@]12C[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@H]43)[C@@H]1C2(C)C		CHEMBL170518		Activity			CHEMBL3920	Homo sapiens	Activity		
	18203866	CHEMBL4044153	Inhibition of wild-type human partial length PRKCQ (L350 to S706 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3920	Homo sapiens	Activity	%	100.0
	18253281	CHEMBL4054924	Inhibition of wild-type human partial length PKCT (L350 to S706 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	38.0	CHEMBL3920	Homo sapiens	Activity	%	38.0
	18253282	CHEMBL4054924	Inhibition of wild-type human partial length PKCT (L350 to S706 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	74.0	CHEMBL3920	Homo sapiens	Activity	%	74.0
	18265751	CHEMBL4057201	Inhibition of PKC-theta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	3.0	CHEMBL3920	Homo sapiens	INH	%	3.0
	18265987	CHEMBL4057437	Inhibition of PKC-theta (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	6.0	CHEMBL3920	Homo sapiens	INH	%	6.0
	18282220	CHEMBL4120175	Inhibition of PKCtheta (unknown origin) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	9.3	CHEMBL3920	Homo sapiens	INH	%	9.3
	18282539	CHEMBL4120175	Inhibition of PKCtheta (unknown origin) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	0.3	CHEMBL3920	Homo sapiens	INH	%	0.3
	18282745	CHEMBL4120330	Inhibition of PKC-theta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	3.0	CHEMBL3920	Homo sapiens	INH	%	3.0
	18282972	CHEMBL4120557	Inhibition of PKC-theta (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.7	CHEMBL3920	Homo sapiens	INH	%	1.7
	18283141	CHEMBL4120726	Inhibition of PKC-theta (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	7.0	CHEMBL3920	Homo sapiens	INH	%	7.0
	18434147	CHEMBL4156129	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	-7.0	CHEMBL3920	Homo sapiens	INH	%	-7.0
	18434197	CHEMBL4156129	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	6.0	CHEMBL3920	Homo sapiens	INH	%	6.0
	18434257	CHEMBL4156129	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	8.0	CHEMBL3920	Homo sapiens	INH	%	8.0
	18434329	CHEMBL4156129	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	-2.0	CHEMBL3920	Homo sapiens	INH	%	-2.0
	18440408	CHEMBL4157232	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	86.0	CHEMBL3920	Homo sapiens	Activity	%	86.0
	18463793	CHEMBL4181209	Inhibition of recombinant human full length PKCtheta expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-3.0	CHEMBL3920	Homo sapiens	INH	%	-3.0
	18484364	CHEMBL4186011	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL3920	Homo sapiens	Activity	%	96.0
	18484848	CHEMBL4186011	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL3920	Homo sapiens	Activity	%	99.0
	18507646	CHEMBL4191145	Inhibition of recombinant full-length human PKCtheta at 1 uM using histone H1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	5.0	CHEMBL3920	Homo sapiens	INH	%	5.0
	18653419	CHEMBL4230194	Inhibition of PKC-theta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	0.0	CHEMBL3920	Homo sapiens	INH	%	0.0
	18653420	CHEMBL4230194	Inhibition of PKC-theta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-2.0	CHEMBL3920	Homo sapiens	INH	%	-2.0
	18655324	CHEMBL4230911	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	83.0	CHEMBL3920	Homo sapiens	Activity	%	83.0
	18665470	CHEMBL4233389	Inhibition of PKCtheta (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	18665513	CHEMBL4233389	Inhibition of PKCtheta (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	nM	10000.0
	18674849	CHEMBL4235418	Inhibition of PKCtheta (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	=	Ki	nM	290.0	CHEMBL3920	Homo sapiens	Ki	nM	290.0
Not Determined	18674850	CHEMBL4235418	Inhibition of PKCtheta (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL3920	Homo sapiens	Ki		
	18674939	CHEMBL4235450	Inhibition of PKCtheta (unknown origin) at 2 uM relative to control	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	=	Inhibition	%	75.0	CHEMBL3920	Homo sapiens	INH	%	75.0
Not Active	18723840	CHEMBL4258710	Inhibition of human PKCtheta using histone H1 as substrate at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis	B	CCOc1c(S(=O)(=O)NC2CC(C)(C)NC(C)(C)C2)ccc(Cl)c1Cl		CHEMBL1502722		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
Not Active	18726762	CHEMBL4259286	Inhibition of PKCtheta (unknown origin) at 10 uM	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O		CHEMBL4283413		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	18751207	CHEMBL4263916	Inhibition of PKC-THETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL3920	Homo sapiens	INH	%	1.0
	18752163	CHEMBL4264500	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3920	Homo sapiens	Activity	%	100.0
	18761568	CHEMBL4266619	Inhibition of human PKCtheta at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	42.0	CHEMBL3920	Homo sapiens	INH	%	42.0
	18761839	CHEMBL4266619	Inhibition of human PKCtheta at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	10.0	CHEMBL3920	Homo sapiens	INH	%	10.0
	18762002	CHEMBL4266619	Inhibition of human PKCtheta at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-3.0	CHEMBL3920	Homo sapiens	INH	%	-3.0
	18811752	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4283768	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
	18811753	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2C2CC2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4294341	=	IC50	nM	2.7	CHEMBL3920	Homo sapiens	IC50	nM	2.7
	18811754	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4287122	=	IC50	nM	5.2	CHEMBL3920	Homo sapiens	IC50	nM	5.2
	18811755	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	CCOc1ccccc1CNc1ncc(C#N)c(NC[C@@]23C[C@H]4C[C@@H](C2)[C@H](N)[C@H](C4)C3)n1		CHEMBL4279198	=	IC50	nM	5.4	CHEMBL3920	Homo sapiens	IC50	nM	5.4
	18811756	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	Cc1ccccc1CNc1ncc(C#N)c(NC[C@@]23C[C@H]4C[C@@H](C2)[C@H](N)[C@H](C4)C3)n1		CHEMBL4290543	=	IC50	nM	6.4	CHEMBL3920	Homo sapiens	IC50	nM	6.4
	18811757	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccc(Cl)cc2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4282664	=	IC50	nM	60.0	CHEMBL3920	Homo sapiens	IC50	nM	60.0
	18811758	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2cccc(Cl)c2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4293947	=	IC50	nM	33.0	CHEMBL3920	Homo sapiens	IC50	nM	33.0
	18811759	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2Cl)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4286045	=	IC50	nM	5.4	CHEMBL3920	Homo sapiens	IC50	nM	5.4
	18811760	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2Br)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4281351	=	IC50	nM	5.9	CHEMBL3920	Homo sapiens	IC50	nM	5.9
	18811761	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4289223	=	IC50	nM	39.0	CHEMBL3920	Homo sapiens	IC50	nM	39.0
	18811762	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCC2CCCCC2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4282831	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	nM	130.0
	18811763	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NC2CCCCC2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4290718	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	18811764	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2ccccc2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4279376	=	IC50	nM	28.0	CHEMBL3920	Homo sapiens	IC50	nM	28.0
	18811765	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2cccc(Br)c2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4287302	=	IC50	nM	3.9	CHEMBL3920	Homo sapiens	IC50	nM	3.9
	18811766	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2cccc(Br)c2)nc1NCC1CCNCC1		CHEMBL4280341	=	IC50	nM	36.0	CHEMBL3920	Homo sapiens	IC50	nM	36.0
	18811767	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2cccc(Br)c2)nc1NCC[C@H]1CC[C@H](N)CC1		CHEMBL4278969	=	IC50	nM	51.0	CHEMBL3920	Homo sapiens	IC50	nM	51.0
	18811768	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2cccc(Br)c2)nc1NC[C@H]1CC[C@H](CN)CC1		CHEMBL4286223	=	IC50	nM	14.0	CHEMBL3920	Homo sapiens	IC50	nM	14.0
	18811769	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2cccc(Br)c2)nc1NC[C@H]1CC[C@H](N)CC1		CHEMBL4294119	=	IC50	nM	4.6	CHEMBL3920	Homo sapiens	IC50	nM	4.6
	18811770	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(Nc2cccc(Br)c2)cc1NC[C@H]1CC[C@H](N)CC1		CHEMBL4290595	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	nM	130.0
	18811771	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1nc(C(N)=O)c(Nc2cccc(Br)c2)nc1NC[C@H]1CC[C@H](N)CC1		CHEMBL4280300	=	IC50	nM	24.0	CHEMBL3920	Homo sapiens	IC50	nM	24.0
	18811772	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCC(=O)O)[C@H](C3)C2		CHEMBL4281174	=	IC50	nM	3.1	CHEMBL3920	Homo sapiens	IC50	nM	3.1
	18811773	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCC(N)=O)[C@H](C3)C2		CHEMBL4289064	=	IC50	nM	1.9	CHEMBL3920	Homo sapiens	IC50	nM	1.9
	18811774	CHEMBL4276090	Inhibition of recombinant full-length human PKCtheta using STK1-biotin as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins in presence of ATP by fluorescence analysis	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCCO)[C@H](C3)C2		CHEMBL4289707	=	IC50	nM	0.7	CHEMBL3920	Homo sapiens	IC50	nM	0.7
	18811775	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(Nc2cccc(Br)c2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4287302	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	18811776	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(Nc2ccccc2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4279376	=	IC50	nM	660.0	CHEMBL3920	Homo sapiens	IC50	nM	660.0
Not Determined	18811777	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NC2CCCCC2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4290718		IC50			CHEMBL3920	Homo sapiens	IC50		
Not Determined	18811778	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCC2CCCCC2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4282831		IC50			CHEMBL3920	Homo sapiens	IC50		
Not Determined	18811779	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCc2ccccc2)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4289223		IC50			CHEMBL3920	Homo sapiens	IC50		
	18811780	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCc2ccccc2Br)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4281351	=	IC50	nM	31.0	CHEMBL3920	Homo sapiens	IC50	nM	31.0
	18811781	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](N)[C@H](C3)C2		CHEMBL4283768	=	IC50	nM	22.0	CHEMBL3920	Homo sapiens	IC50	nM	22.0
Not Determined	18811782	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCC(=O)O)[C@H](C3)C2		CHEMBL4281174		IC50			CHEMBL3920	Homo sapiens	IC50		
	18811783	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCC(N)=O)[C@H](C3)C2		CHEMBL4289064	=	IC50	nM	41.0	CHEMBL3920	Homo sapiens	IC50	nM	41.0
	18811784	CHEMBL4276091	Inhibition of PKCtheta in human Jurkat cells transfected with pGL3-IL2 pro 43 plasmid assessed as suppression of IL-2 production after 14 hrs by firefly luciferase assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCCO)[C@H](C3)C2		CHEMBL4289707	=	IC50	nM	6.3	CHEMBL3920	Homo sapiens	IC50	nM	6.3
	18858163	CHEMBL4308009	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL3920	Homo sapiens	Activity	%	100.0
Not Active	18883533	CHEMBL4312758	Activity at human PKCtheta at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL3920	Homo sapiens	Activity		
	18892695	CHEMBL4314554	Inhibition of recombinant full-length human PKCtheta assessed as residual activity at 10 uM using histone H1as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	103.0	CHEMBL3920	Homo sapiens	Activity	%	103.0
	18919532	CHEMBL4322888	Binding affinity to recombinant full-length N-terminal His-GST-tagged PRKCQ (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	28.0	CHEMBL3920	Homo sapiens	Kd	nM	28.0
	18919720	CHEMBL4322888	Binding affinity to recombinant full-length N-terminal His-GST-tagged PRKCQ (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	19.0	CHEMBL3920	Homo sapiens	Kd	nM	19.0
	18938233	CHEMBL4327843	Inhibition of human PKCtheta assessed as residual activity at 1 uM using Histone H1 as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	111.16	CHEMBL3920	Homo sapiens	Activity	%	111.16
	18938234	CHEMBL4327843	Inhibition of human PKCtheta assessed as residual activity at 1 uM using Histone H1 as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	109.64	CHEMBL3920	Homo sapiens	Activity	%	109.64
	18938688	CHEMBL4328207	Inhibition of human PKCtheta assessed as residual activity at 100 uM using Histone H1 as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3920	Homo sapiens	Activity	%	65.0
	18939072	CHEMBL4328571	Inhibition of human PKCtheta using Histone H1 as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.44	CHEMBL3920	Homo sapiens	IC50	10'-9M	1.44
	18958597	CHEMBL4333594	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	57.0	CHEMBL3920	Homo sapiens	Activity	%	57.0
	18964610	CHEMBL4335246	Inhibition of recombinant full length human PKCtheta assessed as residual activity at 1 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	101.0	CHEMBL3920	Homo sapiens	Activity	%	101.0
	18964611	CHEMBL4335246	Inhibition of recombinant full length human PKCtheta assessed as residual activity at 1 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	96.0	CHEMBL3920	Homo sapiens	Activity	%	96.0
	18972059	CHEMBL4337069	Inhibition of recombinant full length human PKCtheta assessed as residual activity at 10 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	70.0	CHEMBL3920	Homo sapiens	Activity	%	70.0
	19030024	CHEMBL4349163	Inhibition of recombinant full length human His-tagged PRKCQ expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	89.0	CHEMBL3920	Homo sapiens	Activity	%	89.0
	19032208	CHEMBL4349801	Inhibition of recombinant human full length N-terminal GST and C-terminal His6-tagged PKC-theta (M1 to S706) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-2.0	CHEMBL3920	Homo sapiens	INH	%	-2.0
Not Active	19040114	CHEMBL4352017	Inhibition of recombinant full-length human PKCtheta at 10 uM using histone H1as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
Active	19041249	CHEMBL4352510	Inhibition of human PKCtheta at 10 uM using Histone H1 as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	19059788	CHEMBL4358089	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	86.0	CHEMBL3920	Homo sapiens	Activity	%	86.0
	19090352	CHEMBL4365926	Inhibition of wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	94.0	CHEMBL3920	Homo sapiens	Activity	%	94.0
	19092081	CHEMBL4366555	Inhibition of human PKCtheta at 100 nM using Histone H1 as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	0.73	CHEMBL3920	Homo sapiens	INH	%	0.73
	19111189	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(NCCO)C(C3)C2		CHEMBL4526554	=	IC50	nM	0.7	CHEMBL3920	Homo sapiens	IC50	nM	0.7
	19111190	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CC(C)NC1C2CC3CC1CC(CNc1nc(NCc4ccccc4OC(F)(F)F)ncc1C#N)(C3)C2		CHEMBL4455647	<	IC50	nM	1.0	CHEMBL3920	Homo sapiens	IC50	nM	1.0
	19111191	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(NC1CCCCC1)C(C3)C2		CHEMBL4585918	=	IC50	nM	1.9	CHEMBL3920	Homo sapiens	IC50	nM	1.9
	19111192	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(NC1CCOCC1)C(C3)C2		CHEMBL4545726	<	IC50	nM	1.0	CHEMBL3920	Homo sapiens	IC50	nM	1.0
	19111193	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(N[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4540382	=	IC50	nM	0.38	CHEMBL3920	Homo sapiens	IC50	nM	0.38
	19111194	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(N[C@H]1CC[C@@H](O)CC1)C(C3)C2		CHEMBL4529215	=	IC50	nM	0.66	CHEMBL3920	Homo sapiens	IC50	nM	0.66
	19111195	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(N[C@H]1CC[C@H](N)CC1)C(C3)C2		CHEMBL4578497	=	IC50	nM	0.1	CHEMBL3920	Homo sapiens	IC50	nM	0.1
	19111196	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(NC[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4580751	=	IC50	nM	0.42	CHEMBL3920	Homo sapiens	IC50	nM	0.42
	19111197	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)nc1NCC12CC3CC(C1)C(NC[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4594002	=	IC50	nM	0.57	CHEMBL3920	Homo sapiens	IC50	nM	0.57
	19111198	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	N#Cc1cnc(NCc2ccccc2Cl)nc1NCC12CC3CC(C1)C(NC[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4464921	=	IC50	nM	1.4	CHEMBL3920	Homo sapiens	IC50	nM	1.4
	19111199	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CSc1ccccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4466775	=	IC50	nM	0.94	CHEMBL3920	Homo sapiens	IC50	nM	0.94
	19111200	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CSc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4575526	=	IC50	nM	0.44	CHEMBL3920	Homo sapiens	IC50	nM	0.44
	19111201	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	COc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4441229	=	IC50	nM	1.9	CHEMBL3920	Homo sapiens	IC50	nM	1.9
	19111202	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	C[S+]([O-])c1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4592349	=	IC50	nM	32.0	CHEMBL3920	Homo sapiens	IC50	nM	32.0
Not Determined	19111203	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CS(=O)(=O)c1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4583637		IC50			CHEMBL3920	Homo sapiens	IC50		
	19111204	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CCSc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4524977	=	IC50	nM	0.46	CHEMBL3920	Homo sapiens	IC50	nM	0.46
	19111205	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CC(C)Sc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4547465	=	IC50	nM	0.23	CHEMBL3920	Homo sapiens	IC50	nM	0.23
	19111206	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	CC(C)Oc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4439095	=	IC50	nM	0.59	CHEMBL3920	Homo sapiens	IC50	nM	0.59
	19111207	CHEMBL4370498	Inhibition of recombinant human full length PKCtheta using biotin-labelled STK substrate-1 as substrate after 60 mins by fluorescence assay	B	COc1nnccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4447795	>	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	19111239	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NCC12CC3CC(C1)C(NC[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4580751	=	IC50	nM	11.0	CHEMBL3920	Homo sapiens	IC50	nM	11.0
	19111240	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)nc1NCC12CC3CC(C1)C(NC[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4594002	=	IC50	nM	17.0	CHEMBL3920	Homo sapiens	IC50	nM	17.0
	19111241	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	N#Cc1cnc(NCc2ccccc2Cl)nc1NCC12CC3CC(C1)C(NC[C@H]1CC[C@H](O)CC1)C(C3)C2		CHEMBL4464921	=	IC50	nM	22.0	CHEMBL3920	Homo sapiens	IC50	nM	22.0
	19111242	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	CSc1ccccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4466775	=	IC50	nM	16.0	CHEMBL3920	Homo sapiens	IC50	nM	16.0
	19111243	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	CSc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4575526	=	IC50	nM	10.0	CHEMBL3920	Homo sapiens	IC50	nM	10.0
	19111244	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	COc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4441229	=	IC50	nM	43.0	CHEMBL3920	Homo sapiens	IC50	nM	43.0
	19111245	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	C[S+]([O-])c1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4592349	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	19111246	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	CS(=O)(=O)c1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4583637	=	IC50	nM	140.0	CHEMBL3920	Homo sapiens	IC50	nM	140.0
	19111247	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	CCSc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4524977	<	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	nM	3.0
	19111248	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	CC(C)Sc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4547465	=	IC50	nM	3.0	CHEMBL3920	Homo sapiens	IC50	nM	3.0
	19111249	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	CC(C)Oc1ncccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4439095	=	IC50	nM	18.0	CHEMBL3920	Homo sapiens	IC50	nM	18.0
Not Determined	19111250	CHEMBL4370501	Inhibition of PKCtheta in human Jurkat cells assessed as reduction in IL2 production after 14 hrs by luciferase reporter gene assay	B	COc1nnccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC[C@H]2CC[C@H](O)CC2)C(C4)C3)n1		CHEMBL4447795		IC50			CHEMBL3920	Homo sapiens	IC50		
	19144806	CHEMBL4377822	Inhibition of recombinant full-length human PKCtheta at 1 uM using histone H1as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	47.0	CHEMBL3920	Homo sapiens	INH	%	47.0
	19148003	CHEMBL4379227	Inhibition of recombinant full length human PKCtheta using histone H1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3920	Homo sapiens	IC50	uM	10.0
	19159616	CHEMBL4382720	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	48.0	CHEMBL3920	Homo sapiens	Activity	%	48.0
	19181119	CHEMBL4387330	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	21.5	CHEMBL3920	Homo sapiens	INH	%	21.5
	19181344	CHEMBL4387330	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	20.5	CHEMBL3920	Homo sapiens	INH	%	20.5
	19191391	CHEMBL4389439	Inhibition of wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL3920	Homo sapiens	INH	%	100.0
	19192102	CHEMBL4389916	Inhibition of wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	95.0	CHEMBL3920	Homo sapiens	INH	%	95.0
	19200358	CHEMBL4391542	Binding affinity to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	27.0	CHEMBL3920	Homo sapiens	Activity	%	27.0
	19230859	CHEMBL4397162	Inhibition of N-terminal FLAG-tagged PKCtheta (unknown origin) expressed in baculovirus expression system at 100 nM using pGS peptide as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 30 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	2.0	CHEMBL3920	Homo sapiens	INH	%	2.0
	19240629	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ccc23)n1		CHEMBL4453941	=	Ki	nM	3.0	CHEMBL3920	Homo sapiens	Ki	nM	3.0
	19240630	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ncc23)n1		CHEMBL4539521	=	Ki	nM	14.0	CHEMBL3920	Homo sapiens	Ki	nM	14.0
	19240631	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ncc23)c1		CHEMBL4559701	=	Ki	nM	28.0	CHEMBL3920	Homo sapiens	Ki	nM	28.0
	19240632	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCC(C)(C#N)c1cccc(-c2ccnc3[nH]ncc23)c1		CHEMBL4447253	=	Ki	nM	72.0	CHEMBL3920	Homo sapiens	Ki	nM	72.0
	19240633	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CC(C)(CN)c1cccc(-c2ccnc3[nH]ncc23)c1		CHEMBL4541215	=	Ki	nM	12.0	CHEMBL3920	Homo sapiens	Ki	nM	12.0
	19240634	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCC(C)(CN)c1cccc(-c2ccnc3[nH]ncc23)c1		CHEMBL4461370	=	Ki	nM	3.0	CHEMBL3920	Homo sapiens	Ki	nM	3.0
	19240635	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	C#CCC(C)(CN)c1cccc(-c2ccnc3[nH]ncc23)c1		CHEMBL4469412	=	Ki	nM	0.2	CHEMBL3920	Homo sapiens	Ki	nM	0.2
	19240636	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]ncc34)c2)CCC1		CHEMBL4566843	=	Ki	nM	17.0	CHEMBL3920	Homo sapiens	Ki	nM	17.0
	19240637	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]ncc34)c2)CCCC1		CHEMBL4584166	=	Ki	nM	22.0	CHEMBL3920	Homo sapiens	Ki	nM	22.0
	19240638	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]ncc34)c2)CCCCC1		CHEMBL4444700	=	Ki	nM	30.0	CHEMBL3920	Homo sapiens	Ki	nM	30.0
	19240639	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]ncc34)c2)CCOCC1		CHEMBL4435004	=	Ki	nM	9.0	CHEMBL3920	Homo sapiens	Ki	nM	9.0
	19240640	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCC(C)(CN)c1cc(C)cc(-c2ccnc3[nH]ncc23)c1		CHEMBL4522851	=	Ki	nM	5.0	CHEMBL3920	Homo sapiens	Ki	nM	5.0
	19240641	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCc1cc(-c2ccnc3[nH]ncc23)cc(C(C)(CC)CN)c1		CHEMBL4567363	=	Ki	nM	14.0	CHEMBL3920	Homo sapiens	Ki	nM	14.0
	19240642	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCCc1cc(-c2ccnc3[nH]ncc23)cc(C(C)(CC)CN)c1		CHEMBL4454086	=	Ki	nM	32.0	CHEMBL3920	Homo sapiens	Ki	nM	32.0
	19240643	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCC(C)(CN)c1cccc(-c2ccnc3[nH]nc(C)c23)c1		CHEMBL4532737	<	Ki	nM	1.0	CHEMBL3920	Homo sapiens	Ki	nM	1.0
	19240644	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCC(C)(CN)c1cccc(-c2ccnc3[nH]nc(Cl)c23)c1		CHEMBL4528271	=	Ki	nM	0.3	CHEMBL3920	Homo sapiens	Ki	nM	0.3
	19240645	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	CCC(C)(CN)c1cccc(-c2ccnc3[nH]nc(C(F)(F)F)c23)c1		CHEMBL4569479	=	Ki	nM	0.4	CHEMBL3920	Homo sapiens	Ki	nM	0.4
	19240646	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	Cc1cc(-c2ccnc3[nH]nc(C(F)(F)F)c23)cc(C2(CN)CCC2)c1		CHEMBL4590477	=	Ki	nM	3.0	CHEMBL3920	Homo sapiens	Ki	nM	3.0
	19240647	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCC1		CHEMBL4589844	=	Ki	nM	2.0	CHEMBL3920	Homo sapiens	Ki	nM	2.0
	19240648	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCOCC1		CHEMBL4457150	=	Ki	nM	9.0	CHEMBL3920	Homo sapiens	Ki	nM	9.0
	19240649	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	Cc1cc(-c2ccnc3[nH]nc(C(F)(F)F)c23)cc(C2(CN)COC2)c1		CHEMBL4587816	=	Ki	nM	8.0	CHEMBL3920	Homo sapiens	Ki	nM	8.0
	19240650	CHEMBL4399584	Inhibition of human recombinant full length His tagged PKC theta expressed in baculovirus using ERMRPRKRQGSVRRRV peptide as substrate incubated for 60 mins in presence of [33P] gammaATP by microbeta liquid scintillation counter	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)COC1		CHEMBL4461649	=	Ki	nM	6.0	CHEMBL3920	Homo sapiens	Ki	nM	6.0
	19242746	CHEMBL4400081	Inhibition of recombinant full length human PKCtheta assessed as residual activity at 10 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	87.0	CHEMBL3920	Homo sapiens	Activity	%	87.0
	19266576	CHEMBL4405526	Inhibition of wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	19276081	CHEMBL4408084	Inhibition of recombinant human full length PKCtheta at 1 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	40.0	CHEMBL3920	Homo sapiens	INH	%	40.0
	19312969	CHEMBL4416524	Inhibition of recombinant human C-terminal His6-tagged full length PKCtheta expressed in Sf21 insect cells at 10 uM using histone H1 as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
Active	19317098	CHEMBL4417292	Inhibition of PRKCQ (unknown origin) at 1000 nM relative to control	B	Cc1c(C(=O)Nc2ccc3ccccc3n2)cnn1-c1ccccc1Br		CHEMBL4555217		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	19476622	CHEMBL4479770	Inhibition of full-length recombinant human His-tagged PRKCQ expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	6600.0	CHEMBL3920	Homo sapiens	IC50	nM	6600.0
	19476722	CHEMBL4479770	Inhibition of full-length recombinant human His-tagged PRKCQ expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	>	IC50	nM	100000.0	CHEMBL3920	Homo sapiens	IC50	nM	100000.0
	19476822	CHEMBL4479770	Inhibition of full-length recombinant human His-tagged PRKCQ expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	270.0	CHEMBL3920	Homo sapiens	IC50	nM	270.0
	19476922	CHEMBL4479770	Inhibition of full-length recombinant human His-tagged PRKCQ expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	8700.0	CHEMBL3920	Homo sapiens	IC50	nM	8700.0
	20600646	CHEMBL4603598	Inhibition of recombinant full length human His-tagged PKCtheta expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3920	Homo sapiens	IC50	uM	100.0
	20601671	CHEMBL4603803	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system using Ser/Thr07 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	4.0	CHEMBL3920	Homo sapiens	INH	%	4.0
	20669060	CHEMBL4620303	Inhibition of biotinylated ligand binding to wild-type human partial length PRKCQ (L350 to S706 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cccc6cnccc56)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637601	>	Inhibition	%	80.0	CHEMBL3920	Homo sapiens	INH	%	80.0
	22392139	CHEMBL4667234	Inhibition of recombinant human His-tagged full length PKCtheta expressed in baculovirus expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.0	CHEMBL3920	Homo sapiens	INH	%	2.0
	22417338	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COc1cc(/C=C(/C(N)=O)n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)ccc1O		CHEMBL4761909	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417339	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@H]1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4787374	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417340	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417341	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	O=C1NC(O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL127277	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417342	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4799894	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417343	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284524	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417344	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	O=C1NCc2c1c1c3cc(O)ccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4294912	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417345	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284275	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417346	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CN1Cc2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C1=O		CHEMBL4783165	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417347	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CNn1c2ccccc2c2c3c(c4c5ccccc5[nH]c4c21)C(=O)NC3		CHEMBL4750632	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417348	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL268368	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417349	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417350	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417351	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417352	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417353	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](N)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4754496	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417354	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](NC(C)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4758448	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417355	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CC(=O)N[C@H]1C[C@H]2O[C@@](C)([C@@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4277459	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417356	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CC(=O)N[C@H]1C[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4780192	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417357	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4216395	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417358	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6cc(O)ccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4279758	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417359	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CC(=O)N[C@@H]1C[C@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4287662	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417360	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4759925	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417361	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](N(C)C(C)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4764299	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417362	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](N(C)C(C)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4777775	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417363	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](N(C)C=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4744662	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417364	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](N(C)C(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4794799	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417365	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](NC=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4751814	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417366	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@H]1[C@@H](N2CC[C@@H](O)C2=O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4754636	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417367	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](NC(=O)C(=O)c2c[nH]c3ccccc23)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4759449	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417368	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4762704	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417369	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4757830	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417370	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@@H]1O[C@@]3(C)[C@H](OC)[C@@H](O)[C@H]1O		CHEMBL4798605	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417371	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@H]1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@@H]1O[C@@]3(C)[C@H](OC)[C@@H](O)[C@H]1O		CHEMBL4749940	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417372	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL4762666	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417373	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL4764914	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417374	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@@H](O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4763267	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417375	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4762923	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417376	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1/C(=N/O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4762628	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417377	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1C(=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4753069	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417378	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@H]1C(=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4793766	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417379	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@]12O[C@H](C[C@@H](O)[C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL4763012	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417380	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1O		CHEMBL4214897	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417381	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)C[C@@H](N)[C@H]1O		CHEMBL4757004	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417382	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1O		CHEMBL4288105	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417383	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1OC(O)C1CO1		CHEMBL4796257	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417384	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](NC=O)[C@H]1O		CHEMBL4741653	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417385	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)C[C@@H](NC=O)[C@H]1O		CHEMBL4753473	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417386	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4207068	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417387	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4740769	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417388	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@H]1NC(=O)c2c1c1c3ccccc3[nH]c1c1c2c2ccccc2n1[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O		CHEMBL4747501	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417389	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)[C@H](O)NC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4782148	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417390	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4745670	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417391	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1n1c2ccccc2c2c3c(c4c5ccccc5[nH]c4c21)CNC3=O		CHEMBL4794897	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417392	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4760895	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417393	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@H]1O[C@@H]2C[C@](O)([C@@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4790533	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417394	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4291517	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417395	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4280872	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417396	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC1=C(C)O[C@@H]2C[C@@]1(OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4784365	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417397	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CO[C@@H]1C(C)(O)O[C@@H]2C[C@@]1(OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4777074	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417398	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417399	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC(=O)[C@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL94678	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417400	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CN[C@]1(C(=O)OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4763650	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417401	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC(=O)[C@@]1(OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4745823	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417402	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC(=O)[C@H]1C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4758636	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417403	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@]12O[C@H](C[C@]1(O)C(=O)O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL4750633	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417404	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	C[C@]12O[C@H](C[C@]1(O)C(=O)O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4745928	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417405	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	COC(=O)c1cccc2c1NC1(C[C@H]3O[C@]1(C)n1c4ccccc4c4c5c(c6c7ccccc7n3c6c41)C(=O)NC5)C(=O)O2		CHEMBL4781676	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417406	CHEMBL4672562	Inhibition of PKCtheta (unknown origin) at 2.5 ug/ml by HTRF assay relative to control	B	CNC(=O)C[C@H]1O[C@@](C)(C(=O)OC)n2c3ccccc3c3c4c(c5c6ccccc6n1c5c32)C(=O)NC4		CHEMBL4744480	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22417407	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COc1cc(/C=C(/C(N)=O)n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)ccc1O		CHEMBL4761909	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417408	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@H]1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4787374	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417409	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417410	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	O=C1NC(O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL127277	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417411	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4799894	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417412	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284524	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417413	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3cc(O)ccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4294912	=	IC50	nM	2110.0	CHEMBL3920	Homo sapiens	IC50	uM	2.11
	22417414	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284275	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417415	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CN1Cc2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C1=O		CHEMBL4783165	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417416	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CNn1c2ccccc2c2c3c(c4c5ccccc5[nH]c4c21)C(=O)NC3		CHEMBL4750632	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417417	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL268368	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417418	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.0	CHEMBL3920	Homo sapiens	IC50	uM	0.005
	22417419	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	uM	0.006
	22417420	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675	=	IC50	nM	17.0	CHEMBL3920	Homo sapiens	IC50	uM	0.017
	22417421	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	uM	0.006
	22417422	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](N)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4754496	=	IC50	nM	36.0	CHEMBL3920	Homo sapiens	IC50	uM	0.036000000000000004
	22417423	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](NC(C)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4758448	=	IC50	nM	38.0	CHEMBL3920	Homo sapiens	IC50	uM	0.038
	22417424	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CC(=O)N[C@H]1C[C@H]2O[C@@](C)([C@@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4277459	=	IC50	nM	270.0	CHEMBL3920	Homo sapiens	IC50	uM	0.27
	22417425	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CC(=O)N[C@H]1C[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4780192	=	IC50	nM	1050.0	CHEMBL3920	Homo sapiens	IC50	uM	1.05
	22417426	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4216395	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417427	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6cc(O)ccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4279758	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417428	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4287662	=	IC50	nM	280.0	CHEMBL3920	Homo sapiens	IC50	uM	0.28
	22417429	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4759925	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417430	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](N(C)C(C)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4764299	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	uM	0.17
	22417431	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](N(C)C(C)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4777775	=	IC50	nM	50.0	CHEMBL3920	Homo sapiens	IC50	uM	0.05
	22417432	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](N(C)C=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4744662	=	IC50	nM	250.0	CHEMBL3920	Homo sapiens	IC50	uM	0.25
	22417433	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](N(C)C(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4794799	=	IC50	nM	400.0	CHEMBL3920	Homo sapiens	IC50	uM	0.4
	22417434	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](NC=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4751814	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417435	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@H]1[C@@H](N2CC[C@@H](O)C2=O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4754636	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	uM	0.17
	22417436	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](NC(=O)C(=O)c2c[nH]c3ccccc23)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4759449	=	IC50	nM	1790.0	CHEMBL3920	Homo sapiens	IC50	uM	1.79
	22417437	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4762704	=	IC50	nM	1010.0	CHEMBL3920	Homo sapiens	IC50	uM	1.01
	22417438	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4757830	=	IC50	nM	1420.0	CHEMBL3920	Homo sapiens	IC50	uM	1.42
	22417439	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@@H]1O[C@@]3(C)[C@H](OC)[C@@H](O)[C@H]1O		CHEMBL4798605	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417440	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@H]1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@@H]1O[C@@]3(C)[C@H](OC)[C@@H](O)[C@H]1O		CHEMBL4749940	=	IC50	nM	890.0	CHEMBL3920	Homo sapiens	IC50	uM	0.89
	22417441	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL4762666	=	IC50	nM	2250.0	CHEMBL3920	Homo sapiens	IC50	uM	2.25
	22417442	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL4764914	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417443	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@@H](O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4763267	=	IC50	nM	480.0	CHEMBL3920	Homo sapiens	IC50	uM	0.48
	22417444	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4762923	=	IC50	nM	1300.0	CHEMBL3920	Homo sapiens	IC50	uM	1.3
	22417445	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1/C(=N/O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4762628	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417446	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1C(=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4753069	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417447	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@H]1C(=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4793766	=	IC50	nM	560.0	CHEMBL3920	Homo sapiens	IC50	uM	0.56
	22417448	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@]12O[C@H](C[C@@H](O)[C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL4763012	=	IC50	nM	600.0	CHEMBL3920	Homo sapiens	IC50	uM	0.6
	22417449	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1O		CHEMBL4214897	=	IC50	nM	260.0	CHEMBL3920	Homo sapiens	IC50	uM	0.26
	22417450	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)C[C@@H](N)[C@H]1O		CHEMBL4757004	=	IC50	nM	1180.0	CHEMBL3920	Homo sapiens	IC50	uM	1.18
	22417451	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1O		CHEMBL4288105	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417452	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1OC(O)C1CO1		CHEMBL4796257	=	IC50	nM	5750.0	CHEMBL3920	Homo sapiens	IC50	uM	5.75
	22417453	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](NC=O)[C@H]1O		CHEMBL4741653	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417454	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)C[C@@H](NC=O)[C@H]1O		CHEMBL4753473	=	IC50	nM	4760.0	CHEMBL3920	Homo sapiens	IC50	uM	4.76
	22417455	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4207068	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417456	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4740769	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417457	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@H]1NC(=O)c2c1c1c3ccccc3[nH]c1c1c2c2ccccc2n1[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O		CHEMBL4747501	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417458	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)[C@H](O)NC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4782148	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417459	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL4745670	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417460	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1n1c2ccccc2c2c3c(c4c5ccccc5[nH]c4c21)CNC3=O		CHEMBL4794897	=	IC50	nM	9430.0	CHEMBL3920	Homo sapiens	IC50	uM	9.43
	22417461	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4760895	=	IC50	nM	1910.0	CHEMBL3920	Homo sapiens	IC50	uM	1.91
	22417462	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@H]1O[C@@H]2C[C@](O)([C@@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4790533	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417463	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4291517	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417464	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4280872	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417465	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC1=C(C)O[C@@H]2C[C@@]1(OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4784365	=	IC50	nM	370.0	CHEMBL3920	Homo sapiens	IC50	uM	0.37
	22417466	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CO[C@@H]1C(C)(O)O[C@@H]2C[C@@]1(OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4777074	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417467	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	IC50	nM	530.0	CHEMBL3920	Homo sapiens	IC50	uM	0.53
	22417468	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC(=O)[C@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL94678	=	IC50	nM	1090.0	CHEMBL3920	Homo sapiens	IC50	uM	1.09
	22417469	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CN[C@]1(C(=O)OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4763650	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417470	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC(=O)[C@@]1(OC)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4745823	=	IC50	nM	520.0	CHEMBL3920	Homo sapiens	IC50	uM	0.52
	22417471	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC(=O)[C@H]1C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4758636	=	IC50	nM	1680.0	CHEMBL3920	Homo sapiens	IC50	uM	1.68
	22417472	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@]12O[C@H](C[C@]1(O)C(=O)O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL4750633	=	IC50	nM	5590.0	CHEMBL3920	Homo sapiens	IC50	uM	5.59
	22417473	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	C[C@]12O[C@H](C[C@]1(O)C(=O)O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4745928	=	IC50	nM	1860.0	CHEMBL3920	Homo sapiens	IC50	uM	1.86
	22417474	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	COC(=O)c1cccc2c1NC1(C[C@H]3O[C@]1(C)n1c4ccccc4c4c5c(c6c7ccccc7n3c6c41)C(=O)NC5)C(=O)O2		CHEMBL4781676	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
	22417475	CHEMBL4672563	Inhibition of PKCtheta (unknown origin) by HTRF assay	B	CNC(=O)C[C@H]1O[C@@](C)(C(=O)OC)n2c3ccccc3c3c4c(c5c6ccccc6n1c5c32)C(=O)NC4		CHEMBL4744480	>	IC50	nM	2500.0	CHEMBL3920	Homo sapiens	IC50	uM	2.5
Active	22417509	CHEMBL4672589	Inhibition of PKCtheta phosphorylation at T538 residue in human BXPC-3 cells at 0.25 uM incubated for 4 hrs by Western blot analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675		Inhibition	%		CHEMBL3920	Homo sapiens	INH		
	22423311	CHEMBL4674231	Inhibition of human PKCtheta using Histone H1 as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	112.29	CHEMBL3920	Homo sapiens	Activity	%	112.29
	22423312	CHEMBL4674231	Inhibition of human PKCtheta using Histone H1 as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	111.94	CHEMBL3920	Homo sapiens	Activity	%	111.94
	22809795	CHEMBL4713330	Inhibition of recombinant full length human PKCtheta assessed as residual activity at 1 uM using histone H1 as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	68.0	CHEMBL3920	Homo sapiens	Activity	%	68.0
	22818124	CHEMBL4715347	Inhibition of recombinant human full-length C-terminal His6-tagged PKCtheta expressed in Sf21 insect cells at 2 uM using Histone H1 as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22836384	CHEMBL4718886	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-4.0	CHEMBL3920	Homo sapiens	INH	%	-4.0
	22836385	CHEMBL4718886	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	5.0	CHEMBL3920	Homo sapiens	INH	%	5.0
	22836386	CHEMBL4718886	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	1.0	CHEMBL3920	Homo sapiens	INH	%	1.0
	22836387	CHEMBL4718886	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	2.0	CHEMBL3920	Homo sapiens	INH	%	2.0
	22836388	CHEMBL4718886	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	5.0	CHEMBL3920	Homo sapiens	INH	%	5.0
	22836389	CHEMBL4718886	Inhibition of recombinant human His-tagged full length PRKCQ expressed in baculovirus expression system at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	12.0	CHEMBL3920	Homo sapiens	INH	%	12.0
	22843600	CHEMBL4720586	Inhibition of human PKCtheta using Histone H1 as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.58	CHEMBL3920	Homo sapiens	IC50	10^-9M	2.58
	22843945	CHEMBL4720931	Inhibition of human PKCtheta assessed as residual activity using Histone H1 as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	119.08	CHEMBL3920	Homo sapiens	Activity	%	119.08
	22844836	CHEMBL4721511	Inhibition of PKCtheta (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	83.74	CHEMBL3920	Homo sapiens	Activity	%	83.74
	22926818	CHEMBL4737725	Inhibition of human full length PKCtheta at 1 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2		CHEMBL4777349	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22926819	CHEMBL4737725	Inhibition of human full length PKCtheta at 1 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2		CHEMBL4791586	>	Inhibition	%	50.0	CHEMBL3920	Homo sapiens	INH	%	50.0
	22926826	CHEMBL4737728	Inhibition of human full length PKCtheta using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		CHEMBL3408213	=	Ki	nM	61.0	CHEMBL3920	Homo sapiens	Ki	uM	0.061
	22926827	CHEMBL4737728	Inhibition of human full length PKCtheta using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2		CHEMBL4777349	=	Ki	nM	109.0	CHEMBL3920	Homo sapiens	Ki	uM	0.109
	22926828	CHEMBL4737728	Inhibition of human full length PKCtheta using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2		CHEMBL4791586	=	Ki	nM	134.0	CHEMBL3920	Homo sapiens	Ki	uM	0.134
	22952966	CHEMBL4766903	Inhibition of recombinant full length human PKCtheta assessed as residual activity at 10 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	99.0	CHEMBL3920	Homo sapiens	Activity	%	99.0
	22955558	CHEMBL4767615	Inhibition of His-tagged full length human PKC theta expressed in baculovirus expression system at 1 uM by Selectscreen kinase assay	B	COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12		CHEMBL4785582	=	Inhibition	%	48.0	CHEMBL3920	Homo sapiens	INH	%	48.0
	23122773	CHEMBL4805124	Inhibition of human PRKCQ assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL3920	Homo sapiens	Activity	%	100.0
	23123468	CHEMBL4805712	Inhibition of human PRKCQ assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	86.0	CHEMBL3920	Homo sapiens	Activity	%	86.0
	23123923	CHEMBL4806167	Inhibition of DNA-tagged human PRKCQ assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	99.0	CHEMBL3920	Homo sapiens	Activity	%	99.0
	23125026	CHEMBL4806729	Inhibition of human PRKCQ assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	90.0	CHEMBL3920	Homo sapiens	Activity	%	90.0
	23125027	CHEMBL4806729	Inhibition of human PRKCQ assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	87.0	CHEMBL3920	Homo sapiens	Activity	%	87.0
	23128482	CHEMBL4807969	Inhibition of PKCtheta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL3920	Homo sapiens	Activity	%	50.0
	23128483	CHEMBL4807969	Inhibition of PKCtheta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3920	Homo sapiens	Activity	%	75.0
	23128484	CHEMBL4807969	Inhibition of PKCtheta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3920	Homo sapiens	Activity	%	75.0
	23234964	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3982723	=	IC50	nM	0.4	CHEMBL3920	Homo sapiens	IC50	nM	0.4
	23234965	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)CC(Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC(C)(C)N1		CHEMBL4854326	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
	23234966	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1C[C@@H](O)C1		CHEMBL4861260	=	IC50	nM	500.0	CHEMBL3920	Homo sapiens	IC50	nM	500.0
	23234967	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1C[C@H](O)C1		CHEMBL4865377	=	IC50	nM	900.0	CHEMBL3920	Homo sapiens	IC50	nM	900.0
	23234968	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NC[C@H]1C[C@@H](O)C1		CHEMBL4878438	=	IC50	nM	300.0	CHEMBL3920	Homo sapiens	IC50	nM	300.0
	23234969	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NC[C@H]1C[C@H](O)C1		CHEMBL4858809	=	IC50	nM	700.0	CHEMBL3920	Homo sapiens	IC50	nM	700.0
	23234970	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1CC[C@@H](O)CC1		CHEMBL4872717	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	23234971	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)cc1N[C@H]1CC[C@@H](O)CC1		CHEMBL4861789	=	IC50	nM	140.0	CHEMBL3920	Homo sapiens	IC50	nM	140.0
	23234972	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1CC[C@H](O)CC1		CHEMBL4870017	=	IC50	nM	350.0	CHEMBL3920	Homo sapiens	IC50	nM	350.0
	23234973	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)cc1N[C@H]1CC[C@H](O)CC1		CHEMBL4872846	=	IC50	nM	4000.0	CHEMBL3920	Homo sapiens	IC50	nM	4000.0
	23234974	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CO[C@H]1CC[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC1		CHEMBL4873755	=	IC50	nM	58.0	CHEMBL3920	Homo sapiens	IC50	nM	58.0
	23234975	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CO[C@H]1CC[C@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC1		CHEMBL4864450	=	IC50	nM	1100.0	CHEMBL3920	Homo sapiens	IC50	nM	1100.0
	23234976	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NC[C@H]1CC[C@@H](O)CC1		CHEMBL4875258	=	IC50	nM	58.0	CHEMBL3920	Homo sapiens	IC50	nM	58.0
	23234977	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NC[C@H]1CC[C@H](O)CC1		CHEMBL4851812	=	IC50	nM	50.0	CHEMBL3920	Homo sapiens	IC50	nM	50.0
	23234978	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CO[C@H]1CC[C@@H](CNc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC1		CHEMBL4864053	=	IC50	nM	70.0	CHEMBL3920	Homo sapiens	IC50	nM	70.0
	23234979	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CO[C@H]1CC[C@H](CNc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC1		CHEMBL4850753	=	IC50	nM	330.0	CHEMBL3920	Homo sapiens	IC50	nM	330.0
	23234980	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NC1CCOCC1		CHEMBL4861249	=	IC50	nM	900.0	CHEMBL3920	Homo sapiens	IC50	nM	900.0
	23234981	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NCC1CCOCC1		CHEMBL4853079	=	IC50	nM	400.0	CHEMBL3920	Homo sapiens	IC50	nM	400.0
	23234982	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1NCCC1CCOCC1		CHEMBL4850342	=	IC50	nM	1200.0	CHEMBL3920	Homo sapiens	IC50	nM	1200.0
	23234983	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)cc1N[C@H]1C[C@@H](C(N)=O)C1		CHEMBL4878146	=	IC50	nM	150.0	CHEMBL3920	Homo sapiens	IC50	nM	150.0
	23234984	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)cc1N[C@H]1C[C@H](C(N)=O)C1		CHEMBL4857437	=	IC50	nM	5000.0	CHEMBL3920	Homo sapiens	IC50	nM	5000.0
	23234985	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2ccccc2C(F)(F)F)cc1N[C@H]1CC[C@@H](C(N)=O)CC1		CHEMBL4858914	=	IC50	nM	20.0	CHEMBL3920	Homo sapiens	IC50	nM	20.0
	23234986	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1CC[C@@H](C(N)=O)CC1		CHEMBL4870774	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	nM	7.0
	23234987	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CNC(=O)[C@H]1CC[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC1		CHEMBL4876360	=	IC50	nM	27.0	CHEMBL3920	Homo sapiens	IC50	nM	27.0
	23234988	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CN(C)C(=O)[C@H]1CC[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC1		CHEMBL4870192	=	IC50	nM	38.0	CHEMBL3920	Homo sapiens	IC50	nM	38.0
	23234989	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1CC[C@@H](c2nc[nH]n2)CC1		CHEMBL4851347	=	IC50	nM	34.0	CHEMBL3920	Homo sapiens	IC50	nM	34.0
	23234990	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cnccc2C(F)(F)F)cc1N[C@H]1CC[C@@H](n2cncn2)CC1		CHEMBL4874653	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	23234991	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2ccccc2)cc1N[C@H]1CC[C@@H](O)CC1		CHEMBL4850639	=	IC50	nM	7000.0	CHEMBL3920	Homo sapiens	IC50	nM	7000.0
	23234992	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cncnc2C(F)(F)F)cc1N[C@H]1CC[C@@H](O)CC1		CHEMBL4851228	=	IC50	nM	450.0	CHEMBL3920	Homo sapiens	IC50	nM	450.0
	23234993	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC(C)(F)c1ncncc1CNc1cc(N[C@H]2CC[C@@H](O)CC2)c(C#N)cn1		CHEMBL4858601	=	IC50	nM	32.0	CHEMBL3920	Homo sapiens	IC50	nM	32.0
	23234994	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cncnc2-c2ccccc2)cc1N[C@H]1CC[C@@H](O)CC1		CHEMBL4856178	=	IC50	nM	90.0	CHEMBL3920	Homo sapiens	IC50	nM	90.0
	23234995	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	COc1ncncc1CNc1cc(N[C@H]2CC[C@@H](O)CC2)c(C#N)cn1		CHEMBL4873015	=	IC50	nM	800.0	CHEMBL3920	Homo sapiens	IC50	nM	800.0
	23234996	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC(C)(C)Oc1ncncc1CNc1cc(N[C@H]2CC[C@@H](O)CC2)c(C#N)cn1		CHEMBL4878871	=	IC50	nM	200.0	CHEMBL3920	Homo sapiens	IC50	nM	200.0
	23234997	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	N#Cc1cnc(NCc2cncnc2OCC(F)F)cc1N[C@H]1CC[C@@H](O)CC1		CHEMBL4865721	=	IC50	nM	90.0	CHEMBL3920	Homo sapiens	IC50	nM	90.0
	23234998	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC(C)(C)[C@@H]1O		CHEMBL4867906	=	IC50	nM	12.0	CHEMBL3920	Homo sapiens	IC50	nM	12.0
	23234999	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC(C)(C)[C@H]1O		CHEMBL4856779	=	IC50	nM	20.0	CHEMBL3920	Homo sapiens	IC50	nM	20.0
	23235000	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC[C@@H]1O		CHEMBL4861883	=	IC50	nM	7.0	CHEMBL3920	Homo sapiens	IC50	nM	7.0
	23235001	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC[C@H]1O		CHEMBL4853493	=	IC50	nM	100.0	CHEMBL3920	Homo sapiens	IC50	nM	100.0
	23235002	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC[C@H]1O		CHEMBL4849429	=	IC50	nM	120.0	CHEMBL3920	Homo sapiens	IC50	nM	120.0
	23235003	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC[C@@H]1O		CHEMBL4855568	=	IC50	nM	120.0	CHEMBL3920	Homo sapiens	IC50	nM	120.0
	23235004	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)C[C@H](Nc2nc(NCc3cnccc3C(F)(F)F)ncc2C#N)CC[C@@H]1O		CHEMBL4851695	=	IC50	nM	6.0	CHEMBL3920	Homo sapiens	IC50	nM	6.0
	23235005	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](O)C[C@H]1Nc1nc(NCc2cnccc2C(F)(F)F)ncc1C#N		CHEMBL4859091	=	IC50	nM	4.0	CHEMBL3920	Homo sapiens	IC50	nM	4.0
	23235006	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@H](O)C[C@H]1Nc1nc(NCc2cnccc2C(F)(F)F)ncc1C#N		CHEMBL4858037	=	IC50	nM	130.0	CHEMBL3920	Homo sapiens	IC50	nM	130.0
	23235007	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](Nc2nc(NCc3cnccc3C(F)(F)F)ncc2C#N)C[C@H]1O		CHEMBL4875806	=	IC50	nM	300.0	CHEMBL3920	Homo sapiens	IC50	nM	300.0
	23235008	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](O)C[C@@H]1Nc1nc(NCc2cnccc2C(F)(F)F)ncc1C#N		CHEMBL4873812	=	IC50	nM	170.0	CHEMBL3920	Homo sapiens	IC50	nM	170.0
	23235009	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](C(N)=O)C[C@H]1Nc1cc(NCc2cnccc2C(F)(F)F)ncc1C#N		CHEMBL4853353	=	IC50	nM	1.4	CHEMBL3920	Homo sapiens	IC50	nM	1.4
	23235010	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)C[C@H]1C(N)=O		CHEMBL4850874	=	IC50	nM	140.0	CHEMBL3920	Homo sapiens	IC50	nM	140.0
	23235011	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)C[C@H]1C(N)=O		CHEMBL4849864	=	IC50	nM	140.0	CHEMBL3920	Homo sapiens	IC50	nM	140.0
	23235012	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](Nc2cc(NCc3cnccc3C(F)(F)F)ncc2C#N)C[C@@H]1C(N)=O		CHEMBL4850891	=	IC50	nM	1100.0	CHEMBL3920	Homo sapiens	IC50	nM	1100.0
	23235013	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC(C)(F)c1ncncc1CNc1ncc(C#N)c(N[C@@H]2C[C@H](O)C2(C)C)n1		CHEMBL4854104	=	IC50	nM	2.2	CHEMBL3920	Homo sapiens	IC50	nM	2.2
	23235014	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC1(C)[C@@H](O)C[C@H]1Nc1nc(NCc2cncnc2OCC(F)F)ncc1C#N		CHEMBL4849510	=	IC50	nM	1.3	CHEMBL3920	Homo sapiens	IC50	nM	1.3
	23235015	CHEMBL4827844	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide incubated for 2 hrs by TR-FRET assay	B	CC(F)(F)COc1ncncc1CNc1ncc(C#N)c(N[C@@H]2CC[C@H](O)C(C)(C)C2)n1		CHEMBL4873647	=	IC50	nM	8.0	CHEMBL3920	Homo sapiens	IC50	nM	8.0
	23235135	CHEMBL4827851	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide at 3 uM incubated for 2 hrs by TR-FRET assay relative to control	B	CC(C)(F)c1ncncc1CNc1ncc(C#N)c(N[C@@H]2C[C@H](O)C2(C)C)n1		CHEMBL4854104	=	Inhibition	%	96.0	CHEMBL3920	Homo sapiens	INH	%	96.0
	23235136	CHEMBL4827851	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide at 3 uM incubated for 2 hrs by TR-FRET assay relative to control	B	CC1(C)[C@@H](O)C[C@H]1Nc1nc(NCc2cncnc2OCC(F)F)ncc1C#N		CHEMBL4849510	=	Inhibition	%	100.0	CHEMBL3920	Homo sapiens	INH	%	100.0
	23235137	CHEMBL4827851	Inhibition of PKA-theta (unknown origin) using Fam-labelled S6-derived peptide at 3 uM incubated for 2 hrs by TR-FRET assay relative to control	B	CC(F)(F)COc1ncncc1CNc1ncc(C#N)c(N[C@@H]2CC[C@H](O)C(C)(C)C2)n1		CHEMBL4873647	=	Inhibition	%	93.0	CHEMBL3920	Homo sapiens	INH	%	93.0
	23235150	CHEMBL4827864	Inhibition of PKC-theta in PBMC isolated from human leukocyte reduction system white blood cells isolated assessed as reduction in anti-CD3/CD28-stimulated IL-2 expression measured for 20 hrs	B	CC(F)(F)COc1ncncc1CNc1ncc(C#N)c(N[C@@H]2CC[C@H](O)C(C)(C)C2)n1		CHEMBL4873647	=	IC50	nM	150.0	CHEMBL3920	Homo sapiens	IC50	uM	0.15
	23235151	CHEMBL4827865	Inhibition of PKC-theta in PBMC isolated from human leukocyte whole blood assessed as reduction in anti-CD3/CD28-stimulated IL-2 expression measured for 20 hrs	B	CC(F)(F)COc1ncncc1CNc1ncc(C#N)c(N[C@@H]2CC[C@H](O)C(C)(C)C2)n1		CHEMBL4873647	=	IC50	nM	330.0	CHEMBL3920	Homo sapiens	IC50	uM	0.33
	23235152	CHEMBL4827866	Inhibition of PKC-theta in human whole blood assessed as reduction in anti-CD3/CD28-stimulated IL-2 expression measured for 20 hrs	B	CC(F)(F)COc1ncncc1CNc1ncc(C#N)c(N[C@@H]2CC[C@H](O)C(C)(C)C2)n1		CHEMBL4873647	=	IC50	nM	1030.0	CHEMBL3920	Homo sapiens	IC50	uM	1.03
	23235153	CHEMBL4827867	Inhibition of PKC-theta in human mixed lymphocyte reaction assessed as reduction in anti-CD3/CD28-stimulated IL-2 expression measured for 20 hrs	B	CC(F)(F)COc1ncncc1CNc1ncc(C#N)c(N[C@@H]2CC[C@H](O)C(C)(C)C2)n1		CHEMBL4873647	=	IC50	nM	290.0	CHEMBL3920	Homo sapiens	IC50	uM	0.29
	23240844	CHEMBL4829169	Inhibition of PKCtheta (unknown origin)	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	IC50	nM	1330.0	CHEMBL3920	Homo sapiens	IC50	uM	1.33
	23246346	CHEMBL4830038	Inhibition of PKCtheta (unknown origin)	B	Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1		CHEMBL4556790	=	IC50	nM	629.0	CHEMBL3920	Homo sapiens	IC50	nM	629.0
Not Active	23317609	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	80.0	CHEMBL3920	Homo sapiens	% Control	%	80.0
Not Active	23318077	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	88.0	CHEMBL3920	Homo sapiens	% Control	%	88.0
Not Active	23318743	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	79.0	CHEMBL3920	Homo sapiens	% Control	%	79.0
Not Active	23319227	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23319864	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23320339	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	78.6	CHEMBL3920	Homo sapiens	% Control	%	78.6
Not Active	23321017	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	98.0	CHEMBL3920	Homo sapiens	% Control	%	98.0
Not Active	23321485	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23322115	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	81.0	CHEMBL3920	Homo sapiens	% Control	%	81.0
Not Active	23322583	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23323272	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	98.0	CHEMBL3920	Homo sapiens	% Control	%	98.0
Not Active	23323740	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23324108	CHEMBL4880727	PKCtheta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	15.0	CHEMBL3920	Homo sapiens	% inhibition	%	15.0
Not Active	23324594	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23325229	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	80.0	CHEMBL3920	Homo sapiens	% Control	%	80.0
Not Active	23325697	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	85.0	CHEMBL3920	Homo sapiens	% Control	%	85.0
Not Active	23326344	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	74.0	CHEMBL3920	Homo sapiens	% Control	%	74.0
Not Active	23326812	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	88.0	CHEMBL3920	Homo sapiens	% Control	%	88.0
Not Active	23327512	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23327980	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	95.0	CHEMBL3920	Homo sapiens	% Control	%	95.0
Not Active	23328567	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	80.0	CHEMBL3920	Homo sapiens	% Control	%	80.0
Not Active	23329035	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	91.0	CHEMBL3920	Homo sapiens	% Control	%	91.0
Not Active	23329489	CHEMBL4881196	PKCtheta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	115.0	CHEMBL3920	Homo sapiens	% residual kinase activity	%	115.0
Not Active	23329981	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	91.0	CHEMBL3920	Homo sapiens	% Control	%	91.0
Not Active	23330449	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL3920	Homo sapiens	% Control	%	93.0
Not Active	23331205	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	86.0	CHEMBL3920	Homo sapiens	% Control	%	86.0
Not Active	23331673	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	87.0	CHEMBL3920	Homo sapiens	% Control	%	87.0
Not Active	23332260	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23332726	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	60.3	CHEMBL3920	Homo sapiens	% Control	%	60.3
Not Active	23333444	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	83.3	CHEMBL3920	Homo sapiens	% Control	%	83.3
Not Active	23334083	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23334551	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23334945	CHEMBL4881567	PKCtheta  (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	42.0	CHEMBL3920	Homo sapiens	% inhibition	%	42.0
Not Active	23335530	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	66.0	CHEMBL3920	Homo sapiens	% Control	%	66.0
Not Active	23335998	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL3920	Homo sapiens	% Control	%	99.0
Not Active	23336625	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23337093	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	91.0	CHEMBL3920	Homo sapiens	% Control	%	91.0
Not Active	23337743	CHEMBL4882114	PRKCQ Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	93.5	CHEMBL3920	Homo sapiens	% Ctrl	%	93.5
Not Active	23338174	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	92.0	CHEMBL3920	Homo sapiens	% Control	%	92.0
Not Active	23338642	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	89.0	CHEMBL3920	Homo sapiens	% Control	%	89.0
Not Active	23339254	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	87.0	CHEMBL3920	Homo sapiens	% Control	%	87.0
Not Active	23339722	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	97.0	CHEMBL3920	Homo sapiens	% Control	%	97.0
Not Active	23340359	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	99.0	CHEMBL3920	Homo sapiens	% Control	%	99.0
Not Active	23340827	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23341484	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	91.0	CHEMBL3920	Homo sapiens	% Control	%	91.0
Not Active	23341952	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	93.0	CHEMBL3920	Homo sapiens	% Control	%	93.0
Not Active	23342568	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	84.0	CHEMBL3920	Homo sapiens	% Control	%	84.0
Not Active	23343036	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	76.0	CHEMBL3920	Homo sapiens	% Control	%	76.0
Not Active	23343666	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL3920	Homo sapiens	% Control	%	97.0
Not Active	23344134	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	99.0	CHEMBL3920	Homo sapiens	% Control	%	99.0
Not Active	23344772	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	73.0	CHEMBL3920	Homo sapiens	% Control	%	73.0
Not Active	23345345	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23345813	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Slightly Active	23346390	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	39.9	CHEMBL3920	Homo sapiens	% Control	%	39.9
Not Active	23346858	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23347460	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23347950	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23348529	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23348997	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23349584	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23350202	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	89.0	CHEMBL3920	Homo sapiens	% Control	%	89.0
Not Active	23350670	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	94.0	CHEMBL3920	Homo sapiens	% Control	%	94.0
Not Active	23351275	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	83.0	CHEMBL3920	Homo sapiens	% Control	%	83.0
Not Active	23351743	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	78.0	CHEMBL3920	Homo sapiens	% Control	%	78.0
Not Active	23352196	CHEMBL4882885	PRKCQ (PKC theta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.465	CHEMBL3920	Homo sapiens	% Inhibition	%	2.4646
Not Active	23352767	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	74.0	CHEMBL3920	Homo sapiens	% Control	%	74.0
Not Active	23353235	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	91.0	CHEMBL3920	Homo sapiens	% Control	%	91.0
Not Active	23354117	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23354585	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23355317	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23355785	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23356421	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23356889	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23357498	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23358145	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	67.0	CHEMBL3920	Homo sapiens	% Control	%	67.0
Not Active	23358613	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23359199	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23359797	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	97.0	CHEMBL3920	Homo sapiens	% Control	%	97.0
Not Active	23360265	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	86.0	CHEMBL3920	Homo sapiens	% Control	%	86.0
Not Active	23360850	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23361318	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	89.0	CHEMBL3920	Homo sapiens	% Control	%	89.0
Not Active	23361891	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23362427	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23362895	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	94.0	CHEMBL3920	Homo sapiens	% Control	%	94.0
Not Active	23363304	CHEMBL4883268	PRKCQ (PKC theta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	4.243	CHEMBL3920	Homo sapiens	% inhibition	%	4.243
Not Active	23363305	CHEMBL4883268	PRKCQ (PKC theta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	5.461	CHEMBL3920	Homo sapiens	% inhibition	%	5.4611
Not Active	23364537	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	89.0	CHEMBL3920	Homo sapiens	% Control	%	89.0
Not Active	23365005	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23365744	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL3920	Homo sapiens	% Control	%	92.0
Not Active	23366287	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23366877	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23367345	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23367712	CHEMBL4884065	PKC-theta ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	99.0	CHEMBL3920	Homo sapiens	% Residual activity with Skepinone-L	%	99.0
Not Active	23368223	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	94.0	CHEMBL3920	Homo sapiens	% Control	%	94.0
Not Active	23368691	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL3920	Homo sapiens	% Control	%	95.0
Not Active	23369290	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23369758	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23370205	CHEMBL4884447	PKCtheta (h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	33.0	CHEMBL3920	Homo sapiens	% residual kinase activity	%	33.0
Active	23370726	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	15.0	CHEMBL3920	Homo sapiens	% Control	%	15.0
Not Active	23371194	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	55.0	CHEMBL3920	Homo sapiens	% Control	%	55.0
Not Active	23372003	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	97.0	CHEMBL3920	Homo sapiens	% Control	%	97.0
Not Active	23372471	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	90.0	CHEMBL3920	Homo sapiens	% Control	%	90.0
	23372865	CHEMBL4884830	PKCtheta(PRKQLGM5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3920	Homo sapiens	pIC50		6.0
	23373274	CHEMBL4885121	PKCtheta(PRKQLGM5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3920	Homo sapiens	pIC50		6.0
	23373630	CHEMBL4885407	PKCtheta(PRKQLGM5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3920	Homo sapiens	pIC50		6.0
Not Active	23375074	CHEMBL4886062	PKC_theta Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	1.0	CHEMBL3920	Homo sapiens	% Inhibition	%	1.0
Not Active	23375350	CHEMBL4886332	protein kinase C, theta  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	2.0	CHEMBL3920	Homo sapiens	% inhibition	%	2.0
Not Active	23375898	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	92.0	CHEMBL3920	Homo sapiens	% Control	%	92.0
Not Active	23376366	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	90.0	CHEMBL3920	Homo sapiens	% Control	%	90.0
Not Active	23376943	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	90.0	CHEMBL3920	Homo sapiens	% Control	%	90.0
Not Active	23377411	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	76.0	CHEMBL3920	Homo sapiens	% Control	%	76.0
Not Active	23378271	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	71.0	CHEMBL3920	Homo sapiens	% Control	%	71.0
Not Active	23378739	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	89.0	CHEMBL3920	Homo sapiens	% Control	%	89.0
Not Active	23379906	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	96.0	CHEMBL3920	Homo sapiens	% Control	%	96.0
Not Active	23380374	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23381068	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23381716	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3920	Homo sapiens	% Control	%	100.0
Not Active	23382184	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	98.0	CHEMBL3920	Homo sapiens	% Control	%	98.0
Not Active	23382808	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	89.0	CHEMBL3920	Homo sapiens	% Control	%	89.0
Not Active	23383276	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	55.0	CHEMBL3920	Homo sapiens	% Control	%	55.0
Not Active	23383956	CHEMBL4887563	PRKCQ Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	101.0	CHEMBL3920	Homo sapiens	% Ctrl	%	101.0
Not Active	23384426	CHEMBL4888021	PKCtheta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-10.11	CHEMBL3920	Homo sapiens	% inhibition	%	-10.11
Not Active	23384697	CHEMBL4888223	PRKCQ (PKC theta) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	35.0	CHEMBL3920	Homo sapiens	% Inhibition	%	35.0
Not Active	23385191	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	93.0	CHEMBL3920	Homo sapiens	% Control	%	93.0
Not Active	23385658	CHEMBL4879915	KinomeScan assay: inhibition of PRKCQ	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	98.0	CHEMBL3920	Homo sapiens	% Control	%	98.0
